data_1tvj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tvj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 10.2 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.45 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 48' ' ' ILE . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 38' ' ' PHE . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.422 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.451 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 128' ' ' PHE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 124' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.494 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.449 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.494 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.425 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.9 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 ' CG2' ' CB ' ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' THR . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 48' ' ' ILE . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 38' ' ' PHE . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HG3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.418 HD21 ' HG3' ' A' ' 53' ' ' LYS . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 102' ' ' ILE . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.428 HG12 ' CE2' ' A' ' 128' ' ' PHE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.428 ' CE2' HG12 ' A' ' 124' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.421 ' CD2' HD22 ' A' ' 153' ' ' LEU . 72.1 m-70 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.495 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 144' ' ' LYS . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.495 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.417 HG23 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 6' ' ' THR . 13.0 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 128' ' ' PHE . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' O ' ' CE1' ' A' ' 89' ' ' TYR . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE1' ' O ' ' A' ' 87' ' ' ALA . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.457 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.44 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.4 ' CG ' HG13 ' A' ' 7' ' ' VAL . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.429 ' HA ' ' CE1' ' A' ' 15' ' ' PHE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.489 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.437 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.411 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 39.7 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' A' ' 127' ' ' LYS . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 120' ' ' SER . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 38' ' ' PHE . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HD3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HD3' ' CG2' ' A' ' 60' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.405 ' CD2' HG21 ' A' ' 158' ' ' VAL . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.443 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 124' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.407 ' CG ' HG13 ' A' ' 7' ' ' VAL . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 124' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.511 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.511 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 89' ' ' TYR . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 11.4 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.421 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 38' ' ' PHE . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.448 HG23 HD13 ' A' ' 102' ' ' ILE . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 124' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.499 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.458 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.499 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 13.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 HG12 ' CG ' ' A' ' 127' ' ' LYS . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 84' ' ' LEU . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 48' ' ' ILE . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.453 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 128' ' ' PHE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' CG ' HG12 ' A' ' 7' ' ' VAL . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 124' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.498 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 144' ' ' LYS . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 11.2 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 29' ' ' ILE . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 25' ' ' THR . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.42 HG22 ' CE2' ' A' ' 38' ' ' PHE . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.438 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.409 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 124' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.489 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.443 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 35.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HA ' HD11 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' THR . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 38' ' ' PHE . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.467 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.467 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.411 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CA ' ' HB ' ' A' ' 5' ' ' VAL . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 124' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.492 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 144' ' ' LYS . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.492 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.409 HG21 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.404 HG23 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 6' ' ' THR . 16.1 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HA ' HD12 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.409 HD22 ' HG3' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.485 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.452 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.421 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.424 ' OG ' HG12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 124' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 84' ' ' LEU . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.408 ' CD2' HD11 ' A' ' 153' ' ' LEU . 48.0 m-70 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.485 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.432 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.442 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.485 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.422 HD11 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' CG ' ' A' ' 127' ' ' LYS . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 29' ' ' ILE . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 25' ' ' THR . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 38' ' ' PHE . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.401 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.501 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.447 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.501 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 140' ' ' LEU . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 6' ' ' THR . 14.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.6 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.462 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.441 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 128' ' ' PHE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 124' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.496 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' THR . 12.4 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 38' ' ' PHE . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.406 ' O ' HD12 ' A' ' 29' ' ' ILE . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 25' ' ' THR . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 48' ' ' ILE . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG21 ' CE1' ' A' ' 38' ' ' PHE . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.44 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 102' ' ' ILE . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.452 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 124' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.483 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 144' ' ' LYS . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.483 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 89' ' ' TYR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 6' ' ' THR . 11.6 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 25' ' ' THR . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 48' ' ' ILE . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.448 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.427 HD11 ' CE3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 124' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 124' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.499 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.421 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.499 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE1' HG23 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' ASN . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.425 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.49 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.49 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' THR . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 38' ' ' PHE . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 102' ' ' ILE . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 153' ' ' LEU . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.476 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.452 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.476 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.431 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 6' ' ' THR . 13.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.411 ' O ' HD13 ' A' ' 29' ' ' ILE . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 25' ' ' THR . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HG3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.488 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.409 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 HD21 ' HG3' ' A' ' 53' ' ' LYS . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.508 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 124' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.471 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' LYS . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' THR . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 38' ' ' PHE . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 102' ' ' ILE . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 153' ' ' LEU . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.476 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.452 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.476 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.431 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE1' HG23 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' ASN . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.425 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.49 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.49 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 43.8 t . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.41 ' O ' HD11 ' A' ' 29' ' ' ILE . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 25' ' ' THR . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.424 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CH2' ' CD2' ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.427 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' CA ' ' HB ' ' A' ' 5' ' ' VAL . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' A' ' 128' ' ' PHE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 124' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.488 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' CG2' ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.41 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.495 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 144' ' ' LYS . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.495 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 140' ' ' LEU . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.432 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.34 150.18 35.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.89 158.54 39.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.057 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.93 151.26 11.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.313 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 10.2 t -117.87 151.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.45 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' THR . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 48' ' ' ILE . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 38' ' ' PHE . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.422 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.451 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG12 ' CE2' ' A' ' 128' ' ' PHE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 124' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.494 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.449 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.494 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.425 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.405 ' CB ' ' CD1' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -130.24 132.68 46.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.42 27.86 17.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.83 -0.08 84.15 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.382 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -112.69 127.15 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 117.025 0.412 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.37 141.11 94.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.154 1.903 . . . . 0.0 112.498 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.405 ' CD1' ' CB ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.161 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.859 0.362 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.64 156.3 19.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -93.95 149.72 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.83 -178.96 34.29 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.571 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.9 t -114.68 152.6 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' CG2' ' CB ' ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' THR . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 48' ' ' ILE . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 38' ' ' PHE . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HG3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.418 HD21 ' HG3' ' A' ' 53' ' ' LYS . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 102' ' ' ILE . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.428 HG12 ' CE2' ' A' ' 128' ' ' PHE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.428 ' CE2' HG12 ' A' ' 124' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.421 ' CD2' HD22 ' A' ' 153' ' ' LEU . 72.1 m-70 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.495 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 144' ' ' LYS . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.495 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.417 HG23 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.85 131.12 42.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 46.78 29.49 1.0 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.288 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.36 -4.38 66.96 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.99 130.29 23.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 117.018 0.409 . . . . 0.0 110.481 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.92 141.74 21.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.166 1.91 . . . . 0.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.766 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.804 0.335 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 123.68 44.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -167.66 -47.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.67 -177.5 27.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.572 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 6' ' ' THR . 13.0 t -112.36 152.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 128' ' ' PHE . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.491 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' O ' ' CE1' ' A' ' 89' ' ' TYR . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE1' ' O ' ' A' ' 87' ' ' ALA . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.457 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.44 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' CG ' HG13 ' A' ' 7' ' ' VAL . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.429 ' HA ' ' CE1' ' A' ' 15' ' ' PHE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.489 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.437 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.411 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.428 HD11 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 135.41 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.92 26.91 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.78 -1.95 85.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.439 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 138.77 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.942 0.371 . . . . 0.0 110.493 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.44 143.01 28.62 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.093 1.862 . . . . 0.0 112.631 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.23 147.2 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.076 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.44 157.18 11.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.73 179.46 28.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 39.7 t -97.4 158.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' A' ' 127' ' ' LYS . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 120' ' ' SER . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 38' ' ' PHE . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CG2' ' HD3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HD3' ' CG2' ' A' ' 60' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.449 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.405 ' CD2' HG21 ' A' ' 158' ' ' VAL . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.443 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.406 ' HB2' ' CG1' ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 124' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' CG ' HG13 ' A' ' 7' ' ' VAL . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.444 ' CE2' HG12 ' A' ' 124' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.511 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.511 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 89' ' ' TYR . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.43 137.3 43.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.14 24.92 11.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.413 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.19 82.13 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.423 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -118.66 141.9 30.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.918 0.359 . . . . 0.0 110.375 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.51 142.79 22.71 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.456 2.104 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.907 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.11 140.22 31.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.18 -41.45 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.36 120.63 1.67 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.511 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 11.4 t -124.01 152.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.421 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' A' ' 38' ' ' PHE . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.448 HG23 HD13 ' A' ' 102' ' ' ILE . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' A' ' 128' ' ' PHE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 124' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.499 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.404 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.458 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.499 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 tp -134.36 128.86 34.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.77 25.9 15.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.93 75.26 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.695 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.69 135.09 21.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 117.102 0.451 . . . . 0.0 110.733 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 138.2 55.8 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.198 1.932 . . . . 0.0 112.869 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.159 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.01 137.71 57.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -148.79 -65.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.02 -164.15 40.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 13.4 t -100.58 152.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 HG12 ' CG ' ' A' ' 127' ' ' LYS . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 84' ' ' LEU . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 48' ' ' ILE . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HA ' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.454 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.453 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.459 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 128' ' ' PHE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' CG ' HG12 ' A' ' 7' ' ' VAL . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 124' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.498 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 144' ' ' LYS . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.498 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.21 125.9 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.92 30.39 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.026 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.75 -5.03 63.9 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.6 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.79 124.42 35.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 117.028 0.414 . . . . 0.0 110.526 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.37 140.72 42.57 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.024 1.816 . . . . 0.0 112.515 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 166.02 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p 59.01 107.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.09 110.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 11.2 t -123.52 152.87 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 29' ' ' ILE . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 25' ' ' THR . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.42 HG22 ' CE2' ' A' ' 38' ' ' PHE . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.438 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.409 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 124' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.489 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.443 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.49 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.12 137.97 41.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.65 26.26 15.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.987 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.16 -0.26 87.33 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.368 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.91 142.43 33.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.915 0.357 . . . . 0.0 110.477 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.29 143.4 15.01 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.26 1.973 . . . . 0.0 112.814 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.934 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.854 0.359 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 148.81 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -61.01 153.73 24.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.05 152.82 12.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.563 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 35.5 t -120.2 158.19 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HA ' HD11 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' THR . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 38' ' ' PHE . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.467 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.411 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CA ' ' HB ' ' A' ' 5' ' ' VAL . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 124' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.492 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 144' ' ' LYS . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.492 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.409 HG21 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.404 HG23 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.13 133.56 43.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.26 26.5 15.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.05 -2.01 85.2 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -117.33 138.82 25.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.027 0.413 . . . . 0.0 110.505 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.54 144.02 11.05 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.309 2.006 . . . . 0.0 112.954 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.826 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mtt . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.24 135.91 34.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -73.12 -48.33 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.13 162.52 34.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.603 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 6' ' ' THR . 16.1 t -109.7 154.73 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HA ' HD12 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.45 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.409 HD22 ' HG3' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.485 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.452 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.421 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.424 ' OG ' HG12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 124' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 84' ' ' LEU . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.408 ' CD2' HD11 ' A' ' 153' ' ' LEU . 48.0 m-70 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.485 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.432 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.442 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.485 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.422 HD11 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.88 137.15 41.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.11 26.98 15.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.307 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.74 0.21 86.15 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.534 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.2 142.28 34.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.974 0.387 . . . . 0.0 110.503 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.19 143.61 14.23 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.421 2.081 . . . . 0.0 112.801 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.926 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.76 0.314 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.95 169.92 17.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t -174.84 74.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.16 162.99 38.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.387 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.8 t -114.06 158.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' CG ' ' A' ' 127' ' ' LYS . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.421 ' O ' HD12 ' A' ' 29' ' ' ILE . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 25' ' ' THR . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' THR . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 38' ' ' PHE . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.401 ' HG2' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.501 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.447 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.501 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 140' ' ' LEU . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.58 127.46 33.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.27 26.61 16.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.71 -1.42 78.52 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.438 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -110.01 126.3 29.3 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 117.066 0.433 . . . . 0.0 110.814 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.97 137.6 80.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.129 1.886 . . . . 0.0 112.585 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.177 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.771 0.319 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.2 142.39 47.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 -66.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.829 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.53 -179.16 53.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 6' ' ' THR . 14.6 t -104.08 152.2 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.6 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.426 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.462 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.441 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 128' ' ' PHE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 124' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.496 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 131.48 39.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.41 27.19 16.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.27 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.68 -2.85 84.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 140.21 25.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.983 0.392 . . . . 0.0 110.338 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.74 141.29 35.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.435 2.09 . . . . 0.0 112.601 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.842 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.51 158.14 30.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -178.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.16 -166.41 34.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.558 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 6' ' ' THR . 12.4 t -107.34 151.64 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 38' ' ' PHE . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.406 ' O ' HD12 ' A' ' 29' ' ' ILE . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 25' ' ' THR . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 48' ' ' ILE . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG21 ' CE1' ' A' ' 38' ' ' PHE . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.44 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 102' ' ' ILE . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.452 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 124' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.483 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 144' ' ' LYS . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.483 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 89' ' ' TYR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.8 tp -133.26 124.69 27.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.33 37.82 28.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.027 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.12 86.31 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.876 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -111.8 134.92 21.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.22 139.28 63.48 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.156 1.904 . . . . 0.0 112.31 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.89 135.91 40.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.0 169.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.24 160.37 9.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.499 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 6' ' ' THR . 11.6 t -111.61 152.32 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.403 ' O ' HD12 ' A' ' 29' ' ' ILE . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 25' ' ' THR . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 48' ' ' ILE . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.448 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.427 HD11 ' CE3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 124' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 124' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.499 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.421 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.499 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.44 127.44 33.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 57.61 29.06 16.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.976 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.71 83.87 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.277 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -106.21 125.38 33.14 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.971 0.386 . . . . 0.0 110.638 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.99 136.8 71.88 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.116 1.877 . . . . 0.0 112.594 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.206 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE1' HG23 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' ASN . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.425 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.49 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.49 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' THR . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 38' ' ' PHE . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 102' ' ' ILE . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 153' ' ' LEU . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.476 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.452 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.476 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.431 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.411 ' CB ' ' CD1' ' A' ' 166' ' ' LEU . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.46 155.27 36.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t 59.39 79.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.64 166.41 34.24 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 6' ' ' THR . 13.6 t -109.88 152.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.411 ' O ' HD13 ' A' ' 29' ' ' ILE . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 25' ' ' THR . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HG3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.488 ' CE1' ' CD1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.409 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 HD21 ' HG3' ' A' ' 53' ' ' LYS . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.508 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CZ3' HD12 ' A' ' 75' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 124' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.471 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' LYS . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tp -130.73 119.32 22.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.3 39.47 12.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.014 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.4 -2.62 83.31 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.508 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.3 115.5 56.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.988 0.394 . . . . 0.0 110.412 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.49 141.9 24.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.187 1.925 . . . . 0.0 112.614 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 6' ' ' THR . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' THR . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 38' ' ' PHE . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 102' ' ' ILE . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 124' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 153' ' ' LEU . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.476 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.452 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.476 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.431 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.411 ' CB ' ' CD1' ' A' ' 166' ' ' LEU . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE1' HG23 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' ASN . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.425 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.49 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 144' ' ' LYS . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.49 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.45 142.2 41.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.09 175.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.54 178.11 25.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.878 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' HB ' ' CA ' ' A' ' 120' ' ' SER . 43.8 t -99.56 159.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.41 ' O ' HD11 ' A' ' 29' ' ' ILE . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 25' ' ' THR . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 84' ' ' LEU . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' CE1' ' A' ' 117' ' ' TYR . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 6' ' ' THR . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.401 ' N ' ' CD1' ' A' ' 71' ' ' PHE . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 73' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.424 HD12 ' CE3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CH2' ' CD2' ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 117' ' ' TYR . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.427 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' CA ' ' HB ' ' A' ' 5' ' ' VAL . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' A' ' 128' ' ' PHE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.435 ' CE2' HG12 ' A' ' 124' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.488 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' CD2' ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.407 ' CB ' ' CD1' ' A' ' 166' ' ' LEU . 1.3 tp -133.39 128.58 35.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.49 25.41 12.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.35 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.28 -0.62 68.81 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.443 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.18 129.55 23.91 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.964 0.382 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.44 137.35 64.4 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.128 1.885 . . . . 0.0 112.622 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.407 ' CD1' ' CB ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.21 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.77 129.07 40.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.31 -62.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.82 142.37 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.56 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 120' ' ' SER . 12.6 t -120.0 153.19 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 53' ' ' LYS . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' CG2' ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' CB ' ' CD2' ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 153' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 102' ' ' ILE . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 75' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.422 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 128' ' ' PHE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.41 ' O ' ' CD2' ' A' ' 15' ' ' PHE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 124' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.495 ' CH2' HG12 ' A' ' 143' ' ' ILE . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 144' ' ' LYS . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.495 HG12 ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 140' ' ' LEU . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.432 ' HB2' ' CH2' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' CB ' ' CD1' ' A' ' 166' ' ' LEU . 0.7 OUTLIER -136.03 131.96 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.92 26.9 12.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.73 -1.76 83.9 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.136 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -106.83 127.28 28.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.885 0.342 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.35 137.53 78.94 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.148 1.899 . . . . 0.0 112.641 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.4 ' CD1' ' CB ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.152 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 116' ' ' ILE . 10.2 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.761 HG21 HG23 ' A' ' 7' ' ' VAL . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.073 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.775 ' SD ' HD23 ' A' ' 84' ' ' LEU . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 20' ' ' VAL . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.805 ' HA ' HD11 ' A' ' 29' ' ' ILE . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 23' ' ' SER . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HB2' HG22 ' A' ' 57' ' ' VAL . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.073 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.032 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.689 ' CD2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 48' ' ' ILE . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.71 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 41' ' ' SER . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 14' ' ' VAL . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.686 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 68' ' ' TYR . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.032 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.647 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.821 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' CG ' HG23 ' A' ' 88' ' ' THR . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.824 HG21 HD21 ' A' ' 153' ' ' LEU . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.725 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.528 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.71 HD12 HG21 ' A' ' 47' ' ' ILE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.703 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.669 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.5 m170 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.949 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.725 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.803 ' CB ' HG12 ' A' ' 137' ' ' VAL . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.949 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.936 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.824 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.401 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.401 HG23 ' HA3' ' A' ' 154' ' ' GLY . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.936 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.9 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.853 HG23 HG21 ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.622 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.853 HG21 HG23 ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.018 HG11 HG21 ' A' ' 36' ' ' VAL . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.813 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.018 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.031 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.668 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.711 HD11 ' CG2' ' A' ' 116' ' ' ILE . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 40' ' ' LEU . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.873 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 14' ' ' VAL . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.732 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 HD12 ' OD1' ' A' ' 59' ' ' ASP . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.89 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.031 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.813 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.641 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.688 ' CB ' HD13 ' A' ' 153' ' ' LEU . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.927 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.848 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 158' ' ' VAL . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.927 ' HG2' HG23 ' A' ' 88' ' ' THR . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.711 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.529 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.873 HD12 HG21 ' A' ' 47' ' ' ILE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.686 ' HG3' HD11 ' A' ' 12' ' ' ILE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CB ' HG22 ' A' ' 100' ' ' VAL . 24.7 m80 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.802 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.704 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.792 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.528 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.802 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.4 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.879 HD11 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 91' ' ' THR . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.849 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.0 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.878 HG23 HG21 ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.652 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.897 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 7' ' ' VAL . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.085 HG11 HG21 ' A' ' 36' ' ' VAL . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.699 ' OD1' HG22 ' A' ' 12' ' ' ILE . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.825 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.532 ' CA ' HD11 ' A' ' 29' ' ' ILE . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 57' ' ' VAL . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.085 HG21 HG11 ' A' ' 14' ' ' VAL . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.093 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.785 HD11 HG23 ' A' ' 116' ' ' ILE . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.82 HG21 HD12 ' A' ' 124' ' ' ILE . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.903 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.662 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 59' ' ' ASP . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.901 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.903 HD22 ' HG3' ' A' ' 53' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.093 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.825 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.635 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.872 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.867 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 HG21 ' HE3' ' A' ' 96' ' ' LYS . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.872 ' HG2' HG23 ' A' ' 88' ' ' THR . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.788 HG21 HD21 ' A' ' 153' ' ' LEU . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 105' ' ' ALA . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.785 HG23 HD11 ' A' ' 40' ' ' LEU . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' A' ' 40' ' ' LEU . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 124' ' ' ILE . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.82 HD12 HG21 ' A' ' 47' ' ' ILE . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.737 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.716 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.768 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 142' ' ' ASP . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.92 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.788 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.506 HG23 ' HA3' ' A' ' 154' ' ' GLY . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.92 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 116' ' ' ILE . 39.7 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 49' ' ' VAL . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 20' ' ' VAL . 8.5 m120 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.672 ' HA ' HD11 ' A' ' 29' ' ' ILE . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' HG22 ' A' ' 57' ' ' VAL . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.988 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.548 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 124' ' ' ILE . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 14' ' ' VAL . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.918 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 64' ' ' VAL . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' O ' HD13 ' A' ' 55' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.94 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.918 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.988 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.895 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.895 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.818 HG21 HD21 ' A' ' 153' ' ' LEU . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.62 ' HA ' HD22 ' A' ' 84' ' ' LEU . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.75 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.512 ' HG3' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.621 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 124' ' ' ILE . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 47' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' ILE . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.693 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.746 ' CB ' HG22 ' A' ' 100' ' ' VAL . 37.9 m80 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.804 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.931 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.807 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.931 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.804 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.93 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.818 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.515 HG23 ' HA3' ' A' ' 154' ' ' GLY . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.93 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.4 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 11' ' ' VAL . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 12' ' ' ILE . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 7' ' ' VAL . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.04 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 20' ' ' VAL . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.804 ' SD ' HD23 ' A' ' 84' ' ' LEU . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.74 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 57' ' ' VAL . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.918 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.007 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CD2' HG22 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 5' ' ' VAL . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.81 HG21 HD12 ' A' ' 124' ' ' ILE . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 14' ' ' VAL . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.549 ' HA ' HD22 ' A' ' 74' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.667 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 59' ' ' ASP . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.62 HG21 ' HG3' ' A' ' 67' ' ' PRO . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' A' ' 60' ' ' ILE . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 53' ' ' LYS . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.007 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.804 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.823 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.851 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.823 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HD21 ' A' ' 153' ' ' LEU . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.427 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.729 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.692 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.507 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 47' ' ' ILE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 131' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.673 ' HB3' HG13 ' A' ' 100' ' ' VAL . 35.8 m170 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.792 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.806 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.792 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.746 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 89' ' ' TYR . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 92' ' ' LYS . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.892 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.758 HG23 HG21 ' A' ' 11' ' ' VAL . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' ILE . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.758 HG21 HG23 ' A' ' 7' ' ' VAL . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 49' ' ' VAL . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.426 ' SD ' HG12 ' A' ' 14' ' ' VAL . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HE2' HD11 ' A' ' 99' ' ' LEU . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 20' ' ' VAL . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.907 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HB2' HG22 ' A' ' 57' ' ' VAL . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.753 HD11 HG23 ' A' ' 116' ' ' ILE . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 116' ' ' ILE . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.514 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 124' ' ' ILE . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 14' ' ' VAL . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.81 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.712 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.862 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 34' ' ' LYS . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' HD12 ' A' ' 56' ' ' LEU . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.474 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HE3' HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.81 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.833 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 158' ' ' VAL . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 88' ' ' THR . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG21 HD21 ' A' ' 153' ' ' LEU . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HA ' HD22 ' A' ' 84' ' ' LEU . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.731 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.753 HG23 HD11 ' A' ' 40' ' ' LEU . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.715 HD12 HG21 ' A' ' 47' ' ' ILE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.691 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.752 ' CB ' HG22 ' A' ' 100' ' ' VAL . 37.2 m80 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 75' ' ' LEU . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.767 ' CB ' HG12 ' A' ' 137' ' ' VAL . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.916 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 91' ' ' THR . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.916 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.2 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.752 HG11 ' HG2' ' A' ' 127' ' ' LYS . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 7' ' ' VAL . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.077 HG11 HG21 ' A' ' 36' ' ' VAL . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.777 ' SD ' HD23 ' A' ' 84' ' ' LEU . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 29' ' ' ILE . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB2' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.077 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.087 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.71 ' CD2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 124' ' ' ILE . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 14' ' ' VAL . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.906 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.689 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.789 ' CE1' HG21 ' A' ' 72' ' ' VAL . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CE1' ' A' ' 68' ' ' TYR . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.777 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 161' ' ' LEU . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.817 ' HG2' HG23 ' A' ' 88' ' ' THR . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 133' ' ' HIS . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 124' ' ' ILE . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HG2' HG11 ' A' ' 7' ' ' VAL . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.737 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.706 ' HB3' HG13 ' A' ' 100' ' ' VAL . 36.7 m80 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.745 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.93 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.764 ' CB ' HG12 ' A' ' 137' ' ' VAL . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.93 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.496 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.957 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.464 HG23 ' HA3' ' A' ' 154' ' ' GLY . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.957 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 116' ' ' ILE . 35.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.607 HG23 HG21 ' A' ' 11' ' ' VAL . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.626 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 7' ' ' VAL . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 49' ' ' VAL . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 116' ' ' ILE . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' HD23 ' A' ' 40' ' ' LEU . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 124' ' ' ILE . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 14' ' ' VAL . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.614 ' HB3' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 67' ' ' PRO . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.535 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.616 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 68' ' ' TYR . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.881 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.865 HG23 ' HG2' ' A' ' 97' ' ' GLU . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.835 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.551 HG21 ' HE2' ' A' ' 96' ' ' LYS . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE2' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 88' ' ' THR . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.862 HG21 HD21 ' A' ' 153' ' ' LEU . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HA ' HD22 ' A' ' 84' ' ' LEU . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.739 ' CH2' HD23 ' A' ' 140' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.427 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.726 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.697 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.739 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.796 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.518 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.794 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.745 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.862 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.835 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 116' ' ' ILE . 16.1 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.677 ' HA ' HD13 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.774 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.062 HG11 HG21 ' A' ' 36' ' ' VAL . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 14' ' ' VAL . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' HD11 ' A' ' 29' ' ' ILE . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.553 HD11 ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 49' ' ' VAL . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 124' ' ' ILE . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG23 ' HB3' ' A' ' 10' ' ' GLU . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 36' ' ' VAL . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.883 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' OD2' ' A' ' 59' ' ' ASP . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.851 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 124' ' ' ILE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.974 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.858 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.831 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 HD21 ' A' ' 153' ' ' LEU . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.597 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.732 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.468 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.774 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.663 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.659 ' HB3' HG13 ' A' ' 100' ' ' VAL . 33.8 m170 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.812 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.732 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.801 ' CB ' HG12 ' A' ' 137' ' ' VAL . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 142' ' ' ASP . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.812 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.803 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 89' ' ' TYR . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 116' ' ' ILE . 27.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.678 ' HA ' HD13 ' A' ' 12' ' ' ILE . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.817 HG21 HG23 ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.803 ' SD ' HD23 ' A' ' 84' ' ' LEU . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 20' ' ' VAL . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 29' ' ' ILE . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' A' ' 57' ' ' VAL . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.872 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.847 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.938 HD23 ' HB2' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 116' ' ' ILE . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.751 HG21 HD12 ' A' ' 124' ' ' ILE . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG21 HG21 ' A' ' 14' ' ' VAL . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HB3' HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.673 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.872 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 34' ' ' LYS . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 67' ' ' PRO . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HG3' HD13 ' A' ' 60' ' ' ILE . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 53' ' ' LYS . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.649 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.832 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.816 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.594 HG21 ' HE3' ' A' ' 96' ' ' LYS . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.832 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 HD21 ' A' ' 153' ' ' LEU . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.724 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 40' ' ' LEU . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.751 HD12 HG21 ' A' ' 47' ' ' ILE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.723 ' HG3' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.724 ' CB ' HG22 ' A' ' 100' ' ' VAL . 36.8 m80 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.724 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' A' ' 137' ' ' VAL . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.91 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 89' ' ' TYR . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 116' ' ' ILE . 14.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.86 HG23 HG21 ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.86 HG21 HG23 ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.098 HG11 HG21 ' A' ' 36' ' ' VAL . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.758 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.514 ' NZ ' HD11 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HE3' HG13 ' A' ' 14' ' ' VAL . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 57' ' ' VAL . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 36' ' ' VAL . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.098 HG21 HG11 ' A' ' 14' ' ' VAL . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.075 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.593 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' THR . 6.9 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.831 HG21 HD12 ' A' ' 124' ' ' ILE . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.904 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 34' ' ' LYS . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.579 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HG3' HG21 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CE1' ' A' ' 68' ' ' TYR . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.904 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.075 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.758 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.857 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.805 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.857 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.848 HG21 HD21 ' A' ' 153' ' ' LEU . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.401 ' HA ' HD12 ' A' ' 84' ' ' LEU . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.674 ' HH2' HD22 ' A' ' 140' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.593 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 47' ' ' ILE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.68 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.696 ' CB ' HG22 ' A' ' 100' ' ' VAL . 33.9 m170 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.925 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.778 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.755 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.925 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.805 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.4 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 7' ' ' VAL . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.732 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.002 HG11 HG21 ' A' ' 36' ' ' VAL . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 20' ' ' VAL . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.823 ' SD ' HD23 ' A' ' 84' ' ' LEU . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.761 ' HE3' HD21 ' A' ' 99' ' ' LEU . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HB2' HG22 ' A' ' 57' ' ' VAL . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.002 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.663 ' CD1' HG22 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.474 ' O ' HD23 ' A' ' 40' ' ' LEU . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 124' ' ' ILE . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.663 HG22 ' CD1' ' A' ' 38' ' ' PHE . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.938 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.733 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 34' ' ' LYS . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.546 ' OD2' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' O ' HD13 ' A' ' 55' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.823 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.661 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.873 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.904 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 158' ' ' VAL . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 88' ' ' THR . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.761 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.836 HG21 HD21 ' A' ' 153' ' ' LEU . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.746 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.664 ' CG2' HD11 ' A' ' 40' ' ' LEU . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.56 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 131' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.723 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.2 m80 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.729 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.957 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.746 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.802 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.957 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.836 HD21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 91' ' ' THR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.904 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.8 tp . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' OG ' ' A' ' 120' ' ' SER . 11.6 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.754 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.87 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 7' ' ' VAL . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 49' ' ' VAL . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.947 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.564 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.469 ' O ' HD23 ' A' ' 40' ' ' LEU . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 14' ' ' VAL . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.922 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.871 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.606 HD13 ' HG3' ' A' ' 67' ' ' PRO . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.623 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.935 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.935 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.861 HG23 ' HG2' ' A' ' 97' ' ' GLU . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.836 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.861 ' HG2' HG23 ' A' ' 88' ' ' THR . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.776 HG21 HD21 ' A' ' 153' ' ' LEU . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.619 ' HA ' HD22 ' A' ' 84' ' ' LEU . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.759 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.636 HD12 HG21 ' A' ' 47' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 12' ' ' ILE . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.704 ' CB ' HG22 ' A' ' 100' ' ' VAL . 34.1 m170 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.811 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.951 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.408 ' HA ' ' CD ' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.951 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 141' ' ' ASP . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.811 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 89' ' ' TYR . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.8 m80 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 12.9 m120 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 89' ' ' TYR . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.4 m80 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HG21 ' A' ' 11' ' ' VAL . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.892 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 7' ' ' VAL . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 36' ' ' VAL . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 20' ' ' VAL . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.468 ' SD ' HG12 ' A' ' 14' ' ' VAL . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.536 ' HA ' HD11 ' A' ' 29' ' ' ILE . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 57' ' ' VAL . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.011 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' HG22 ' A' ' 49' ' ' VAL . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 116' ' ' ILE . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 124' ' ' ILE . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 10' ' ' GLU . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.701 HG21 ' CE1' ' A' ' 68' ' ' TYR . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.011 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.883 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 158' ' ' VAL . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.827 ' HG2' HG23 ' A' ' 88' ' ' THR . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.841 HG21 HD21 ' A' ' 153' ' ' LEU . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.562 ' HA ' HD22 ' A' ' 84' ' ' LEU . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.728 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 40' ' ' LEU . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.524 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.709 ' CB ' HG22 ' A' ' 100' ' ' VAL . 44.0 m80 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.728 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.77 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.889 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' HG22 ' A' ' 91' ' ' THR . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.883 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.4 tp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.4 m80 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.8 m80 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 12.9 m120 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 89' ' ' TYR . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 116' ' ' ILE . 43.8 t . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.888 HG23 HG21 ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.888 HG21 HG23 ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.093 HG11 HG21 ' A' ' 36' ' ' VAL . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 20' ' ' VAL . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.576 ' SD ' HG12 ' A' ' 14' ' ' VAL . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 20' ' ' VAL . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.591 ' HA ' HD11 ' A' ' 29' ' ' ILE . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' HG22 ' A' ' 57' ' ' VAL . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.093 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.69 ' CD1' HG22 ' A' ' 49' ' ' VAL . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.7 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 48' ' ' ILE . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HD3' HD11 ' A' ' 116' ' ' ILE . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.585 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.689 HD11 ' OG ' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 41' ' ' SER . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 10' ' ' GLU . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.932 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.668 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 55' ' ' ILE . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.665 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 68' ' ' TYR . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.932 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.783 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.792 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.783 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 153' ' ' LEU . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.717 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.431 HD13 ' HD3' ' A' ' 114' ' ' LYS . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD3' HD13 ' A' ' 111' ' ' LEU . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HD11 ' A' ' 40' ' ' LEU . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 47' ' ' ILE . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' ILE . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.64 HD12 HG21 ' A' ' 47' ' ' ILE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.725 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.769 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.0 m170 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.796 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.937 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.717 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.852 ' HB2' HG12 ' A' ' 137' ' ' VAL . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.937 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.435 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.796 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 89' ' ' TYR . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.3 tp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.493 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.738 HG23 HG21 ' A' ' 11' ' ' VAL . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 12' ' ' ILE . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.738 HG21 HG23 ' A' ' 7' ' ' VAL . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.674 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 36' ' ' VAL . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' HD11 ' A' ' 99' ' ' LEU . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 20' ' ' VAL . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 29' ' ' ILE . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 57' ' ' VAL . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.896 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 83' ' ' ALA . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.784 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' HD11 ' A' ' 116' ' ' ILE . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 14' ' ' VAL . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.651 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 34' ' ' LYS . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 59' ' ' ASP . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.482 ' O ' HD13 ' A' ' 55' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.883 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HG3' ' HG ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 71' ' ' PHE . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.883 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.889 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.889 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 153' ' ' LEU . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 84' ' ' LEU . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 112' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.574 ' N ' HD12 ' A' ' 111' ' ' LEU . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 124' ' ' ILE . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.825 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.674 ' HG3' HD11 ' A' ' 12' ' ' ILE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.682 ' HB3' HG13 ' A' ' 100' ' ' VAL . 38.5 m80 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.815 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 5.8 m120 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.81 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.815 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.954 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.954 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.34 150.18 35.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.89 158.54 39.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.057 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.93 151.26 11.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.313 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 116' ' ' ILE . 10.2 t -117.87 151.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.761 HG21 HG23 ' A' ' 7' ' ' VAL . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.073 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.775 ' SD ' HD23 ' A' ' 84' ' ' LEU . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 20' ' ' VAL . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.805 ' HA ' HD11 ' A' ' 29' ' ' ILE . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 23' ' ' SER . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HB2' HG22 ' A' ' 57' ' ' VAL . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.073 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.032 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.689 ' CD2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 48' ' ' ILE . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.71 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 41' ' ' SER . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 14' ' ' VAL . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.686 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 68' ' ' TYR . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.032 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.647 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.821 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' CG ' HG23 ' A' ' 88' ' ' THR . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.824 HG21 HD21 ' A' ' 153' ' ' LEU . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.725 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.528 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.71 HD12 HG21 ' A' ' 47' ' ' ILE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.703 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.669 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.5 m170 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.949 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.725 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.803 ' CB ' HG12 ' A' ' 137' ' ' VAL . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.949 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.536 ' HA ' HD21 ' A' ' 166' ' ' LEU . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.936 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.824 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.401 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.401 HG23 ' HA3' ' A' ' 154' ' ' GLY . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.936 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.5 OUTLIER -130.24 132.68 46.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.42 27.86 17.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.83 -0.08 84.15 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.382 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -112.69 127.15 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 117.025 0.412 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.37 141.11 94.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.154 1.903 . . . . 0.0 112.498 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.161 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.859 0.362 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.64 156.3 19.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -93.95 149.72 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.83 -178.96 34.29 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.571 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.9 t -114.68 152.6 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG23 HG21 ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.622 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.853 HG21 HG23 ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.018 HG11 HG21 ' A' ' 36' ' ' VAL . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.813 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.018 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.031 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.668 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.711 HD11 ' CG2' ' A' ' 116' ' ' ILE . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 40' ' ' LEU . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.873 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 14' ' ' VAL . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.732 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 HD12 ' OD1' ' A' ' 59' ' ' ASP . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.89 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.031 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.813 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.641 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.688 ' CB ' HD13 ' A' ' 153' ' ' LEU . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.927 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.848 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 158' ' ' VAL . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.927 ' HG2' HG23 ' A' ' 88' ' ' THR . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.711 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.529 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.873 HD12 HG21 ' A' ' 47' ' ' ILE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.686 ' HG3' HD11 ' A' ' 12' ' ' ILE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CB ' HG22 ' A' ' 100' ' ' VAL . 24.7 m80 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.802 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.704 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.792 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.528 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.802 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.4 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.879 HD11 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 91' ' ' THR . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.849 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp -131.85 131.12 42.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.538 ' CD ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER 46.78 29.49 1.0 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.288 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.36 -4.38 66.96 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.99 130.29 23.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 117.018 0.409 . . . . 0.0 110.481 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.92 141.74 21.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.166 1.91 . . . . 0.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.766 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.804 0.335 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 123.68 44.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -167.66 -47.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.67 -177.5 27.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.572 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.0 t -112.36 152.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.878 HG23 HG21 ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.652 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.897 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 7' ' ' VAL . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.085 HG11 HG21 ' A' ' 36' ' ' VAL . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.699 ' OD1' HG22 ' A' ' 12' ' ' ILE . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.825 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.532 ' CA ' HD11 ' A' ' 29' ' ' ILE . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 57' ' ' VAL . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.085 HG21 HG11 ' A' ' 14' ' ' VAL . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.093 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.785 HD11 HG23 ' A' ' 116' ' ' ILE . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.82 HG21 HD12 ' A' ' 124' ' ' ILE . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.903 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.662 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 59' ' ' ASP . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.901 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.903 HD22 ' HG3' ' A' ' 53' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.093 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.825 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.635 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.872 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.867 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 HG21 ' HE3' ' A' ' 96' ' ' LYS . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.872 ' HG2' HG23 ' A' ' 88' ' ' THR . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.788 HG21 HD21 ' A' ' 153' ' ' LEU . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 105' ' ' ALA . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.785 HG23 HD11 ' A' ' 40' ' ' LEU . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' A' ' 40' ' ' LEU . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 124' ' ' ILE . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.82 HD12 HG21 ' A' ' 47' ' ' ILE . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.737 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.716 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.768 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 142' ' ' ASP . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.92 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.788 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.506 HG23 ' HA3' ' A' ' 154' ' ' GLY . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.92 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -134.89 135.41 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.92 26.91 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.78 -1.95 85.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.439 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 138.77 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.942 0.371 . . . . 0.0 110.493 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.44 143.01 28.62 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.093 1.862 . . . . 0.0 112.631 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.944 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.23 147.2 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.076 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.44 157.18 11.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.73 179.46 28.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 116' ' ' ILE . 39.7 t -97.4 158.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 49' ' ' VAL . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 20' ' ' VAL . 8.5 m120 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.672 ' HA ' HD11 ' A' ' 29' ' ' ILE . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' HG22 ' A' ' 57' ' ' VAL . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.988 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.548 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 124' ' ' ILE . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 14' ' ' VAL . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.918 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 64' ' ' VAL . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' O ' HD13 ' A' ' 55' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.94 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.918 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.988 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.895 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.895 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.818 HG21 HD21 ' A' ' 153' ' ' LEU . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.62 ' HA ' HD22 ' A' ' 84' ' ' LEU . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.75 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.512 ' HG3' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.621 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 124' ' ' ILE . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 47' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' ILE . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.693 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.746 ' CB ' HG22 ' A' ' 100' ' ' VAL . 37.9 m80 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.804 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.931 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.807 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.931 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.804 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.93 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.818 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.515 HG23 ' HA3' ' A' ' 154' ' ' GLY . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.93 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -134.43 137.3 43.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.14 24.92 11.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.413 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.19 82.13 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.423 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -118.66 141.9 30.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.918 0.359 . . . . 0.0 110.375 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.51 142.79 22.71 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.456 2.104 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.907 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.11 140.22 31.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.18 -41.45 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.36 120.63 1.67 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.511 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.4 t -124.01 152.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 11' ' ' VAL . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 12' ' ' ILE . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 7' ' ' VAL . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.04 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 20' ' ' VAL . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.804 ' SD ' HD23 ' A' ' 84' ' ' LEU . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.74 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 57' ' ' VAL . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.918 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.007 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CD2' HG22 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 5' ' ' VAL . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.81 HG21 HD12 ' A' ' 124' ' ' ILE . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 14' ' ' VAL . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.549 ' HA ' HD22 ' A' ' 74' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.667 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 59' ' ' ASP . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.62 HG21 ' HG3' ' A' ' 67' ' ' PRO . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' A' ' 60' ' ' ILE . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 53' ' ' LYS . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.007 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.804 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.823 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.851 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.823 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HD21 ' A' ' 153' ' ' LEU . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.427 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.729 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.692 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.507 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 47' ' ' ILE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 131' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.673 ' HB3' HG13 ' A' ' 100' ' ' VAL . 35.8 m170 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.792 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.806 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.792 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.746 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.493 ' CG1' HD13 ' A' ' 166' ' ' LEU . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 92' ' ' LYS . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.892 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp -134.36 128.86 34.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.77 25.9 15.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.93 75.26 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.695 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.69 135.09 21.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 117.102 0.451 . . . . 0.0 110.733 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 138.2 55.8 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.198 1.932 . . . . 0.0 112.869 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.159 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.01 137.71 57.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -148.79 -65.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.02 -164.15 40.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.4 t -100.58 152.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.758 HG23 HG21 ' A' ' 11' ' ' VAL . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' ILE . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.758 HG21 HG23 ' A' ' 7' ' ' VAL . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 49' ' ' VAL . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.426 ' SD ' HG12 ' A' ' 14' ' ' VAL . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HE2' HD11 ' A' ' 99' ' ' LEU . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 20' ' ' VAL . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.907 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HB2' HG22 ' A' ' 57' ' ' VAL . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.753 HD11 HG23 ' A' ' 116' ' ' ILE . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 116' ' ' ILE . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.514 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 124' ' ' ILE . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 14' ' ' VAL . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.81 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.712 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.862 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 34' ' ' LYS . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' HD12 ' A' ' 56' ' ' LEU . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.474 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HE3' HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.81 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.833 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 158' ' ' VAL . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 88' ' ' THR . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG21 HD21 ' A' ' 153' ' ' LEU . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HA ' HD22 ' A' ' 84' ' ' LEU . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.731 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.753 HG23 HD11 ' A' ' 40' ' ' LEU . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.715 HD12 HG21 ' A' ' 47' ' ' ILE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.691 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.752 ' CB ' HG22 ' A' ' 100' ' ' VAL . 37.2 m80 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 75' ' ' LEU . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.767 ' CB ' HG12 ' A' ' 137' ' ' VAL . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.916 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 91' ' ' THR . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.916 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -130.21 125.9 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.92 30.39 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.026 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.75 -5.03 63.9 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.6 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.79 124.42 35.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 117.028 0.414 . . . . 0.0 110.526 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.37 140.72 42.57 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.024 1.816 . . . . 0.0 112.515 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 166.02 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p 59.01 107.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.09 110.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.2 t -123.52 152.87 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.752 HG11 ' HG2' ' A' ' 127' ' ' LYS . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 7' ' ' VAL . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.077 HG11 HG21 ' A' ' 36' ' ' VAL . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.777 ' SD ' HD23 ' A' ' 84' ' ' LEU . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 29' ' ' ILE . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB2' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.077 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.087 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.71 ' CD2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 124' ' ' ILE . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 14' ' ' VAL . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.906 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.689 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.789 ' CE1' HG21 ' A' ' 72' ' ' VAL . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CE1' ' A' ' 68' ' ' TYR . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.777 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 161' ' ' LEU . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.817 ' HG2' HG23 ' A' ' 88' ' ' THR . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 133' ' ' HIS . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 124' ' ' ILE . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HG2' HG11 ' A' ' 7' ' ' VAL . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.737 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.706 ' HB3' HG13 ' A' ' 100' ' ' VAL . 36.7 m80 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.745 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.93 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.764 ' CB ' HG12 ' A' ' 137' ' ' VAL . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.93 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.496 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.957 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.464 HG23 ' HA3' ' A' ' 154' ' ' GLY . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.957 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -136.12 137.97 41.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.65 26.26 15.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.987 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.16 -0.26 87.33 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.368 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.91 142.43 33.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.915 0.357 . . . . 0.0 110.477 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.29 143.4 15.01 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.26 1.973 . . . . 0.0 112.814 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.934 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.854 0.359 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 148.81 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -61.01 153.73 24.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.05 152.82 12.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.563 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 116' ' ' ILE . 35.5 t -120.2 158.19 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.607 HG23 HG21 ' A' ' 11' ' ' VAL . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.626 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 7' ' ' VAL . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 49' ' ' VAL . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 116' ' ' ILE . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' HD23 ' A' ' 40' ' ' LEU . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 124' ' ' ILE . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 14' ' ' VAL . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.614 ' HB3' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 67' ' ' PRO . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.616 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 68' ' ' TYR . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.881 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.865 HG23 ' HG2' ' A' ' 97' ' ' GLU . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.835 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.551 HG21 ' HE2' ' A' ' 96' ' ' LYS . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE2' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 88' ' ' THR . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.862 HG21 HD21 ' A' ' 153' ' ' LEU . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HA ' HD22 ' A' ' 84' ' ' LEU . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.739 ' CH2' HD23 ' A' ' 140' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.427 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.726 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.697 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.739 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.796 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.518 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.794 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.745 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.862 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.835 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -133.13 133.56 43.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.26 26.5 15.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.05 -2.01 85.2 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -117.33 138.82 25.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.027 0.413 . . . . 0.0 110.505 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.54 144.02 11.05 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.309 2.006 . . . . 0.0 112.954 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mtt . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.24 135.91 34.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -73.12 -48.33 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.13 162.52 34.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.603 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 116' ' ' ILE . 16.1 t -109.7 154.73 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.677 ' HA ' HD13 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.774 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.062 HG11 HG21 ' A' ' 36' ' ' VAL . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 14' ' ' VAL . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' HD11 ' A' ' 29' ' ' ILE . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.553 HD11 ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 49' ' ' VAL . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 124' ' ' ILE . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG23 ' HB3' ' A' ' 10' ' ' GLU . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 36' ' ' VAL . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.883 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' OD2' ' A' ' 59' ' ' ASP . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.851 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 124' ' ' ILE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.974 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.858 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.831 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 HD21 ' A' ' 153' ' ' LEU . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.597 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.732 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.468 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.774 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.663 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.659 ' HB3' HG13 ' A' ' 100' ' ' VAL . 33.8 m170 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.812 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.732 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.801 ' CB ' HG12 ' A' ' 137' ' ' VAL . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 142' ' ' ASP . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.812 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.803 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 89' ' ' TYR . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.9 OUTLIER -135.88 137.15 41.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.11 26.98 15.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.307 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.74 0.21 86.15 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.534 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.2 142.28 34.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.974 0.387 . . . . 0.0 110.503 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.19 143.61 14.23 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.421 2.081 . . . . 0.0 112.801 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.926 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.76 0.314 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.95 169.92 17.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t -174.84 74.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.16 162.99 38.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.387 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 116' ' ' ILE . 27.8 t -114.06 158.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.678 ' HA ' HD13 ' A' ' 12' ' ' ILE . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.817 HG21 HG23 ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.803 ' SD ' HD23 ' A' ' 84' ' ' LEU . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 20' ' ' VAL . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 29' ' ' ILE . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' A' ' 57' ' ' VAL . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.872 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.938 HD23 ' HB2' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 116' ' ' ILE . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.751 HG21 HD12 ' A' ' 124' ' ' ILE . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG21 HG21 ' A' ' 14' ' ' VAL . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HB3' HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.673 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.872 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 34' ' ' LYS . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 67' ' ' PRO . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HG3' HD13 ' A' ' 60' ' ' ILE . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 53' ' ' LYS . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.649 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.832 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.816 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.594 HG21 ' HE3' ' A' ' 96' ' ' LYS . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.832 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 HD21 ' A' ' 153' ' ' LEU . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.724 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 40' ' ' LEU . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.751 HD12 HG21 ' A' ' 47' ' ' ILE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.723 ' HG3' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.724 ' CB ' HG22 ' A' ' 100' ' ' VAL . 36.8 m80 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.724 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' A' ' 137' ' ' VAL . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.91 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 166' ' ' LEU . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -133.58 127.46 33.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.27 26.61 16.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.71 -1.42 78.52 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.438 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -110.01 126.3 29.3 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 117.066 0.433 . . . . 0.0 110.814 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.97 137.6 80.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.129 1.886 . . . . 0.0 112.585 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.771 0.319 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.2 142.39 47.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 -66.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.829 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.53 -179.16 53.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 116' ' ' ILE . 14.6 t -104.08 152.2 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.86 HG23 HG21 ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.86 HG21 HG23 ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.098 HG11 HG21 ' A' ' 36' ' ' VAL . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.758 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.514 ' NZ ' HD11 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HE3' HG13 ' A' ' 14' ' ' VAL . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 57' ' ' VAL . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 36' ' ' VAL . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.098 HG21 HG11 ' A' ' 14' ' ' VAL . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.075 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.593 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' THR . 6.9 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.831 HG21 HD12 ' A' ' 124' ' ' ILE . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.904 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 34' ' ' LYS . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.579 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HG3' HG21 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CE1' ' A' ' 68' ' ' TYR . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.904 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.075 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.758 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.857 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.805 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.857 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.848 HG21 HD21 ' A' ' 153' ' ' LEU . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.401 ' HA ' HD12 ' A' ' 84' ' ' LEU . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.674 ' HH2' HD22 ' A' ' 140' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.593 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 47' ' ' ILE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.68 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.696 ' CB ' HG22 ' A' ' 100' ' ' VAL . 33.9 m170 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.925 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.778 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.755 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.925 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.805 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -133.45 131.48 39.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.41 27.19 16.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.27 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.68 -2.85 84.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 140.21 25.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.983 0.392 . . . . 0.0 110.338 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.74 141.29 35.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.435 2.09 . . . . 0.0 112.601 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.681 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.842 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.51 158.14 30.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -178.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.16 -166.41 34.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.558 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.4 t -107.34 151.64 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 7' ' ' VAL . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.732 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.002 HG11 HG21 ' A' ' 36' ' ' VAL . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 20' ' ' VAL . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.823 ' SD ' HD23 ' A' ' 84' ' ' LEU . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.761 ' HE3' HD21 ' A' ' 99' ' ' LEU . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HB2' HG22 ' A' ' 57' ' ' VAL . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.002 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.663 ' CD1' HG22 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.474 ' O ' HD23 ' A' ' 40' ' ' LEU . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 124' ' ' ILE . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.663 HG22 ' CD1' ' A' ' 38' ' ' PHE . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.938 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.733 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 34' ' ' LYS . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.546 ' OD2' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' O ' HD13 ' A' ' 55' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.823 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.661 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.873 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.904 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 158' ' ' VAL . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 88' ' ' THR . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.761 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.836 HG21 HD21 ' A' ' 153' ' ' LEU . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.746 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.664 ' CG2' HD11 ' A' ' 40' ' ' LEU . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.56 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 131' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.723 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.2 m80 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.729 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.957 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.746 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.802 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.957 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.836 HD21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 91' ' ' THR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.904 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.8 tp -133.26 124.69 27.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.517 ' OE1' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 54.33 37.82 28.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.027 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.12 86.31 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.876 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -111.8 134.92 21.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.22 139.28 63.48 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.156 1.904 . . . . 0.0 112.31 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.89 135.91 40.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.0 169.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.24 160.37 9.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.499 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' OG ' ' A' ' 120' ' ' SER . 11.6 t -111.61 152.32 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.754 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.87 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 7' ' ' VAL . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 49' ' ' VAL . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.947 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.564 ' HD2' HG22 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.469 ' O ' HD23 ' A' ' 40' ' ' LEU . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 14' ' ' VAL . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.922 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.871 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.606 HD13 ' HG3' ' A' ' 67' ' ' PRO . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.623 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.935 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.935 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.861 HG23 ' HG2' ' A' ' 97' ' ' GLU . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.836 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.861 ' HG2' HG23 ' A' ' 88' ' ' THR . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.776 HG21 HD21 ' A' ' 153' ' ' LEU . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.619 ' HA ' HD22 ' A' ' 84' ' ' LEU . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.759 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.636 HD12 HG21 ' A' ' 47' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 12' ' ' ILE . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.704 ' CB ' HG22 ' A' ' 100' ' ' VAL . 34.1 m170 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.811 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.951 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.408 ' HA ' ' CD ' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.951 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 141' ' ' ASP . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.811 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 89' ' ' TYR . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.8 OUTLIER -133.44 127.44 33.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 57.61 29.06 16.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.976 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.71 83.87 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.277 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -106.21 125.38 33.14 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.971 0.386 . . . . 0.0 110.638 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.99 136.8 71.88 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.116 1.877 . . . . 0.0 112.594 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.206 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.8 m80 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 12.9 m120 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' HD21 ' A' ' 166' ' ' LEU . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 166' ' ' LEU . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.4 m80 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 166' ' ' LEU . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.789 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.46 155.27 36.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t 59.39 79.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.64 166.41 34.24 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.6 t -109.88 152.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HG21 ' A' ' 11' ' ' VAL . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.892 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 7' ' ' VAL . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 36' ' ' VAL . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 20' ' ' VAL . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.468 ' SD ' HG12 ' A' ' 14' ' ' VAL . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.536 ' HA ' HD11 ' A' ' 29' ' ' ILE . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 57' ' ' VAL . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.011 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' HG22 ' A' ' 49' ' ' VAL . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 116' ' ' ILE . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 124' ' ' ILE . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 10' ' ' GLU . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG21 ' CE1' ' A' ' 68' ' ' TYR . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.011 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.883 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 158' ' ' VAL . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.827 ' HG2' HG23 ' A' ' 88' ' ' THR . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.841 HG21 HD21 ' A' ' 153' ' ' LEU . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.562 ' HA ' HD22 ' A' ' 84' ' ' LEU . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.728 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 40' ' ' LEU . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.524 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.709 ' CB ' HG22 ' A' ' 100' ' ' VAL . 44.0 m80 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.728 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.77 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.889 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' HG22 ' A' ' 91' ' ' THR . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.883 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.4 tp -130.73 119.32 22.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.77 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER 48.3 39.47 12.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.014 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.4 -2.62 83.31 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.508 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.3 115.5 56.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.988 0.394 . . . . 0.0 110.412 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.49 141.9 24.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.187 1.925 . . . . 0.0 112.614 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 38.4 m80 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 166' ' ' LEU . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.789 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.8 m80 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 12.9 m120 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' HD21 ' A' ' 166' ' ' LEU . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 166' ' ' LEU . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.45 142.2 41.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.09 175.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.54 178.11 25.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.878 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 116' ' ' ILE . 43.8 t -99.56 159.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.888 HG23 HG21 ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.888 HG21 HG23 ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.093 HG11 HG21 ' A' ' 36' ' ' VAL . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 20' ' ' VAL . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.576 ' SD ' HG12 ' A' ' 14' ' ' VAL . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 20' ' ' VAL . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.591 ' HA ' HD11 ' A' ' 29' ' ' ILE . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' HG22 ' A' ' 57' ' ' VAL . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.093 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.69 ' CD1' HG22 ' A' ' 49' ' ' VAL . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.7 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 48' ' ' ILE . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HD3' HD11 ' A' ' 116' ' ' ILE . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.585 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.689 HD11 ' OG ' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 41' ' ' SER . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 10' ' ' GLU . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.932 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.668 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 55' ' ' ILE . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.665 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 68' ' ' TYR . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.932 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.783 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.792 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.783 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 153' ' ' LEU . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.717 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.431 HD13 ' HD3' ' A' ' 114' ' ' LYS . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD3' HD13 ' A' ' 111' ' ' LEU . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HD11 ' A' ' 40' ' ' LEU . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 47' ' ' ILE . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' ILE . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.64 HD12 HG21 ' A' ' 47' ' ' ILE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.725 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.769 ' CB ' HG22 ' A' ' 100' ' ' VAL . 35.0 m170 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.796 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.937 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.717 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.852 ' HB2' HG12 ' A' ' 137' ' ' VAL . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.937 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.439 ' HA ' HD21 ' A' ' 166' ' ' LEU . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.435 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.796 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 89' ' ' TYR . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.3 tp -133.39 128.58 35.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.49 25.41 12.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.35 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.28 -0.62 68.81 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.443 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.18 129.55 23.91 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.964 0.382 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.44 137.35 64.4 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.128 1.885 . . . . 0.0 112.622 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.21 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.77 129.07 40.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.31 -62.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.82 142.37 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.56 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.493 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.6 t -120.0 153.19 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.738 HG23 HG21 ' A' ' 11' ' ' VAL . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 12' ' ' ILE . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.738 HG21 HG23 ' A' ' 7' ' ' VAL . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.674 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 36' ' ' VAL . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' HD11 ' A' ' 99' ' ' LEU . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 20' ' ' VAL . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 29' ' ' ILE . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 57' ' ' VAL . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.896 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 83' ' ' ALA . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.784 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' HD11 ' A' ' 116' ' ' ILE . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 14' ' ' VAL . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.651 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 34' ' ' LYS . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 59' ' ' ASP . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.482 ' O ' HD13 ' A' ' 55' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.883 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HG3' ' HG ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 71' ' ' PHE . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.883 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.889 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.889 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 153' ' ' LEU . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 84' ' ' LEU . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 112' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.574 ' N ' HD12 ' A' ' 111' ' ' LEU . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 124' ' ' ILE . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.825 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.674 ' HG3' HD11 ' A' ' 12' ' ' ILE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.682 ' HB3' HG13 ' A' ' 100' ' ' VAL . 38.5 m80 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.815 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 105' ' ' ALA . 5.8 m120 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.81 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.414 ' HA ' HD21 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.815 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.954 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.954 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -136.03 131.96 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.92 26.9 12.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.73 -1.76 83.9 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.136 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -106.83 127.28 28.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.885 0.342 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.35 137.53 78.94 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.148 1.899 . . . . 0.0 112.641 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.152 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 116' ' ' ILE . 10.2 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.761 HG21 HG23 ' A' ' 7' ' ' VAL . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.073 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.775 ' SD ' HD23 ' A' ' 84' ' ' LEU . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 20' ' ' VAL . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.805 ' HA ' HD11 ' A' ' 29' ' ' ILE . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 23' ' ' SER . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HB2' HG22 ' A' ' 57' ' ' VAL . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.073 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.032 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.689 ' CD2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 48' ' ' ILE . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.71 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 41' ' ' SER . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 14' ' ' VAL . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.686 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 68' ' ' TYR . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.032 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.647 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.821 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' CG ' HG23 ' A' ' 88' ' ' THR . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.824 HG21 HD21 ' A' ' 153' ' ' LEU . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.725 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.528 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.71 HD12 HG21 ' A' ' 47' ' ' ILE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.703 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.669 ' CB ' HG22 ' A' ' 100' ' ' VAL . 63.1 m-70 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.949 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.725 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.803 ' CB ' HG12 ' A' ' 137' ' ' VAL . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.949 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.936 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.824 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.401 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.401 HG23 ' HA3' ' A' ' 154' ' ' GLY . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.936 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.9 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.853 HG23 HG21 ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.622 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.853 HG21 HG23 ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.018 HG11 HG21 ' A' ' 36' ' ' VAL . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.813 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.018 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.031 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.668 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.711 HD11 ' CG2' ' A' ' 116' ' ' ILE . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 40' ' ' LEU . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.873 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 14' ' ' VAL . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.732 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 HD12 ' OD1' ' A' ' 59' ' ' ASP . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.89 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.031 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.813 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.641 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.688 ' CB ' HD13 ' A' ' 153' ' ' LEU . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.927 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.848 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 158' ' ' VAL . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.927 ' HG2' HG23 ' A' ' 88' ' ' THR . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.711 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.529 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.873 HD12 HG21 ' A' ' 47' ' ' ILE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.686 ' HG3' HD11 ' A' ' 12' ' ' ILE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.1 m-70 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.802 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.704 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.792 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.528 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.802 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.4 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.879 HD11 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 91' ' ' THR . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.849 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.0 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.878 HG23 HG21 ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.652 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.897 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 7' ' ' VAL . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.085 HG11 HG21 ' A' ' 36' ' ' VAL . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.699 ' OD1' HG22 ' A' ' 12' ' ' ILE . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.825 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.532 ' CA ' HD11 ' A' ' 29' ' ' ILE . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 57' ' ' VAL . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.085 HG21 HG11 ' A' ' 14' ' ' VAL . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.093 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.785 HD11 HG23 ' A' ' 116' ' ' ILE . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.82 HG21 HD12 ' A' ' 124' ' ' ILE . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.903 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.662 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.494 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 59' ' ' ASP . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.901 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.903 HD22 ' HG3' ' A' ' 53' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.093 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.825 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.635 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.872 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.867 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.474 HG21 ' HE3' ' A' ' 96' ' ' LYS . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.872 ' HG2' HG23 ' A' ' 88' ' ' THR . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.788 HG21 HD21 ' A' ' 153' ' ' LEU . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 105' ' ' ALA . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.785 HG23 HD11 ' A' ' 40' ' ' LEU . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' A' ' 40' ' ' LEU . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 124' ' ' ILE . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.82 HD12 HG21 ' A' ' 47' ' ' ILE . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.737 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.716 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.768 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 142' ' ' ASP . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.92 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.788 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.506 HG23 ' HA3' ' A' ' 154' ' ' GLY . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.92 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 116' ' ' ILE . 39.7 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 49' ' ' VAL . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 20' ' ' VAL . 19.4 m-80 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.672 ' HA ' HD11 ' A' ' 29' ' ' ILE . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' HG22 ' A' ' 57' ' ' VAL . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.988 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.548 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 124' ' ' ILE . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 14' ' ' VAL . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.918 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 64' ' ' VAL . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' O ' HD13 ' A' ' 55' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.94 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.918 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.988 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.895 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.895 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.818 HG21 HD21 ' A' ' 153' ' ' LEU . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.62 ' HA ' HD22 ' A' ' 84' ' ' LEU . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.75 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.512 ' HG3' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.621 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 124' ' ' ILE . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 47' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' ILE . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.693 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.746 ' CB ' HG22 ' A' ' 100' ' ' VAL . 82.0 m-70 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.804 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.931 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.807 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.931 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.804 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.93 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.818 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.515 HG23 ' HA3' ' A' ' 154' ' ' GLY . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.93 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.4 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 11' ' ' VAL . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 12' ' ' ILE . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 7' ' ' VAL . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.04 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 20' ' ' VAL . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.804 ' SD ' HD23 ' A' ' 84' ' ' LEU . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.74 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 57' ' ' VAL . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.918 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.007 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CD2' HG22 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 5' ' ' VAL . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.81 HG21 HD12 ' A' ' 124' ' ' ILE . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 14' ' ' VAL . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.549 ' HA ' HD22 ' A' ' 74' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.667 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 59' ' ' ASP . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.62 HG21 ' HG3' ' A' ' 67' ' ' PRO . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' A' ' 60' ' ' ILE . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 53' ' ' LYS . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.007 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.804 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.823 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.851 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.823 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HD21 ' A' ' 153' ' ' LEU . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.427 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.729 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.692 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.507 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 47' ' ' ILE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 131' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.673 ' HB3' HG13 ' A' ' 100' ' ' VAL . 66.6 m-70 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.792 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.806 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.792 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.746 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 89' ' ' TYR . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 92' ' ' LYS . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.892 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.4 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.758 HG23 HG21 ' A' ' 11' ' ' VAL . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' ILE . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.758 HG21 HG23 ' A' ' 7' ' ' VAL . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 49' ' ' VAL . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.426 ' SD ' HG12 ' A' ' 14' ' ' VAL . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HE2' HD11 ' A' ' 99' ' ' LEU . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 20' ' ' VAL . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.907 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HB2' HG22 ' A' ' 57' ' ' VAL . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.753 HD11 HG23 ' A' ' 116' ' ' ILE . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 116' ' ' ILE . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.514 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 124' ' ' ILE . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 14' ' ' VAL . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.81 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.712 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.862 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 34' ' ' LYS . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' HD12 ' A' ' 56' ' ' LEU . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.474 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HE3' HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.81 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.833 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 158' ' ' VAL . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 88' ' ' THR . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG21 HD21 ' A' ' 153' ' ' LEU . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HA ' HD22 ' A' ' 84' ' ' LEU . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.731 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.753 HG23 HD11 ' A' ' 40' ' ' LEU . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.715 HD12 HG21 ' A' ' 47' ' ' ILE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.691 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.752 ' CB ' HG22 ' A' ' 100' ' ' VAL . 77.6 m-70 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 75' ' ' LEU . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.767 ' CB ' HG12 ' A' ' 137' ' ' VAL . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.916 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 91' ' ' THR . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.916 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.2 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.752 HG11 ' HG2' ' A' ' 127' ' ' LYS . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 7' ' ' VAL . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.077 HG11 HG21 ' A' ' 36' ' ' VAL . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.777 ' SD ' HD23 ' A' ' 84' ' ' LEU . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 29' ' ' ILE . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB2' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.077 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.087 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.71 ' CD2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 124' ' ' ILE . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 14' ' ' VAL . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.906 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.689 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.789 ' CE1' HG21 ' A' ' 72' ' ' VAL . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CE1' ' A' ' 68' ' ' TYR . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.777 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 161' ' ' LEU . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.817 ' HG2' HG23 ' A' ' 88' ' ' THR . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 133' ' ' HIS . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 124' ' ' ILE . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HG2' HG11 ' A' ' 7' ' ' VAL . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.737 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.706 ' HB3' HG13 ' A' ' 100' ' ' VAL . 74.1 m-70 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.745 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.93 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.764 ' CB ' HG12 ' A' ' 137' ' ' VAL . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.93 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.496 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.957 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.464 HG23 ' HA3' ' A' ' 154' ' ' GLY . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.957 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 116' ' ' ILE . 35.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.607 HG23 HG21 ' A' ' 11' ' ' VAL . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.462 ' ND2' HD12 ' A' ' 48' ' ' ILE . 48.3 t30 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.626 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 7' ' ' VAL . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 49' ' ' VAL . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 116' ' ' ILE . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' HD23 ' A' ' 40' ' ' LEU . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 124' ' ' ILE . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' ND2' ' A' ' 8' ' ' ASN . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 14' ' ' VAL . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.614 ' HB3' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 67' ' ' PRO . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.535 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.616 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 68' ' ' TYR . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.881 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.865 HG23 ' HG2' ' A' ' 97' ' ' GLU . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.835 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.551 HG21 ' HE2' ' A' ' 96' ' ' LYS . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE2' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 88' ' ' THR . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.862 HG21 HD21 ' A' ' 153' ' ' LEU . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HA ' HD22 ' A' ' 84' ' ' LEU . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.739 ' CH2' HD23 ' A' ' 140' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.427 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.726 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.697 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.739 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.796 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.518 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.794 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.745 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.862 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.835 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 116' ' ' ILE . 16.1 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.677 ' HA ' HD13 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.774 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.062 HG11 HG21 ' A' ' 36' ' ' VAL . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 14' ' ' VAL . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' HD11 ' A' ' 29' ' ' ILE . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.553 HD11 ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 49' ' ' VAL . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 124' ' ' ILE . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.728 HG23 ' HB3' ' A' ' 10' ' ' GLU . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 36' ' ' VAL . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.883 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' OD2' ' A' ' 59' ' ' ASP . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.851 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 124' ' ' ILE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.974 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.858 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.831 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 HD21 ' A' ' 153' ' ' LEU . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.597 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.732 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.468 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.774 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.663 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.659 ' HB3' HG13 ' A' ' 100' ' ' VAL . 48.0 m-70 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.812 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.732 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.801 ' CB ' HG12 ' A' ' 137' ' ' VAL . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 142' ' ' ASP . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.812 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.803 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 89' ' ' TYR . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 116' ' ' ILE . 27.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.678 ' HA ' HD13 ' A' ' 12' ' ' ILE . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.817 HG21 HG23 ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.803 ' SD ' HD23 ' A' ' 84' ' ' LEU . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 20' ' ' VAL . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 29' ' ' ILE . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' A' ' 57' ' ' VAL . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.872 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.847 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.938 HD23 ' HB2' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 116' ' ' ILE . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.751 HG21 HD12 ' A' ' 124' ' ' ILE . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG21 HG21 ' A' ' 14' ' ' VAL . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HB3' HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.673 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.872 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 34' ' ' LYS . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 67' ' ' PRO . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HG3' HD13 ' A' ' 60' ' ' ILE . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 53' ' ' LYS . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.649 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.832 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.816 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.594 HG21 ' HE3' ' A' ' 96' ' ' LYS . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.832 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 HD21 ' A' ' 153' ' ' LEU . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.724 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 40' ' ' LEU . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.751 HD12 HG21 ' A' ' 47' ' ' ILE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.723 ' HG3' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.724 ' CB ' HG22 ' A' ' 100' ' ' VAL . 76.5 m-70 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.724 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' A' ' 137' ' ' VAL . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.91 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 89' ' ' TYR . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 116' ' ' ILE . 14.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.86 HG23 HG21 ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.86 HG21 HG23 ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.098 HG11 HG21 ' A' ' 36' ' ' VAL . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.758 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.514 ' NZ ' HD11 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HE3' HG13 ' A' ' 14' ' ' VAL . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 57' ' ' VAL . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 36' ' ' VAL . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.098 HG21 HG11 ' A' ' 14' ' ' VAL . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.075 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.593 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.6 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.831 HG21 HD12 ' A' ' 124' ' ' ILE . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.904 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 34' ' ' LYS . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.579 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HG3' HG21 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CE1' ' A' ' 68' ' ' TYR . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.904 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.075 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.758 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.857 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.805 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.857 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.848 HG21 HD21 ' A' ' 153' ' ' LEU . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.401 ' HA ' HD12 ' A' ' 84' ' ' LEU . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.674 ' HH2' HD22 ' A' ' 140' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.593 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 47' ' ' ILE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.68 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.696 ' CB ' HG22 ' A' ' 100' ' ' VAL . 57.1 m-70 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.925 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.778 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.755 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.925 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.805 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.4 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 7' ' ' VAL . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.732 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.002 HG11 HG21 ' A' ' 36' ' ' VAL . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 20' ' ' VAL . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.823 ' SD ' HD23 ' A' ' 84' ' ' LEU . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.761 ' HE3' HD21 ' A' ' 99' ' ' LEU . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HB2' HG22 ' A' ' 57' ' ' VAL . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.002 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.663 ' CD1' HG22 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.474 ' O ' HD23 ' A' ' 40' ' ' LEU . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 124' ' ' ILE . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 14' ' ' VAL . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.938 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.733 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 34' ' ' LYS . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.546 ' OD2' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.652 ' O ' HD13 ' A' ' 55' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.823 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.661 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.873 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.904 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 158' ' ' VAL . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 88' ' ' THR . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.761 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.836 HG21 HD21 ' A' ' 153' ' ' LEU . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.746 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.664 ' CG2' HD11 ' A' ' 40' ' ' LEU . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.56 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 131' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.723 ' CB ' HG22 ' A' ' 100' ' ' VAL . 84.8 m-70 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.729 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.957 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.746 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.802 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.957 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.836 HD21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 91' ' ' THR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.904 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.8 tp . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' OG ' ' A' ' 120' ' ' SER . 11.6 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.754 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.87 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 7' ' ' VAL . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 49' ' ' VAL . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.947 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.469 ' O ' HD23 ' A' ' 40' ' ' LEU . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 14' ' ' VAL . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.922 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.871 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.606 HD13 ' HG3' ' A' ' 67' ' ' PRO . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.623 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.935 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.935 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.861 HG23 ' HG2' ' A' ' 97' ' ' GLU . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.836 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.861 ' HG2' HG23 ' A' ' 88' ' ' THR . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.776 HG21 HD21 ' A' ' 153' ' ' LEU . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.619 ' HA ' HD22 ' A' ' 84' ' ' LEU . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.759 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.636 HD12 HG21 ' A' ' 47' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 12' ' ' ILE . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.704 ' CB ' HG22 ' A' ' 100' ' ' VAL . 51.5 m-70 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.811 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.951 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.408 ' HA ' ' CD ' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.951 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 141' ' ' ASP . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.811 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 89' ' ' TYR . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 89' ' ' TYR . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HG21 ' A' ' 11' ' ' VAL . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.892 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 7' ' ' VAL . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 36' ' ' VAL . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 20' ' ' VAL . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.468 ' SD ' HG12 ' A' ' 14' ' ' VAL . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.536 ' HA ' HD11 ' A' ' 29' ' ' ILE . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 57' ' ' VAL . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.011 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' HG22 ' A' ' 49' ' ' VAL . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 116' ' ' ILE . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 124' ' ' ILE . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 10' ' ' GLU . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.701 HG21 ' CE1' ' A' ' 68' ' ' TYR . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.011 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.883 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 158' ' ' VAL . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.827 ' HG2' HG23 ' A' ' 88' ' ' THR . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.841 HG21 HD21 ' A' ' 153' ' ' LEU . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.562 ' HA ' HD22 ' A' ' 84' ' ' LEU . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.728 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 40' ' ' LEU . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.524 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.709 ' CB ' HG22 ' A' ' 100' ' ' VAL . 95.4 m-70 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.728 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.77 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.889 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' HG22 ' A' ' 91' ' ' THR . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.883 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.4 tp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 89' ' ' TYR . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 116' ' ' ILE . 43.8 t . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.888 HG23 HG21 ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.888 HG21 HG23 ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.093 HG11 HG21 ' A' ' 36' ' ' VAL . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 20' ' ' VAL . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.576 ' SD ' HG12 ' A' ' 14' ' ' VAL . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 20' ' ' VAL . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.591 ' HA ' HD11 ' A' ' 29' ' ' ILE . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' HG22 ' A' ' 57' ' ' VAL . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.093 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.69 ' CD1' HG22 ' A' ' 49' ' ' VAL . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.7 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 48' ' ' ILE . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HD3' HD11 ' A' ' 116' ' ' ILE . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.585 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.689 HD11 ' OG ' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 41' ' ' SER . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 10' ' ' GLU . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.932 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.668 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 55' ' ' ILE . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.665 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 68' ' ' TYR . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.932 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.783 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.792 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.783 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 153' ' ' LEU . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.717 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.431 HD13 ' HD3' ' A' ' 114' ' ' LYS . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD3' HD13 ' A' ' 111' ' ' LEU . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HD11 ' A' ' 40' ' ' LEU . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 47' ' ' ILE . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' ILE . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.64 HD12 HG21 ' A' ' 47' ' ' ILE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.725 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.769 ' CB ' HG22 ' A' ' 100' ' ' VAL . 59.5 m-70 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.796 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.937 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.717 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.852 ' HB2' HG12 ' A' ' 137' ' ' VAL . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.937 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.435 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.796 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 89' ' ' TYR . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.3 tp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.493 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.738 HG23 HG21 ' A' ' 11' ' ' VAL . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 48' ' ' ILE . 57.3 t30 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 12' ' ' ILE . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.738 HG21 HG23 ' A' ' 7' ' ' VAL . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.674 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 36' ' ' VAL . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' HD11 ' A' ' 99' ' ' LEU . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 20' ' ' VAL . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 29' ' ' ILE . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 57' ' ' VAL . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.896 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 83' ' ' ALA . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.784 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' HD11 ' A' ' 116' ' ' ILE . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.469 HD12 ' ND2' ' A' ' 8' ' ' ASN . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 14' ' ' VAL . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.651 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 34' ' ' LYS . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 59' ' ' ASP . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.482 ' O ' HD13 ' A' ' 55' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.883 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HG3' ' HG ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 71' ' ' PHE . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.883 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.889 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.889 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 153' ' ' LEU . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 84' ' ' LEU . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 112' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.574 ' N ' HD12 ' A' ' 111' ' ' LEU . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 124' ' ' ILE . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.825 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.674 ' HG3' HD11 ' A' ' 12' ' ' ILE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.682 ' HB3' HG13 ' A' ' 100' ' ' VAL . 88.4 m-70 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.815 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.81 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.815 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.954 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.954 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.34 150.18 35.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.89 158.54 39.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.057 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.93 151.26 11.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.313 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 116' ' ' ILE . 10.2 t -117.87 151.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.93 171.46 9.69 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -102.19 119.68 50.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.394 0.616 . . . . 0.0 110.446 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -61.72 144.2 55.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.526 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.2 m-20 -49.18 -25.57 2.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.882 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.752 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.63 -35.7 74.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.761 HG21 HG23 ' A' ' 7' ' ' VAL . 53.2 t -63.44 -27.88 43.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.737 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.3 mp -75.02 -50.62 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -32.3 43.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.444 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.073 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -76.76 -36.86 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.437 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.3 t80 -70.95 -45.4 64.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -66.85 -32.69 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.013 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.63 -45.08 31.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.858 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.775 ' SD ' HD23 ' A' ' 84' ' ' LEU . 81.4 mtp -75.44 -17.53 60.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.042 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -90.92 -19.69 23.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 20' ' ' VAL . 40.7 t -119.45 12.88 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.821 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.15 112.57 1.95 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -114.24 145.25 41.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.762 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.805 ' HA ' HD11 ' A' ' 29' ' ' ILE . 56.1 p -102.13 116.3 32.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -120.8 -63.01 1.39 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.8 p -131.68 139.94 36.77 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.096 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.66 -25.59 11.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.324 2.016 . . . . 0.0 112.223 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.79 -42.13 97.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.795 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.49 -30.0 30.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 23' ' ' SER . 22.3 mm -60.02 -26.01 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 20.9 ttpt -65.07 -24.19 67.39 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.539 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -96.67 -9.16 29.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -68.02 111.92 4.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.003 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -71.99 110.12 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HB2' HG22 ' A' ' 57' ' ' VAL . 11.7 tttp -98.57 -26.79 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.16 140.97 22.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.073 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.11 139.62 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.049 0.452 . . . . 0.0 111.166 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.032 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -108.9 135.94 49.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.896 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.689 ' CD2' HG22 ' A' ' 49' ' ' VAL . 38.6 m-85 -102.28 144.1 31.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.639 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -137.54 172.28 13.2 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.86 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.58 137.78 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.369 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 48' ' ' ILE . 5.7 m -62.46 171.32 2.0 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -19.83 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.67 -15.46 39.55 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.325 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 56.55 32.42 20.82 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 tttp -118.81 -14.19 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.739 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -142.71 174.68 10.43 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.897 0.379 . . . . 0.0 111.676 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.71 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -102.41 116.12 45.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.786 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.463 HG21 ' OG ' ' A' ' 41' ' ' SER . 14.0 tt -128.3 153.53 37.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.132 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 14' ' ' VAL . 56.1 t -75.56 146.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.14 0.495 . . . . 0.0 111.616 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -108.71 110.22 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.232 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -53.44 -29.37 35.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.001 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -19.14 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.55 74.8 1.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.626 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.686 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.53 160.25 42.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.479 179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.1 mt -137.82 113.67 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.164 0.506 . . . . 0.0 111.042 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 172.19 8.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.857 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.7 t -78.35 -24.43 13.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.385 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.56 -28.34 22.17 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.182 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.41 -34.84 72.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.534 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.2 mt -74.34 100.16 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.417 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.13 -6.02 23.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.191 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 -59.38 1.89 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.67 -9.49 8.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.007 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.8 136.48 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.93 -32.84 45.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.692 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.1 146.18 13.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.97 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.4 Cg_endo -72.8 -35.34 5.81 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.1 1.867 . . . . 0.0 111.64 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.4 t80 -70.7 -56.68 5.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.107 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.8 m -55.72 -33.05 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.043 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -42.85 98.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.97 -40.95 75.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.225 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 68' ' ' TYR . 90.7 t -62.46 -25.28 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.972 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.77 -35.36 38.77 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.7 mt -77.37 -35.06 54.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -54.95 114.83 7.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -89.56 122.3 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.466 2.111 . . . . 0.0 111.584 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.0 mt -68.88 -23.73 64.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.95 14.28 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.502 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -152.48 139.91 19.59 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -93.78 150.83 20.06 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.447 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -160.31 173.15 16.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.177 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.492 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 67.0 m-85 -115.44 159.45 21.13 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.032 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 131.84 11.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 111.945 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.775 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -108.91 130.09 55.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.647 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 20.1 t80 -142.5 152.19 42.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.37 0.605 . . . . 0.0 111.018 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 22.5 t70 -101.92 114.24 28.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.848 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.06 113.16 23.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.821 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.4 m -100.69 114.57 28.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.75 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.9 p90 -136.66 164.88 27.21 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -130.86 123.81 29.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.017 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.6 p -93.25 175.34 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.044 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -70.81 -8.56 53.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.871 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -105.64 -47.03 4.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.922 0.391 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.8 m -160.84 163.44 32.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.06 129.97 45.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.956 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.22 165.26 26.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.161 0.505 . . . . 0.0 111.897 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' CG ' HG23 ' A' ' 88' ' ' THR . 2.2 mp0 -133.13 151.71 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.618 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.2 175.62 13.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.12 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 111.001 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.824 HG21 HD21 ' A' ' 153' ' ' LEU . 39.5 t -129.29 148.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.071 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -96.61 109.48 22.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.631 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.33 141.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.309 0.576 . . . . 0.0 111.903 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -118.35 106.78 13.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.725 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.2 t-105 -88.57 109.51 20.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.61 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.73 86.34 22.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 54.6 Cg_endo -69.6 161.36 46.22 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.798 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.52 -10.02 59.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.218 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.94 -13.92 35.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.685 0.279 . . . . 0.0 111.448 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.52 92.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.35 146.72 40.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.224 1.949 . . . . 0.0 112.117 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.03 -30.81 49.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -69.38 -22.62 63.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.2 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.84 -38.07 19.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.182 0.515 . . . . 0.0 109.662 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.98 -40.42 39.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.374 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.718 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.83 -49.26 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.1 m-85 -69.5 -37.73 77.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.424 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.48 -30.96 63.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 0.0 110.38 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 m -74.69 -31.9 62.02 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.528 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.28 -13.85 29.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.66 -40.35 9.0 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -42.8 38.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.918 0.389 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.21 -44.48 95.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.186 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.71 HD12 HG21 ' A' ' 47' ' ' ILE . 4.8 tt -69.04 -31.06 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.826 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -79.46 -32.56 42.65 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.024 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -40.77 95.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.0 -14.31 62.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.724 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.703 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.1 m-85 -96.4 39.67 1.15 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -57.46 113.85 1.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.47 -10.16 24.04 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.238 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.77 106.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.013 0.435 . . . . 0.0 110.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -89.37 0.43 56.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.298 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.669 ' CB ' HG22 ' A' ' 100' ' ' VAL . 63.1 m-70 -127.13 152.02 47.88 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.202 0.525 . . . . 0.0 111.405 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -150.91 120.27 6.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.833 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -113.1 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.89 102.43 11.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.462 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.949 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.49 121.02 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.44 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.98 -46.05 12.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.419 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.98 179.34 16.19 Favored Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.725 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.7 mt -69.68 -27.15 64.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -70.35 -17.51 63.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.693 0.282 . . . . 0.0 111.107 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.803 ' CB ' HG12 ' A' ' 137' ' ' VAL . 1.5 m-20 -83.41 -20.63 33.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.08 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.949 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.46 -16.46 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -57.87 -29.3 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.046 -0.409 . . . . 0.0 110.667 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.85 104.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.114 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -28.84 22.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.715 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.536 ' HA ' HD21 ' A' ' 166' ' ' LEU . 16.1 t -74.91 -34.15 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 110.965 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.4 m -57.96 -29.2 65.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.43 -53.94 4.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.217 0.532 . . . . 0.0 110.769 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.936 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.33 -21.69 27.42 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.192 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -85.98 -43.26 13.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -58.7 -33.14 69.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.075 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.824 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.401 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.3 -44.57 0.72 Allowed Glycine 0 C--N 1.322 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.922 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.65 -125.89 8.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -85.71 1.08 50.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.81 -15.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.401 HG23 ' HA3' ' A' ' 154' ' ' GLY . 90.9 t -80.8 112.64 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.23 0.538 . . . . 0.0 111.125 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.8 t -75.75 -27.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.269 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.32 147.03 9.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.233 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.936 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.5 OUTLIER -130.24 132.68 46.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.047 0.451 . . . . 0.0 110.713 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.42 27.86 17.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.866 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.83 -0.08 84.15 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.382 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -112.69 127.15 27.2 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 117.025 0.412 . . . . 0.0 110.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.37 141.11 94.77 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.154 1.903 . . . . 0.0 112.498 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.161 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.859 0.362 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.64 156.3 19.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -93.95 149.72 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.83 -178.96 34.29 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.571 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.9 t -114.68 152.6 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.047 0.451 . . . . 0.0 110.739 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.22 171.18 8.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.445 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG23 HG21 ' A' ' 11' ' ' VAL . 6.9 p -105.32 120.64 56.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.561 . . . . 0.0 110.563 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -61.98 144.42 55.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.622 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.2 m-20 -47.92 -26.41 1.7 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.0 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.33 -39.83 76.69 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.322 0.582 . . . . 0.0 110.395 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.853 HG21 HG23 ' A' ' 7' ' ' VAL . 48.5 t -60.05 -27.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.871 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -79.98 -49.45 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -58.08 -31.98 67.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.048 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.018 HG11 HG21 ' A' ' 36' ' ' VAL . 45.8 t -79.36 -31.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.103 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 29.6 t80 -73.02 -47.17 47.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.98 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 20' ' ' VAL . 79.4 m-20 -66.78 -29.8 69.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.064 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.52 -47.52 17.15 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.813 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.5 mtp -71.93 -20.11 61.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.446 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.38 -18.31 25.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 34.1 t -118.91 14.46 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.004 0.431 . . . . 0.0 111.525 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -59.92 112.27 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.966 0.412 . . . . 0.0 110.976 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -121.41 144.05 48.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.542 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.4 p -92.73 116.32 28.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.24 -67.27 1.01 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.843 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.0 p -131.49 138.85 33.63 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.884 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.21 -25.6 13.61 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.267 1.978 . . . . 0.0 112.155 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.52 -40.68 89.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.569 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.73 -30.77 32.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 19.9 mm -59.6 -29.36 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 7.6 ttpt -64.08 -23.78 67.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.717 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -97.32 -9.69 27.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.637 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.7 113.15 4.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 103.9 4.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 32.5 ttmt -91.07 -28.77 17.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.823 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.03 140.34 25.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.018 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.34 138.9 7.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.22 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.031 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.2 mt -107.43 136.05 47.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.648 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.668 ' CD1' HG22 ' A' ' 49' ' ' VAL . 58.1 m-85 -101.45 145.46 28.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.214 0.53 . . . . 0.0 111.54 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -138.09 172.86 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.792 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.711 HD11 ' CG2' ' A' ' 116' ' ' ILE . 4.1 mt -81.07 135.56 35.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.767 0.318 . . . . 0.0 110.476 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.74 171.48 2.06 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.1 -20.52 6.71 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.007 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -84.64 -15.7 44.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 1.5 ttmt 55.83 32.26 19.25 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.111 0.482 . . . . 0.0 111.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 ttpp -122.41 -10.93 8.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.852 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 40' ' ' LEU . 15.0 pt20 -142.83 174.52 10.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.7 0.286 . . . . 0.0 111.396 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.873 HG21 HD12 ' A' ' 124' ' ' ILE . 18.8 mm -103.84 112.37 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.069 0.462 . . . . 0.0 111.623 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 tt -125.13 157.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.18 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 14' ' ' VAL . 52.0 t -75.71 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -111.97 111.41 22.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.139 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -27.98 44.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.061 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.51 61.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.11 75.55 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.17 0.51 . . . . 0.0 111.462 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.732 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.27 42.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.587 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.823 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.6 mt -137.53 115.73 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.0 110.846 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 HD12 ' OD1' ' A' ' 59' ' ' ASP . 7.1 mt -94.56 171.03 9.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.068 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.9 t -78.96 -23.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.514 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.82 -30.79 22.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.465 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.7 -37.01 75.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.832 0.348 . . . . 0.0 110.764 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 67' ' ' PRO . 14.3 mt -74.12 99.82 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.561 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -5.69 21.95 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.351 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.16 -59.18 1.97 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 -7.8 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.107 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 47.5 t -114.67 137.29 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 120.823 0.344 . . . . 0.0 111.436 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.24 -28.68 20.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.17 129.68 3.91 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.171 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' A' ' 60' ' ' ILE . 18.1 Cg_endo -62.92 -30.1 76.67 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.026 1.818 . . . . 0.0 111.975 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -71.6 -59.59 2.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.585 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.5 m -53.68 -32.52 52.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 111.406 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.14 89.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.89 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.05 -37.65 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.543 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 68' ' ' TYR . 92.3 t -61.25 -32.65 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -77.3 -31.73 54.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.385 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.1 mt -75.24 -37.44 61.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 111.345 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.6 mt -55.28 117.7 15.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.66 122.03 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.633 2.222 . . . . 0.0 111.337 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mt -69.12 -24.76 64.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.924 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.42 14.65 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.447 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.68 135.88 15.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.401 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 10.4 m -89.42 157.07 18.28 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 110.529 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.8 mtm-85 -164.17 171.04 15.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.5 m-85 -116.99 159.99 21.63 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.031 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.4 131.99 11.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.097 0.475 . . . . 0.0 111.997 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.813 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.06 129.92 55.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.641 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.0 t80 -141.2 152.01 44.26 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.025 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.4 t70 -104.58 113.28 26.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.666 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.688 ' CB ' HD13 ' A' ' 153' ' ' LEU . . . -84.19 108.16 16.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.413 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.927 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.1 m -96.62 113.65 25.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.848 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -135.77 164.44 27.89 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.163 0.506 . . . . 0.0 111.102 -179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -133.15 123.39 25.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.553 178.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 158' ' ' VAL . 56.5 p -93.74 177.56 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -74.09 -4.0 32.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.987 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -110.55 -47.5 3.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.744 0.306 . . . . 0.0 111.247 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 m -161.31 150.45 16.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.502 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -81.81 131.69 35.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.004 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -138.54 157.64 45.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 111.718 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.927 ' HG2' HG23 ' A' ' 88' ' ' THR . 5.1 mp0 -133.24 150.61 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -155.7 175.6 13.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.896 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -127.12 145.67 50.66 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.376 0.607 . . . . 0.0 111.573 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 153' ' ' LEU . 14.3 t -128.52 143.92 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.169 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 125' ' ' LYS . 6.1 t80 -96.53 108.74 21.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.82 143.48 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.252 0.549 . . . . 0.0 112.02 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.5 t80 -120.78 106.5 11.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.656 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.9 t-105 -88.82 109.3 20.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.808 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.94 86.8 20.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 59.8 Cg_endo -72.96 159.97 46.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.304 2.003 . . . . 0.0 112.77 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.32 -11.45 59.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.303 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.39 -12.72 48.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.921 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -74.19 145.25 82.9 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.72 147.25 50.36 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.247 1.965 . . . . 0.0 111.993 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.37 -31.46 54.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.28 -22.67 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.13 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.6 t -84.76 -38.11 20.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.519 . . . . 0.0 109.773 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -74.68 -31.05 61.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.478 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -41.77 43.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.711 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -58.76 -48.25 86.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.463 0.649 . . . . 0.0 110.446 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.4 m-85 -70.96 -38.49 72.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.364 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -54.8 -30.94 58.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.75 -31.16 56.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.726 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.529 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.46 -14.46 30.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.36 179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.406 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.7 -40.65 13.68 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -43.71 45.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.777 0.322 . . . . 0.0 110.655 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.37 -45.18 94.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.345 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.873 HD12 HG21 ' A' ' 47' ' ' ILE . 8.4 tt -66.66 -31.04 51.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.051 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -83.09 -31.63 27.18 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.275 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.36 87.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.826 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.686 ' HG3' HD11 ' A' ' 12' ' ' ILE . 20.7 mmtm -72.98 -9.27 58.54 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.889 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.0 m-30 -95.46 40.53 1.11 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.4 m -59.45 114.93 2.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.8 -10.11 25.49 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 5.0 tp -69.81 104.42 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.028 0.442 . . . . 0.0 110.123 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -89.69 0.01 57.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.155 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.555 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.1 m-70 -129.57 140.71 51.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.324 0.583 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.43 140.66 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.75 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.802 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -130.56 124.15 31.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -106.9 102.7 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.6 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 122.6 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -86.85 -45.54 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.08 -179.3 15.75 Favored Glycine 0 CA--C 1.504 -0.612 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.429 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.704 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -71.35 -28.53 64.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.5 m-20 -70.97 -16.29 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.792 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -82.99 -20.38 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.57 -16.74 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.52 -30.28 53.2 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 122.017 -0.427 . . . . 0.0 110.711 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -67.21 104.83 1.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.169 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -31.63 43.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -72.21 -34.24 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.144 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.528 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 18.7 m -57.03 -29.19 63.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.802 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.9 tp -88.12 -56.78 3.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.4 -18.74 30.62 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.613 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.4 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 2.7 mt-10 -86.01 -40.75 15.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.01 0.405 . . . . 0.0 112.054 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -53.23 -37.92 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.879 HD11 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -89.45 -47.28 8.1 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 112.32 -178.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.88 -44.46 1.11 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.136 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 96.33 -131.1 10.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.75 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.78 1.35 52.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.73 -14.7 9.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 91' ' ' THR . 93.1 t -83.07 121.53 36.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.9 -27.57 12.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.228 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.93 152.65 17.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.849 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp -131.85 131.12 42.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.538 ' CD ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER 46.78 29.49 1.0 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.288 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.36 -4.38 66.96 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.99 130.29 23.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 117.018 0.409 . . . . 0.0 110.481 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.92 141.74 21.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.166 1.91 . . . . 0.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.766 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.804 0.335 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.92 123.68 44.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -167.66 -47.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.67 -177.5 27.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.572 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.0 t -112.36 152.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 110.543 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.66 171.17 9.04 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.698 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.878 HG23 HG21 ' A' ' 11' ' ' VAL . 4.3 p -104.1 119.06 52.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.322 0.582 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -61.72 144.48 54.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.557 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.652 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.8 t70 -48.27 -25.84 1.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.904 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.897 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.3 tp10 -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.878 HG21 HG23 ' A' ' 7' ' ' VAL . 40.8 t -60.48 -27.49 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.821 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.737 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -78.87 -49.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -56.67 -29.51 62.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.085 HG11 HG21 ' A' ' 36' ' ' VAL . 31.8 t -78.95 -37.26 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.289 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 20.0 t80 -71.03 -44.76 65.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.699 ' OD1' HG22 ' A' ' 12' ' ' ILE . 3.8 m120 -65.54 -29.57 70.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -81.11 -47.15 13.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.825 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.1 mtp -70.52 -20.78 62.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 15' ' ' PHE . 5.5 mmmt -91.48 -16.24 27.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.196 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.6 t -118.55 15.14 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.724 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -60.05 111.75 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.951 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -121.88 104.71 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.532 ' CA ' HD11 ' A' ' 29' ' ' ILE . 36.5 p -61.95 115.95 4.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.009 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.92 -72.24 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.408 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.2 p -132.04 148.49 70.05 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.298 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -39.11 -37.38 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.255 2.636 . . . . 0.0 113.717 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.94 -33.04 71.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.597 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.11 -35.25 31.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CA ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -61.92 -28.65 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.299 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 18.7 ttpt -65.51 -26.13 67.77 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.71 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -93.89 -11.35 31.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.499 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 138.01 58.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 107.56 19.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 57' ' ' VAL . 8.4 ttpp -95.87 -30.25 13.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.888 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -147.97 146.32 28.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.085 HG21 HG11 ' A' ' 14' ' ' VAL . 3.3 m -157.25 144.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.093 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -113.45 134.59 54.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.174 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 49' ' ' VAL . 28.2 m-85 -101.9 142.05 33.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.064 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.93 173.7 11.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.795 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.785 HD11 HG23 ' A' ' 116' ' ' ILE . 5.6 mt -80.75 134.93 35.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.84 0.352 . . . . 0.0 110.713 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.97 171.41 2.21 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.647 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -54.36 -20.55 7.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.95 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.83 -15.89 46.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.646 0.26 . . . . 0.0 111.28 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.8 ttmm 55.41 32.25 18.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.047 0.451 . . . . 0.0 111.356 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 ttpp -122.64 -10.86 8.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.95 174.35 10.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.494 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.82 HG21 HD12 ' A' ' 124' ' ' ILE . 21.8 mm -103.64 112.06 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.136 0.494 . . . . 0.0 111.617 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.0 tt -124.71 153.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.23 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 38' ' ' PHE . 59.9 t -75.87 146.29 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.828 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -110.61 111.84 23.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.131 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -29.03 28.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . . . -75.05 -19.63 59.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.903 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -122.05 75.07 1.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 111.622 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.662 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.65 160.27 42.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.212 178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.888 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.0 mt -135.21 114.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.125 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.78 172.75 7.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.783 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.0 t -80.03 -22.4 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.086 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.73 -36.95 12.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.0 m-20 -55.64 -38.52 69.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.707 0.289 . . . . 0.0 111.14 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.52 101.24 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.676 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.43 -9.23 24.33 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.37 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 -59.27 1.82 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.67 -7.75 7.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.152 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 59' ' ' ASP . 44.2 t -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 120.912 0.387 . . . . 0.0 111.476 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.13 -37.55 87.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.698 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 149.15 16.25 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.973 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 36.4 Cg_endo -71.91 -30.47 13.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.117 1.878 . . . . 0.0 111.671 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.1 t80 -71.27 -53.24 14.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.1 m -57.98 -33.83 69.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.734 0.302 . . . . 0.0 110.947 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.07 98.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.569 0.7 . . . . 0.0 109.575 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.901 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -72.19 -38.54 69.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.0 t -62.31 -28.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.988 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.46 -31.83 37.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.099 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.903 HD22 ' HG3' ' A' ' 53' ' ' LYS . 22.7 mt -77.57 -35.14 53.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.68 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.5 mt -55.51 112.63 4.44 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.74 121.74 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mt -68.76 -26.15 65.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.841 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.53 14.38 26.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.479 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.78 137.27 16.76 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.683 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 3.9 m -96.62 145.32 25.85 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.44 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -157.81 175.44 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 68.8 m-85 -117.27 159.7 22.27 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.83 0.347 . . . . 0.0 110.62 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.093 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.27 134.15 13.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.522 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.825 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.0 tp -108.51 131.68 54.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.635 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 11.6 t80 -142.34 152.15 42.63 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.42 0.629 . . . . 0.0 111.156 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -102.71 112.82 25.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.31 109.31 18.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.838 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.872 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.3 m -94.33 114.45 26.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.867 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.6 p90 -136.31 164.7 27.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.326 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -133.52 124.06 26.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.019 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.474 HG21 ' HE3' ' A' ' 96' ' ' LYS . 8.5 p -89.63 177.22 6.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.5 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -74.28 -4.73 37.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.017 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.85 -43.18 3.84 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.955 0.407 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -160.67 163.41 32.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.06 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.2 pttt -98.9 133.37 43.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.389 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -140.65 163.68 32.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.135 0.493 . . . . 0.0 111.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.872 ' HG2' HG23 ' A' ' 88' ' ' THR . 12.1 mp0 -133.23 152.78 51.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.63 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -157.14 175.6 13.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.647 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -127.91 145.29 51.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.322 0.582 . . . . 0.0 111.301 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.788 HG21 HD21 ' A' ' 153' ' ' LEU . 45.8 t -128.8 149.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.315 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -97.56 108.75 21.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -100.92 142.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.286 0.565 . . . . 0.0 111.953 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 105' ' ' ALA . 2.3 t80 -119.12 106.54 12.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.587 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.7 t-105 -89.05 109.17 20.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . . . -137.02 86.45 20.5 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.95 158.14 42.55 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.188 1.926 . . . . 0.0 112.67 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -9.05 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.493 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -12.91 48.16 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 110.937 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -78.93 137.81 57.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.073 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.4 Cg_exo -61.24 150.52 84.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.115 1.877 . . . . 0.0 112.2 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -31.78 65.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -68.51 -25.33 64.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.888 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.9 t -81.6 -38.86 25.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.135 0.493 . . . . 0.0 109.786 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.03 -32.29 65.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.416 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mtp -77.06 -39.53 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.583 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.785 HG23 HD11 ' A' ' 40' ' ' LEU . 3.8 tt -60.16 -51.45 72.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 110.675 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.446 ' CE2' HD12 ' A' ' 40' ' ' LEU . 37.5 m-85 -69.92 -37.94 76.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.086 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.5 -29.72 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.017 0.437 . . . . 0.0 110.537 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -75.65 -30.4 59.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.594 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.74 -14.1 26.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.353 179.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 124' ' ' ILE . 16.0 pttt -45.42 -39.1 6.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -41.43 44.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.388 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.67 -48.19 81.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.115 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.82 HD12 HG21 ' A' ' 47' ' ' ILE . 8.2 tt -62.62 -33.28 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -31.7 34.23 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 110.192 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -43.37 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.993 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.737 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.8 mmpt? -73.14 -9.34 58.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.866 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.725 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -95.1 40.17 1.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.9 m -57.65 113.66 1.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.99 -11.02 22.73 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.254 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.88 107.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 109.97 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -1.43 58.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.304 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.716 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.5 m-70 -125.17 150.21 47.16 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.299 0.571 . . . . 0.0 111.413 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.04 125.73 11.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.661 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -118.16 123.07 44.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -105.83 102.52 11.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.473 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.13 123.04 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.59 -45.97 11.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -127.05 177.98 17.1 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.3 mt -66.57 -28.6 68.65 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 6.6 m-20 -69.86 -16.49 63.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.642 0.258 . . . . 0.0 111.306 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.768 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.0 m-20 -85.08 -21.04 29.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.197 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.63 -20.56 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -55.33 -29.02 57.51 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.131 -0.355 . . . . 0.0 110.937 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.64 104.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.975 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -31.41 15.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.012 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.0 -34.66 64.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.296 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 142' ' ' ASP . 59.9 m -57.36 -29.27 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.866 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.7 tp -88.0 -55.1 3.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.283 0.563 . . . . 0.0 111.196 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.92 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.19 -20.98 30.68 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.377 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -86.2 -41.49 14.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 111.818 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -59.57 -35.39 74.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.788 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.68 -48.37 10.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.134 0.492 . . . . 0.0 111.377 -179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.75 -44.7 0.68 Allowed Glycine 0 C--N 1.323 -0.189 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.889 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.44 -122.57 7.57 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.672 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -87.98 1.03 55.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -95.27 -15.12 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.506 HG23 ' HA3' ' A' ' 154' ' ' GLY . 98.7 t -81.49 113.0 20.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 111.427 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.83 -26.92 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.253 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.22 148.72 16.94 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.936 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.92 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -134.89 135.41 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.179 0.514 . . . . 0.0 111.208 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.92 26.91 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.29 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.78 -1.95 85.62 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.439 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 23.5 mmtt -115.45 138.77 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.942 0.371 . . . . 0.0 110.493 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.44 143.01 28.62 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.093 1.862 . . . . 0.0 112.631 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.944 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.23 147.2 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.076 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.44 157.18 11.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.73 179.46 28.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 116' ' ' ILE . 39.7 t -97.4 158.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.087 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.27 170.83 12.59 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.963 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -105.58 118.56 53.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.439 0.638 . . . . 0.0 110.823 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -60.92 144.55 52.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.766 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -48.76 -25.95 2.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.965 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.0 tt0 -59.32 -34.99 73.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.212 0.529 . . . . 0.0 110.497 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 89.3 t -64.58 -27.27 42.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.717 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.51 -51.33 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -53.7 -29.86 41.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.365 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 49' ' ' VAL . 29.7 t -78.8 -37.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 8.9 t80 -69.55 -45.7 68.14 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 20' ' ' VAL . 19.4 m-80 -65.79 -30.95 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.147 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -77.71 -46.37 22.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.691 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.3 mtp -71.54 -20.52 62.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.557 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -91.4 -16.57 27.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.946 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.5 t -118.82 12.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.826 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -60.38 111.66 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.027 0.441 . . . . 0.0 111.003 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -122.11 135.52 54.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.527 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.672 ' HA ' HD11 ' A' ' 29' ' ' ILE . 47.4 p -86.97 115.92 24.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.797 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.5 p -117.59 -64.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -131.82 139.64 35.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.81 -28.76 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.149 2.566 . . . . 0.0 113.371 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -74.36 -33.87 63.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.45 -35.18 40.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -61.8 -28.15 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.037 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.5 ttmm -63.32 -27.62 69.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.921 0.391 . . . . 0.0 110.688 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -93.71 -11.11 32.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -62.75 121.73 14.16 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.749 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -83.33 104.01 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.972 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' HG22 ' A' ' 57' ' ' VAL . 17.9 ttmt -90.64 -28.59 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.43 143.14 24.6 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.993 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -154.79 138.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.988 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.1 mt -101.29 149.66 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.661 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -119.47 144.45 46.98 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.118 -178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.48 173.72 11.55 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.316 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -80.76 136.07 36.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.777 0.322 . . . . 0.0 110.742 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.6 2.04 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.45 -20.39 7.5 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.966 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.66 -15.7 44.49 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.633 0.254 . . . . 0.0 111.358 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 55.04 33.59 20.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 -14.83 8.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.972 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.548 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.0 pt20 -142.82 175.04 10.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.784 0.326 . . . . 0.0 111.377 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 124' ' ' ILE . 28.6 mm -101.65 122.39 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.301 0.572 . . . . 0.0 111.447 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tt -133.73 148.66 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.545 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.062 HG21 HG21 ' A' ' 14' ' ' VAL . 97.9 t -75.8 144.44 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.244 0.545 . . . . 0.0 111.98 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -100.64 112.33 24.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.675 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -29.73 64.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.4 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.84 -19.49 58.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.905 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.918 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.0 mptt -121.14 73.87 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.228 0.537 . . . . 0.0 111.364 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 160.43 41.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.436 179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.4 mt -134.4 112.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.181 0.515 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.69 173.7 7.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.949 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.2 t -79.93 -23.32 11.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.46 -39.8 17.39 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.749 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' HG21 ' A' ' 64' ' ' VAL . 4.3 m-20 -55.25 -39.06 69.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 67' ' ' PRO . 12.8 mt -72.62 100.63 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.51 -12.1 21.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.98 -60.2 1.61 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.608 0.718 . . . . 0.0 109.064 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 -8.49 8.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.127 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.1 t -114.7 150.41 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 120.89 0.376 . . . . 0.0 111.308 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -102.29 -29.41 11.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.136 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.67 122.42 2.69 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.346 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' O ' HD13 ' A' ' 55' ' ' ILE . 11.0 Cg_endo -56.83 -29.32 80.82 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.141 1.894 . . . . 0.0 111.751 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.6 t80 -70.04 -59.01 3.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.552 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.6 m -53.85 -32.34 52.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 0.0 111.39 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.3 91.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.618 0.723 . . . . 0.0 109.27 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.94 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.72 -39.29 73.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.397 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 68' ' ' TYR . 94.0 t -60.55 -30.78 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.587 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 -34.24 59.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.918 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.68 -33.8 53.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.994 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 15.7 mt -55.54 117.22 14.2 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -89.81 121.83 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.425 2.083 . . . . 0.0 111.188 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -70.86 -24.7 62.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.014 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -101.28 14.1 33.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.43 138.26 18.0 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.731 0.3 . . . . 0.0 111.518 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.402 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.5 m -90.91 154.86 19.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.945 0.402 . . . . 0.0 110.472 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -164.19 175.42 10.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 73.2 m-85 -120.09 161.17 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.988 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.61 132.53 13.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.098 0.475 . . . . 0.0 111.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.62 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.94 116.51 32.09 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.7 t80 -131.05 151.97 50.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.386 0.612 . . . . 0.0 111.27 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.8 t70 -104.08 114.39 28.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.478 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.54 108.77 18.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.134 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.895 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.5 m -97.17 112.87 24.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.5 p90 -136.47 164.98 26.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.099 0.476 . . . . 0.0 111.382 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 12.9 pt-20 -132.82 123.74 26.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.714 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 p -91.65 175.24 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -73.2 -6.12 43.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -109.72 -42.86 4.16 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -161.0 163.34 31.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.019 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -100.91 132.69 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.039 179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.29 162.93 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.895 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.9 mp0 -133.37 150.75 51.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.53 175.6 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.45 144.61 50.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.316 0.579 . . . . 0.0 110.99 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.818 HG21 HD21 ' A' ' 153' ' ' LEU . 40.7 t -130.37 147.56 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.747 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.62 ' HA ' HD22 ' A' ' 84' ' ' LEU . 18.8 t80 -96.7 109.11 21.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.785 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -97.33 141.4 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.4 0.619 . . . . 0.0 111.778 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 5.1 t80 -117.37 106.23 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.553 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.75 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.5 t-105 -89.01 110.07 20.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.72 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.7 86.31 22.57 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 51.4 Cg_endo -69.45 161.06 47.4 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.217 1.945 . . . . 0.0 112.722 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 -9.93 59.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.246 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -13.7 32.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 111.383 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.31 135.35 79.32 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -59.14 148.5 85.41 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.101 1.868 . . . . 0.0 112.143 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -55.77 -32.46 63.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -67.63 -24.18 65.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.126 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -82.24 -38.96 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.101 0.477 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.12 -32.36 63.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.512 ' HG3' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -75.43 -42.2 54.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.335 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 40' ' ' LEU . 3.3 tt -58.5 -49.2 83.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.523 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.7 m-85 -69.9 -37.11 75.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.75 -44.74 58.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.91 0.386 . . . . 0.0 111.121 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.0 m -68.79 -31.05 69.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.479 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.621 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.7 p -77.94 -27.93 49.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.25 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 124' ' ' ILE . 29.7 ttpt -42.84 -45.05 4.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.862 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.61 -42.7 67.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.381 . . . . 0.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.88 79.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.263 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 47' ' ' ILE . 5.6 tt -64.5 -31.87 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.097 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.89 -33.05 40.26 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 110.088 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -43.16 85.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.952 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' ILE . 5.5 mmpt? -73.47 -10.26 59.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.693 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.8 m-85 -95.07 42.26 1.09 Allowed 'General case' 0 N--CA 1.458 -0.053 0 CA-C-O 120.929 0.395 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.0 m -57.79 112.96 1.64 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.48 -10.72 21.76 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.321 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.9 tp -70.16 104.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.019 0.437 . . . . 0.0 110.197 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -91.04 5.36 49.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.387 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.746 ' CB ' HG22 ' A' ' 100' ' ' VAL . 82.0 m-70 -131.6 153.06 50.3 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.161 0.505 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -152.11 123.62 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.83 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.804 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.8 t90 -113.71 122.76 48.1 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -103.65 102.81 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.941 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.931 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.06 123.08 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.432 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -86.6 -45.9 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.528 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.41 -179.43 15.73 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.5 mt -70.8 -26.79 63.48 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.232 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.67 -17.29 63.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.722 0.296 . . . . 0.0 111.324 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.807 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.8 m-20 -86.25 -19.23 30.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.293 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.931 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.78 -18.95 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -56.45 -31.95 64.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.799 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -65.82 104.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.123 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -31.62 28.63 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.566 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.5 p -71.2 -38.35 72.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 52.9 m -56.33 -27.02 54.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.891 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.804 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 11.7 tp -87.44 -55.45 3.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 110.812 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.93 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -60.46 -17.66 48.29 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.078 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -85.54 -37.64 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.868 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mmmt -63.89 -34.6 78.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.871 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.818 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.33 -47.9 10.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.151 0.5 . . . . 0.0 111.095 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -114.71 -44.53 0.69 Allowed Glycine 0 C--N 1.322 -0.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.991 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.37 -122.39 7.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.454 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -88.27 1.23 55.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.59 -14.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.515 HG23 ' HA3' ' A' ' 154' ' ' GLY . 94.3 t -81.05 112.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.338 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -77.36 -26.88 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.269 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.42 148.45 14.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.93 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -134.43 137.3 43.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.161 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 58.14 24.92 11.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.413 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.19 82.13 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.423 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -118.66 141.9 30.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.918 0.359 . . . . 0.0 110.375 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.51 142.79 22.71 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.456 2.104 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.649 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.907 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.11 140.22 31.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.18 -41.45 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.36 120.63 1.67 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.511 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.4 t -124.01 152.81 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.952 0.406 . . . . 0.0 110.843 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.84 171.38 9.7 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.666 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 11' ' ' VAL . 3.2 p -102.11 120.91 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 0.0 110.553 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.01 144.7 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.509 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 12' ' ' ILE . 87.7 m-20 -48.85 -25.36 1.84 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.06 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.853 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.2 tp10 -59.44 -36.04 75.17 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.245 0.545 . . . . 0.0 110.482 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 7' ' ' VAL . 58.6 t -63.43 -27.84 43.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.613 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.86 -51.51 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -53.62 -29.77 39.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.413 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.04 HG11 HG21 ' A' ' 36' ' ' VAL . 21.7 t -80.16 -35.91 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 128' ' ' PHE . 19.2 t80 -71.54 -44.3 64.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.836 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 20' ' ' VAL . 47.6 m-20 -68.17 -31.33 70.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.036 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -77.66 -45.81 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.533 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.804 ' SD ' HD23 ' A' ' 84' ' ' LEU . 74.4 mtp -72.71 -19.6 61.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.59 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -90.88 -18.48 24.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.69 12.49 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 112.15 1.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -121.33 139.02 53.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.549 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -89.97 116.31 27.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.91 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -110.68 -65.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.708 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -131.34 136.83 29.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.541 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.86 -29.09 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.185 2.59 . . . . 0.0 113.581 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -73.7 -33.88 64.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.71 0.291 . . . . 0.0 111.449 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.38 -34.94 35.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.107 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.88 -24.79 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.495 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.3 mtpt -65.38 -27.92 68.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.501 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -93.55 -9.91 36.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.542 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.74 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.74 116.45 6.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.723 0.297 . . . . 0.0 110.995 -179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -73.8 118.99 17.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 57' ' ' VAL . 81.1 tttt -110.57 -26.92 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.918 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.5 140.77 26.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.04 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -156.19 138.17 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.172 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.007 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -107.95 135.29 49.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.831 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CD2' HG22 ' A' ' 49' ' ' VAL . 49.7 m-85 -101.83 143.57 31.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.405 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -137.45 172.21 13.31 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.616 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.5 mt -81.44 136.51 35.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.834 0.35 . . . . 0.0 110.55 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.81 171.29 2.18 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.77 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.82 -20.88 6.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.085 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.43 -15.59 45.63 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 7.4 ttmm 54.98 32.62 18.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.172 0.511 . . . . 0.0 111.265 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 5' ' ' VAL . 48.8 tptt -120.83 -13.05 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.793 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.4 pt20 -142.67 174.42 10.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.886 0.374 . . . . 0.0 111.533 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.81 HG21 HD12 ' A' ' 124' ' ' ILE . 23.0 mm -101.86 116.93 46.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.536 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 tt -130.38 154.25 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.991 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 14' ' ' VAL . 56.3 t -75.43 146.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.652 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -109.8 110.74 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.126 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -53.98 -30.49 47.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.59 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.8 -9.83 59.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.964 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.549 ' HA ' HD22 ' A' ' 74' ' ' LEU . 3.8 mptt -134.35 74.24 1.53 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.136 0.493 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.667 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.59 160.01 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.705 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.918 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 7.8 mt -136.93 122.3 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.173 0.511 . . . . 0.0 111.054 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 59' ' ' ASP . 4.1 mt -98.86 175.55 5.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.038 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -81.28 -22.18 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.315 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -88.52 -32.87 10.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.315 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -59.32 -32.98 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.62 HG21 ' HG3' ' A' ' 67' ' ' PRO . 7.2 mt -74.89 100.72 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.49 22.54 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.202 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -59.51 1.78 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.83 -12.21 9.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.941 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 61.5 t -114.58 122.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.267 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.92 -33.43 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.809 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.18 149.44 16.6 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' A' ' 60' ' ' ILE . 7.6 Cg_exo -68.88 -29.89 27.51 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.147 1.898 . . . . 0.0 111.357 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.29 -59.66 2.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.352 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.7 m -53.45 -33.83 55.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -65.73 -42.94 90.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 0.0 109.203 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.11 -37.84 78.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.448 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.11 -31.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.566 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -36.98 67.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.21 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 53' ' ' LYS . 11.5 mt -74.75 -37.03 62.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.934 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 19.4 mt -54.88 116.54 11.46 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.48 122.21 0.9 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.488 2.125 . . . . 0.0 111.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 4.9 mt -68.83 -23.51 64.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.68 14.36 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.24 139.31 19.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.83 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 7.9 m -92.27 151.06 20.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.424 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -160.26 169.26 23.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.1 m-85 -113.24 158.41 20.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.007 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.85 131.76 11.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.026 0.441 . . . . 0.0 112.118 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.804 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.9 tp -109.0 131.31 55.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.2 t80 -144.09 152.25 40.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.368 0.604 . . . . 0.0 110.954 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 10.4 t70 -100.0 112.59 24.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.539 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -85.64 110.34 19.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.823 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.6 m -98.41 114.76 27.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.923 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.851 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.42 164.65 27.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -129.71 123.77 31.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.028 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.85 176.46 6.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.709 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -73.27 -5.79 41.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.99 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -111.45 -42.72 3.82 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.914 0.388 . . . . 0.0 111.032 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.0 m -160.71 163.54 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.246 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.53 130.41 46.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.118 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 164.83 27.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.831 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.823 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.1 mp0 -133.28 151.79 51.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.68 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.11 175.87 13.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.491 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.66 144.75 50.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 0.0 110.998 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HD21 ' A' ' 153' ' ' LEU . 37.1 t -129.59 148.83 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.427 ' CE2' ' HD3' ' A' ' 125' ' ' LYS . 14.2 t80 -96.46 108.86 21.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.84 141.76 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.279 0.562 . . . . 0.0 111.763 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.3 t80 -118.8 106.61 12.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.854 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.729 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.9 t-105 -88.78 110.12 20.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.482 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.26 23.13 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 48.5 Cg_endo -69.06 161.04 47.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.227 1.951 . . . . 0.0 112.758 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 -10.76 59.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.22 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -13.88 35.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.717 0.294 . . . . 0.0 111.53 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -71.61 148.05 92.59 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.29 146.2 39.92 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.81 -30.33 44.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.238 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -23.88 64.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.928 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -84.63 -37.66 20.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 109.65 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -74.06 -30.55 62.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.541 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mmt -79.09 -41.59 28.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.591 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.692 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.2 tt -57.66 -49.14 81.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.281 0.563 . . . . 0.0 110.686 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 82' ' ' TYR . 27.1 m-85 -68.9 -36.88 78.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.63 67.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.186 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -33.52 65.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.8 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.507 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.23 -13.77 32.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.354 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -44.12 -39.0 3.98 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.76 -42.84 32.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.866 0.365 . . . . 0.0 110.339 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.41 95.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.136 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.81 HD12 HG21 ' A' ' 47' ' ' ILE . 10.1 tt -68.73 -30.38 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.902 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HD3' ' CE2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -81.31 -32.73 32.98 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.088 0.47 . . . . 0.0 110.261 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -58.15 -43.21 87.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.061 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 3.0 mmpt? -74.73 -9.17 58.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 131' ' ' ILE . 19.7 m-30 -97.66 40.59 1.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.095 0.474 . . . . 0.0 110.755 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 30.8 m -59.84 114.79 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.857 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.33 -11.49 21.85 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.143 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.6 tp -69.93 104.45 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.053 0.454 . . . . 0.0 109.927 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -90.3 4.08 51.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.439 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.673 ' HB3' HG13 ' A' ' 100' ' ' VAL . 66.6 m-70 -130.29 153.09 49.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.144 0.497 . . . . 0.0 111.511 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -151.08 120.36 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.957 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.792 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.36 122.71 48.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -105.44 102.69 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.759 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.08 121.28 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.392 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -84.22 -45.88 12.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.616 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.89 178.54 16.41 Favored Glycine 0 CA--C 1.502 -0.773 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.083 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.729 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.7 mt -70.15 -26.44 63.93 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.379 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.91 -17.62 62.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.806 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.99 -18.21 40.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.096 179.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.32 -17.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' LEU . 31.2 pttt -54.16 -32.42 55.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.6 OUTLIER -67.67 104.64 1.68 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.152 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -52.49 -29.34 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.45 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.7 m -72.41 -35.9 68.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 35.7 m -56.29 -28.67 59.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.631 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.792 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.1 tp -87.09 -56.32 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.231 0.539 . . . . 0.0 110.552 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.84 -21.3 15.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.607 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 25.6 tt0 -85.79 -47.21 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.151 0.476 . . . . 0.0 111.451 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -55.37 -23.34 23.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.746 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -93.2 -49.0 6.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.74 -44.86 0.62 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.099 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 96.3 -122.69 7.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.973 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -81.35 1.01 34.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.3 m -97.27 -15.67 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.024 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 89' ' ' TYR . 58.2 t -82.56 112.92 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.309 0.576 . . . . 0.0 111.127 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 92' ' ' LYS . 15.5 t -78.26 -22.14 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.602 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.36 151.22 9.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.892 HD13 ' HA2' ' A' ' 150' ' ' GLY . 1.1 tp -134.36 128.86 34.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.834 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.77 25.9 15.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.93 75.26 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.695 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.69 135.09 21.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 117.102 0.451 . . . . 0.0 110.733 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 138.2 55.8 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.198 1.932 . . . . 0.0 112.869 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.655 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.159 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.824 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.01 137.71 57.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -148.79 -65.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.02 -164.15 40.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG12 ' OG ' ' A' ' 120' ' ' SER . 13.4 t -100.58 152.23 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.723 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -122.52 171.23 9.26 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.54 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.758 HG23 HG21 ' A' ' 11' ' ' VAL . 6.3 p -104.12 118.65 51.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.348 0.594 . . . . 0.0 110.387 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.88 144.5 54.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.796 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' ILE . 6.6 m-20 -48.6 -26.44 2.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.784 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.7 tp10 -58.45 -34.5 70.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.253 0.549 . . . . 0.0 110.436 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.758 HG21 HG23 ' A' ' 7' ' ' VAL . 71.7 t -65.31 -26.96 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.671 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.44 -50.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -54.38 -31.06 53.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.352 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 49' ' ' VAL . 27.7 t -78.68 -36.5 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.412 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 128' ' ' PHE . 13.1 t80 -71.19 -43.73 66.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -69.09 -31.96 71.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.044 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.5 -46.04 34.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.292 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.426 ' SD ' HG12 ' A' ' 14' ' ' VAL . 72.0 mtp -72.69 -20.3 61.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.318 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HE2' HD11 ' A' ' 99' ' ' LEU . 11.9 tppt? -91.26 -17.76 25.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.999 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 20' ' ' VAL . 29.2 t -119.1 13.03 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 111.809 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.39 112.26 1.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.996 0.427 . . . . 0.0 110.946 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -121.24 149.85 42.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.434 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.907 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.7 p -97.7 116.54 30.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 111.314 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 p -118.14 -65.96 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.478 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -131.62 138.69 33.2 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.713 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.3 -26.02 10.82 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 112.307 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -66.88 -39.76 87.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.766 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -80.56 -31.2 36.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.907 HD11 ' HA ' ' A' ' 23' ' ' SER . 27.1 mm -59.52 -27.86 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 23.8 mtmt -64.61 -23.92 67.42 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.598 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -95.42 -10.94 28.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.446 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.73 111.72 3.84 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.79 0.329 . . . . 0.0 110.648 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -70.36 104.66 2.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HB2' HG22 ' A' ' 57' ' ' VAL . 16.6 tttt -88.62 -31.62 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.862 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.93 145.18 26.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.64 138.2 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.986 0.422 . . . . 0.0 111.407 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.95 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.0 mt -100.47 146.26 27.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.401 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.1 m-85 -112.72 144.87 41.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.105 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -144.15 172.38 12.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.033 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.753 HD11 HG23 ' A' ' 116' ' ' ILE . 3.9 mt -81.42 137.51 35.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.831 0.348 . . . . 0.0 110.477 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.46 171.36 1.98 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.26 -20.34 6.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.06 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.66 -15.62 41.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.307 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HG2' HD11 ' A' ' 116' ' ' ILE . 0.5 OUTLIER 56.19 32.0 19.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.113 0.482 . . . . 0.0 111.249 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.7 tttt -119.89 -13.38 9.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.841 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.514 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.8 pt20 -142.81 175.19 10.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 111.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 124' ' ' ILE . 23.9 mm -101.44 124.54 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.305 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.1 tt -139.57 151.96 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.612 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.952 HG21 HG21 ' A' ' 14' ' ' VAL . 84.7 t -75.15 144.7 11.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.111 0.482 . . . . 0.0 111.548 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.53 110.84 22.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.417 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -29.56 50.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.945 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.68 -19.94 61.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.81 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.3 mptt -125.28 78.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.38 0.61 . . . . 0.0 111.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.712 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.3 159.43 43.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.436 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.862 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mt -135.21 110.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.282 0.563 . . . . 0.0 111.171 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.9 mt -91.19 168.47 11.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.816 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 34' ' ' LYS . 16.3 t -75.39 -25.95 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.275 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -85.96 -29.83 24.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.116 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' HD12 ' A' ' 56' ' ' LEU . 9.9 m-20 -58.8 -37.96 77.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.2 mt -72.69 102.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 0.0 110.581 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -19.09 15.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.69 -61.03 1.52 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.649 0.738 . . . . 0.0 109.387 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -11.85 9.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.053 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.48 129.15 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.502 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.38 -30.44 61.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.56 143.63 12.8 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.474 ' O ' HD13 ' A' ' 55' ' ' ILE . 36.2 Cg_endo -71.25 -31.63 14.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.091 1.86 . . . . 0.0 111.772 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.2 t80 -72.0 -59.65 2.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.1 m -52.25 -34.67 47.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.378 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -42.46 95.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.596 0.713 . . . . 0.0 109.171 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.833 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.91 -38.57 79.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.2 t -62.31 -34.29 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.532 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' HE3' HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -75.53 -29.75 59.55 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.397 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.81 HD22 ' HG3' ' A' ' 53' ' ' LYS . 14.0 mt -79.75 -37.15 36.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.34 . . . . 0.0 111.706 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.833 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.0 mt -56.04 118.4 20.6 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -91.44 122.3 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 111.782 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.82 -24.79 64.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.98 14.18 30.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.489 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.89 137.76 17.12 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.672 0.272 . . . . 0.0 111.52 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.8 m -93.37 146.34 23.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.354 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -155.36 175.08 14.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.208 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 69.3 m-85 -116.26 161.76 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.716 0.293 . . . . 0.0 110.329 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.95 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 129.81 11.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.148 0.499 . . . . 0.0 111.706 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.51 116.16 31.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.659 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 19.8 t80 -129.74 151.98 49.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.413 0.625 . . . . 0.0 111.38 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 8.5 t70 -105.68 114.17 28.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.253 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -84.8 108.31 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -95.69 106.71 18.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.381 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.852 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -132.5 165.04 25.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -142.46 125.57 16.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.412 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 158' ' ' VAL . 44.1 p -89.95 178.34 6.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.444 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -6.8 28.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.7 -45.66 4.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.778 0.323 . . . . 0.0 111.003 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.8 m -160.7 163.66 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.062 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -87.54 128.55 35.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.183 178.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 145.3 50.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.271 0.558 . . . . 0.0 112.282 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 88' ' ' THR . 8.4 mp0 -128.99 143.88 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.72 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -157.43 175.55 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -128.37 145.06 51.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.368 0.604 . . . . 0.0 111.227 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG21 HD21 ' A' ' 153' ' ' LEU . 40.2 t -130.31 147.97 33.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.758 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HA ' HD22 ' A' ' 84' ' ' LEU . 9.9 t80 -97.02 110.83 23.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.782 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.731 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.02 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 111.863 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.19 106.51 12.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.598 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.615 ' CE3' HD13 ' A' ' 75' ' ' LEU . 59.0 t-105 -88.88 108.67 19.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.644 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.85 87.2 19.97 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.28 159.9 48.41 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.283 1.989 . . . . 0.0 112.886 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.68 -8.73 58.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.405 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.79 33.94 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.979 -0.289 . . . . 0.0 111.491 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.27 148.09 85.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.283 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.33 150.07 36.25 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 14.0 mt -55.45 -29.6 58.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.303 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -66.71 -24.43 66.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.267 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 t -86.0 -36.67 19.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.565 . . . . 0.0 109.715 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.6 mttt -74.48 -28.91 61.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.487 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 -41.45 21.04 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.753 HG23 HD11 ' A' ' 40' ' ' LEU . 5.5 tt -57.77 -49.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.377 0.608 . . . . 0.0 110.576 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 27.2 m-85 -71.1 -37.51 72.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.601 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.49 -30.67 61.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.047 0.451 . . . . 0.0 110.587 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -75.97 -30.58 58.67 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.956 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.53 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.58 -12.97 26.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.532 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.02 -37.45 9.27 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.67 -42.53 34.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 110.3 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.01 -47.93 83.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.029 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.715 HD12 HG21 ' A' ' 47' ' ' ILE . 8.7 tt -64.08 -32.52 57.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.743 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -33.68 44.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.109 0.48 . . . . 0.0 110.207 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -43.27 88.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.992 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.691 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.7 mmpt? -73.24 -10.93 60.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.755 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 131' ' ' ILE . 18.3 m-30 -97.16 40.01 1.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.021 0.438 . . . . 0.0 110.558 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 m -60.06 113.8 2.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.98 22.69 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.306 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.3 tp -69.45 105.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.877 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -89.21 1.52 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.633 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.752 ' CB ' HG22 ' A' ' 100' ' ' VAL . 77.6 m-70 -128.3 152.54 48.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.137 0.494 . . . . 0.0 111.306 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -151.75 122.54 7.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.855 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -115.27 123.37 48.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -106.15 102.46 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.68 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.35 122.8 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -87.59 -45.49 10.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -125.16 165.98 18.08 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.461 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 75' ' ' LEU . 1.9 mm? -58.86 -26.87 64.62 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.417 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 10.2 m-20 -70.88 -17.4 62.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.61 0.243 . . . . 0.0 111.066 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.767 ' CB ' HG12 ' A' ' 137' ' ' VAL . 10.9 m-20 -83.28 -19.47 36.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.986 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.16 -16.78 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.37 -30.33 60.14 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.072 -0.392 . . . . 0.0 110.783 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.9 t0 -65.61 104.75 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.197 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -28.68 18.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -33.54 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.3 m -56.98 -30.9 64.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.645 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.6 tp -87.71 -56.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.106 0.479 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.916 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.36 -22.13 14.56 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.41 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 14.8 tt0 -86.14 -48.63 8.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.946 0.373 . . . . 0.0 111.436 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 3.2 mmmt -49.0 -29.26 4.63 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.802 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -92.42 -48.74 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 111.502 -178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.75 -44.85 0.62 Allowed Glycine 0 C--N 1.323 -0.16 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.864 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 102.15 -130.26 10.18 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.525 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -85.73 1.7 48.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.48 -14.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.57 ' HA ' HG22 ' A' ' 91' ' ' THR . 96.5 t -83.57 124.07 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.3 t -81.91 -29.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.427 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.44 151.81 19.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.556 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.916 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -130.21 125.9 36.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.92 30.39 1.96 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.026 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.75 -5.03 63.9 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.6 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.79 124.42 35.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 117.028 0.414 . . . . 0.0 110.526 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.37 140.72 42.57 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.024 1.816 . . . . 0.0 112.515 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.715 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.05 166.02 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p 59.01 107.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.09 110.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 116' ' ' ILE . 11.2 t -123.52 152.87 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 111.0 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.49 171.14 9.01 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.752 HG11 ' HG2' ' A' ' 127' ' ' LYS . 7.5 p -106.06 117.46 51.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.253 0.549 . . . . 0.0 110.661 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.14 143.85 56.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.8 p30 -50.67 -24.89 3.67 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.818 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 14' ' ' VAL . 2.5 tp10 -59.61 -36.46 76.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.326 0.584 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 7' ' ' VAL . 41.5 t -62.78 -28.53 45.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.3 mp -76.39 -49.52 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -52.61 -30.39 31.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.435 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.077 HG11 HG21 ' A' ' 36' ' ' VAL . 30.5 t -77.76 -37.36 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 24.2 t80 -69.86 -48.0 60.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . 72.1 m-20 -63.97 -29.07 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.12 -46.7 14.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.777 ' SD ' HD23 ' A' ' 84' ' ' LEU . 76.7 mtp -70.5 -20.39 62.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.499 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -91.18 -16.3 27.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.088 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 24.4 t -118.31 12.69 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 120.798 0.333 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -60.64 112.52 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.976 0.417 . . . . 0.0 110.953 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -121.33 139.37 53.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.543 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 29' ' ' ILE . 20.5 p -89.87 116.28 27.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.995 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -114.93 -64.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -131.69 137.17 29.74 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.601 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -40.72 -29.4 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.211 2.607 . . . . 0.0 113.602 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -72.81 -34.76 67.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.828 0.347 . . . . 0.0 111.133 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -78.07 -36.45 48.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.27 -22.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.651 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 14.5 ttpt -68.72 -27.66 66.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.351 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -92.34 -10.72 37.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.426 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.532 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.15 111.5 1.98 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.483 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 104.48 4.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.959 0.409 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB2' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -90.83 -28.44 18.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.071 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.11 145.82 27.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.036 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.077 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -157.55 142.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.087 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -111.43 134.97 52.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.13 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.71 ' CD2' HG22 ' A' ' 49' ' ' VAL . 33.2 m-85 -101.87 142.78 32.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -138.24 173.17 11.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.009 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.1 mt -81.01 137.15 36.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.901 0.381 . . . . 0.0 110.87 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.38 2.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -54.47 -20.4 7.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.78 -15.66 44.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.642 0.258 . . . . 0.0 111.317 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.8 tttm 55.44 32.85 19.73 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.971 0.415 . . . . 0.0 111.527 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -121.87 -11.12 8.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 pt20 -143.05 174.75 10.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.828 0.347 . . . . 0.0 111.304 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 124' ' ' ILE . 27.2 mm -103.38 119.64 52.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.135 0.493 . . . . 0.0 111.304 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.9 tt -134.44 154.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.083 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 14' ' ' VAL . 48.5 t -75.79 146.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.201 0.524 . . . . 0.0 112.021 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 6.4 mm-40 -107.83 112.0 24.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.87 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.75 -33.26 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.21 -19.01 60.67 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.906 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -118.58 74.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.347 0.594 . . . . 0.0 111.889 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.689 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.56 160.37 42.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.18 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.3 mt -134.66 115.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.147 0.499 . . . . 0.0 111.02 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.77 169.36 9.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.946 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 34' ' ' LYS . 11.0 t -78.42 -25.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.277 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.48 -29.72 23.7 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.386 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.07 -35.58 75.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 110.401 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.0 mt -72.92 102.3 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.96 -20.7 14.25 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.11 -60.96 1.62 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.623 0.725 . . . . 0.0 109.33 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -9.57 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.211 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 59' ' ' ASP . 38.7 t -114.69 122.92 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 120.864 0.364 . . . . 0.0 111.485 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -63.61 -36.49 83.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.995 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.07 149.89 17.19 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.261 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.5 Cg_endo -73.23 -31.81 9.01 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.106 1.871 . . . . 0.0 111.557 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.789 ' CE1' HG21 ' A' ' 72' ' ' VAL . 1.6 t80 -71.69 -52.46 17.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.998 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.1 m -57.7 -33.98 68.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.58 98.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.453 0.644 . . . . 0.0 109.327 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.43 -40.05 74.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.495 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CE1' ' A' ' 68' ' ' TYR . 67.9 t -63.23 -26.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.665 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -37.18 57.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.1 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 53' ' ' LYS . 12.0 mt -78.95 -34.64 44.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.7 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.885 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.3 mt -54.79 110.58 2.25 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.56 122.09 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.291 1.994 . . . . 0.0 111.496 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.7 mt -68.17 -25.03 65.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -100.06 13.86 32.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.54 138.2 17.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.625 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.415 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 m -92.96 151.5 19.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.978 0.418 . . . . 0.0 110.521 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -161.53 171.21 18.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.096 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.0 m-85 -116.61 158.44 23.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.087 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.87 134.62 13.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.996 0.427 . . . . 0.0 111.94 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.777 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.04 131.45 55.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 12.7 t80 -142.39 152.09 42.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.324 0.583 . . . . 0.0 110.981 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.0 t70 -100.67 114.43 28.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.028 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -86.44 108.77 18.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.817 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.8 111.82 24.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.872 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 161' ' ' LEU . 2.1 p90 -135.66 164.9 26.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.2 pt-20 -133.02 124.67 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.34 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 p -92.3 177.13 6.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.62 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -74.9 -3.98 35.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.55 -42.63 3.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.89 0.376 . . . . 0.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.9 m -160.81 163.28 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.146 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -93.27 133.0 36.93 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.56 148.28 52.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 112.295 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.817 ' HG2' HG23 ' A' ' 88' ' ' THR . 21.9 mp0 -133.23 142.77 48.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.377 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.76 176.25 12.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.828 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -124.79 144.76 50.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.32 0.581 . . . . 0.0 111.112 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 133' ' ' HIS . 33.7 t -126.73 148.73 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.07 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -96.8 110.18 22.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.669 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -101.11 142.12 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.298 0.571 . . . . 0.0 111.843 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.1 t80 -118.89 106.6 12.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.796 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 62.1 t-105 -89.02 108.54 19.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.88 86.57 21.0 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 59.2 Cg_endo -72.36 159.73 48.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.144 1.896 . . . . 0.0 112.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.51 -8.65 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.368 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 -13.83 33.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.496 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.19 135.97 76.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.2 Cg_exo -59.23 148.37 86.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.074 1.85 . . . . 0.0 112.047 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -56.14 -31.29 63.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.981 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -24.78 65.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -81.79 -39.1 24.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.121 0.486 . . . . 0.0 109.781 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.78 -32.32 63.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.1 -40.18 53.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.353 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.54 -50.8 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.171 0.51 . . . . 0.0 110.585 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.439 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 31.1 m-85 -67.66 -37.93 83.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.398 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.65 -30.16 65.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 110.22 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.04 -31.37 61.29 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.817 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -93.67 -13.4 27.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.423 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.414 ' O ' HG22 ' A' ' 124' ' ' ILE . 23.7 ttpt -43.76 -43.89 6.35 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.32 -39.74 71.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.903 0.382 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.07 -54.7 37.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.784 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -58.11 -33.07 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.137 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -79.85 -32.66 40.55 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 109.944 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -43.01 81.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.918 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HG2' HG11 ' A' ' 7' ' ' VAL . 9.9 mmpt? -70.56 -14.48 62.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.472 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.737 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.9 m-30 -94.62 41.44 1.09 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -61.24 113.37 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.17 -9.54 22.71 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.334 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.9 tp -69.67 106.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 110.139 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -89.35 -1.6 58.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.706 ' HB3' HG13 ' A' ' 100' ' ' VAL . 74.1 m-70 -123.73 150.87 43.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -149.68 119.22 6.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.964 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.745 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.6 t90 -111.73 122.36 47.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.07 102.45 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.712 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.93 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.93 123.0 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.464 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.87 -45.82 11.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.88 178.42 16.68 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.0 mt -68.36 -27.84 66.61 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.77 -16.91 62.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.65 0.262 . . . . 0.0 111.134 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.764 ' CB ' HG12 ' A' ' 137' ' ' VAL . 5.1 m-20 -82.94 -20.5 35.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.069 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.93 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.7 -19.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -28.28 38.77 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 122.066 -0.396 . . . . 0.0 111.035 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 4.6 t0 -68.94 104.66 2.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.261 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.5 mtm-85 -52.41 -27.23 14.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.74 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 89.2 p -76.47 -33.78 58.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 27.2 m -56.72 -30.43 63.5 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.496 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 13.2 tp -87.61 -56.41 3.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.209 0.528 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.957 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -50.34 -23.87 6.57 Favored Glycine 0 CA--C 1.518 0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.801 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.2 tp10 -86.42 -47.04 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.011 0.405 . . . . 0.0 111.484 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -51.04 -24.74 4.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.696 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -98.57 -48.02 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.411 . . . . 0.0 111.6 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.13 -44.88 0.65 Allowed Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.903 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 95.81 -125.46 8.41 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.681 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -83.97 1.07 45.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.86 -15.3 7.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.464 HG23 ' HA3' ' A' ' 154' ' ' GLY . 86.2 t -82.07 112.48 19.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.92 -26.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.297 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.07 149.45 17.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.094 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.957 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -136.12 137.97 41.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 59.65 26.26 15.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.987 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.16 -0.26 87.33 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.368 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -119.91 142.43 33.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.915 0.357 . . . . 0.0 110.477 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.29 143.4 15.01 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.26 1.973 . . . . 0.0 112.814 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.675 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.934 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.854 0.359 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.75 148.81 22.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.087 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -61.01 153.73 24.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.05 152.82 12.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.563 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 116' ' ' ILE . 35.5 t -120.2 158.19 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.1 0.476 . . . . 0.0 111.272 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -127.5 170.82 12.17 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.156 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.607 HG23 HG21 ' A' ' 11' ' ' VAL . 3.4 p -105.19 120.8 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.246 0.546 . . . . 0.0 110.711 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.462 ' ND2' HD12 ' A' ' 48' ' ' ILE . 48.3 t30 -65.59 144.89 56.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.626 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.2 m-20 -48.9 -26.05 2.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.855 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.773 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.9 tp10 -59.73 -35.28 74.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.293 0.568 . . . . 0.0 110.479 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 7' ' ' VAL . 99.7 t -65.25 -26.8 40.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.746 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -74.26 -51.41 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -53.12 -31.76 43.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.23 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 49' ' ' VAL . 26.9 t -77.19 -38.47 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.202 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.65 -45.13 72.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.8 m-80 -67.72 -31.91 72.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.074 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.2 -46.45 50.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.169 0.509 . . . . 0.0 110.281 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 77.7 mtp -73.94 -18.93 60.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.453 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -18.43 24.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.907 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.5 t -118.59 12.63 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.13 112.83 2.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.122 0.487 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -113.91 147.0 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.908 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.914 ' HA ' HD11 ' A' ' 29' ' ' ILE . 2.6 p -102.02 116.56 32.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -128.4 -65.2 0.9 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.817 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 p -131.51 139.48 35.45 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.56 -25.99 11.81 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.393 2.062 . . . . 0.0 112.173 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -63.89 -41.07 97.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.27 -30.81 30.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.52 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 23' ' ' SER . 28.3 mm -62.22 -28.19 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 12.8 ttpt -64.57 -23.54 67.3 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.531 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -94.81 -11.88 28.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.447 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -66.68 111.72 3.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.879 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -71.83 105.95 3.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.833 0.349 . . . . 0.0 110.78 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HB2' HG22 ' A' ' 57' ' ' VAL . 22.1 tttm -93.48 -27.93 16.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.215 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.752 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.6 139.27 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -155.08 136.91 5.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.417 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 83' ' ' ALA . 12.7 mt -100.43 148.36 24.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.336 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CE2' HG13 ' A' ' 11' ' ' VAL . 1.6 m-85 -115.48 145.52 42.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.121 0.486 . . . . 0.0 111.169 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.5 t -142.09 172.13 13.11 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.023 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 116' ' ' ILE . 2.5 mt -81.77 139.41 34.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.36 . . . . 0.0 110.981 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.2 m -62.56 171.45 1.99 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.609 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -54.31 -20.39 7.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.008 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -84.8 -15.75 43.83 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.325 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 20.7 ttmt 55.94 31.77 18.52 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -9.38 8.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' HD23 ' A' ' 40' ' ' LEU . 9.0 pt20 -143.18 175.12 10.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.732 0.301 . . . . 0.0 111.187 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 124' ' ' ILE . 30.0 mm -102.71 128.77 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.037 0.446 . . . . 0.0 111.161 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' ND2' ' A' ' 8' ' ' ASN . 10.4 tt -144.3 149.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 14' ' ' VAL . 99.3 t -75.5 145.0 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.148 0.499 . . . . 0.0 111.422 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -107.9 113.24 26.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.401 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -52.75 -25.98 12.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.24 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.95 -19.45 61.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.614 ' HB3' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -124.16 75.96 1.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.082 0.467 . . . . 0.0 111.44 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.758 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.29 157.16 43.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 10.8 mt -139.04 114.07 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.137 0.494 . . . . 0.0 110.81 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -91.49 169.31 10.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.857 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 34' ' ' LYS . 17.1 t -75.03 -25.01 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.468 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.58 -30.69 20.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.201 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.292 . . . . 0.0 110.67 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 67' ' ' PRO . 4.2 mt -73.0 100.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.701 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.57 -6.77 24.43 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.388 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.79 -59.24 1.91 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.84 -11.23 9.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.887 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.61 135.4 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.21 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.81 -40.53 75.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.16 155.0 25.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.5 Cg_exo -73.98 -31.58 7.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.118 1.879 . . . . 0.0 111.56 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.616 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.44 -55.74 6.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.281 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.7 m -57.44 -34.79 69.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.73 99.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.677 0.751 . . . . 0.0 109.203 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.3 -40.38 77.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.374 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 68' ' ' TYR . 68.6 t -62.91 -27.16 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.36 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -80.78 -31.88 35.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.535 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.2 mt -76.64 -36.01 57.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.881 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.0 mt -55.29 117.87 16.28 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.09 122.21 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.633 2.222 . . . . 0.0 111.47 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.8 mt -69.68 -23.89 63.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.4 13.99 33.34 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.479 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.27 138.38 18.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.629 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 11.6 m -91.48 149.24 21.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.459 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -159.39 176.0 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 92.4 m-85 -118.81 161.91 19.35 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.427 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.23 132.92 13.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 0.0 111.85 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.586 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.96 116.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 32.5 t80 -128.1 152.25 48.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.475 0.655 . . . . 0.0 111.534 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.1 t70 -108.29 113.6 26.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.596 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -87.17 114.05 23.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.966 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.865 HG23 ' HG2' ' A' ' 97' ' ' GLU . 3.1 m -103.05 112.44 25.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.8 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.835 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.62 165.34 26.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.1 pt-20 -128.82 123.88 33.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.838 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.551 HG21 ' HE2' ' A' ' 96' ' ' LYS . 21.7 p -92.08 177.21 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.768 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -4.66 37.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.873 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -109.87 -47.66 3.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.802 0.334 . . . . 0.0 111.08 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -161.57 152.08 17.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.287 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 17.1 mttt -82.73 132.57 35.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.886 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE2' HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.58 161.81 37.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.157 0.503 . . . . 0.0 111.823 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.865 ' HG2' HG23 ' A' ' 88' ' ' THR . 4.1 mp0 -133.3 151.0 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -154.8 175.35 13.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -129.5 145.09 51.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.317 0.579 . . . . 0.0 111.215 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.862 HG21 HD21 ' A' ' 153' ' ' LEU . 38.3 t -129.55 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.056 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HA ' HD22 ' A' ' 84' ' ' LEU . 7.3 t80 -96.87 108.64 21.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.386 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -98.8 141.96 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.251 0.548 . . . . 0.0 111.937 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.3 t80 -118.2 105.94 12.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.448 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.739 ' CH2' HD23 ' A' ' 140' ' ' LEU . 58.6 t-105 -88.89 110.52 21.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.95 85.79 22.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 50.6 Cg_endo -69.39 160.17 50.85 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.171 1.914 . . . . 0.0 112.747 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -79.7 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.356 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -13.9 32.68 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.689 0.281 . . . . 0.0 111.658 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.29 149.75 91.68 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.85 148.36 45.82 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.258 1.972 . . . . 0.0 112.259 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.6 -30.97 61.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.92 63.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 t -83.7 -38.49 21.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 109.723 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -32.39 62.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -40.65 51.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.31 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 5' ' ' VAL . 3.7 tt -59.41 -49.41 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.335 0.588 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.427 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 25.7 m-85 -69.89 -36.9 75.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.193 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.97 63.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.198 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -69.5 -31.83 70.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.63 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.523 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.3 p -77.34 -27.84 52.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.216 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -42.05 -38.44 1.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.989 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -43.23 32.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.842 0.354 . . . . 0.0 110.345 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.482 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -59.92 -47.21 86.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.97 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -65.76 -31.21 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.862 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -33.17 43.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -60.39 -42.05 95.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -74.2 -13.14 60.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.039 178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.726 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.7 m-30 -96.83 40.76 1.13 Allowed 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 120.993 0.425 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.8 m -57.61 116.06 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.217 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.72 -10.68 27.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.242 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.726 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.2 tp -69.97 104.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.044 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -89.71 3.07 53.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.397 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.697 ' CB ' HG22 ' A' ' 100' ' ' VAL . 72.5 m-70 -128.58 153.26 47.41 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 121.27 0.557 . . . . 0.0 111.504 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -152.04 124.0 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.87 123.91 48.2 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.6 102.82 12.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.853 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.939 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.69 119.1 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 12.2 m-20 -81.27 -47.34 13.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.024 0.44 . . . . 0.0 110.456 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -122.68 179.46 16.15 Favored Glycine 0 CA--C 1.5 -0.882 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.645 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.739 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.4 mt -67.4 -42.59 83.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -54.34 -22.66 12.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.621 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.796 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.2 m-20 -77.87 -20.2 53.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.302 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.939 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.5 -13.87 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.035 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' LEU . 4.0 mmmt -55.47 -31.81 62.28 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.534 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -66.98 108.22 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.6 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -29.57 59.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.285 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 95.6 p -74.04 -34.53 64.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.06 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.518 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.1 m -56.94 -30.53 64.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.537 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.794 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -88.05 -55.58 3.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.134 0.492 . . . . 0.0 111.345 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.745 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.62 -21.38 28.28 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.212 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -85.89 -44.76 12.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 111.583 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -56.0 -33.58 64.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.862 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.0 -48.86 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.016 0.436 . . . . 0.0 111.478 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.17 -44.8 0.65 Allowed Glycine 0 C--N 1.322 -0.224 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.927 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.76 -128.32 9.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.594 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.17 1.38 50.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.93 -15.11 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 89' ' ' TYR . 87.0 t -81.45 112.43 19.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.288 0.566 . . . . 0.0 111.138 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.21 -25.3 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.477 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.62 149.97 11.78 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.285 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.835 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -133.13 133.56 43.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.962 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.26 26.5 15.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.05 -2.01 85.2 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -117.33 138.82 25.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.027 0.413 . . . . 0.0 110.505 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.54 144.02 11.05 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.309 2.006 . . . . 0.0 112.954 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mtt . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.24 135.91 34.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -73.12 -48.33 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.13 162.52 34.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.603 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 116' ' ' ILE . 16.1 t -109.7 154.73 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.883 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.18 171.14 10.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 11' ' ' VAL . 6.4 p -103.21 118.73 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.345 0.593 . . . . 0.0 110.459 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.75 144.68 51.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.625 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.677 ' HA ' HD13 ' A' ' 12' ' ' ILE . 84.7 m-20 -47.15 -26.71 1.2 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.108 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.887 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -57.13 -40.55 77.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.286 0.565 . . . . 0.0 110.629 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 7' ' ' VAL . 64.8 t -60.55 -27.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.838 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.774 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -78.89 -50.1 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -55.83 -32.78 63.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.984 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.062 HG11 HG21 ' A' ' 36' ' ' VAL . 35.4 t -76.58 -35.19 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.324 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -71.52 -45.67 61.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.9 m-20 -67.74 -33.3 74.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.75 -46.34 37.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.548 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 14' ' ' VAL . 79.9 mtp -73.68 -18.57 61.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.558 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -88.17 -20.23 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 26.4 t -118.66 13.24 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.46 111.94 1.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.005 0.431 . . . . 0.0 111.237 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -122.0 143.95 49.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.631 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' HD11 ' A' ' 29' ' ' ILE . 10.1 p -93.13 115.65 28.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.794 0.33 . . . . 0.0 110.751 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.14 -67.39 0.93 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.4 p -131.02 143.27 48.73 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.805 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.08 -26.92 5.58 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.873 2.382 . . . . 0.0 112.689 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.7 -30.7 61.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -87.21 -30.34 21.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.209 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.553 HD11 ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -60.5 -25.0 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.577 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.2 ttpt -66.12 -27.19 67.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.225 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -93.44 -10.68 34.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.413 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.43 115.75 4.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.592 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -76.0 110.82 10.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 9.1 ttmm -100.12 -27.14 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.417 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -149.19 142.32 24.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -154.81 140.55 11.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.255 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.974 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.4 mt -109.73 135.57 50.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.744 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 49' ' ' VAL . 35.6 m-85 -101.63 146.08 28.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.281 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.64 173.12 11.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.172 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 116' ' ' ILE . 3.8 mt -81.02 135.18 35.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -62.59 171.24 2.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.7 -20.09 7.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.99 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -85.89 -15.67 41.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.617 0.246 . . . . 0.0 111.289 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 5.9 tttp 55.83 33.12 20.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.074 0.464 . . . . 0.0 111.3 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 ttpt -119.06 -15.47 9.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.804 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.617 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.1 pt20 -143.13 175.09 10.13 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.876 0.369 . . . . 0.0 111.576 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 124' ' ' ILE . 13.3 mm -102.21 110.43 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.152 0.501 . . . . 0.0 111.904 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.64 158.81 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.728 HG23 ' HB3' ' A' ' 10' ' ' GLU . 53.6 t -75.63 146.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.735 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -111.53 110.37 20.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.266 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.09 -31.5 42.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.715 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.0 -8.63 56.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.731 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.64 79.69 1.81 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.221 0.534 . . . . 0.0 111.726 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB3' HG12 ' A' ' 36' ' ' VAL . 2.5 mt-30 -146.89 160.56 42.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.323 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.883 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -138.78 111.32 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.673 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' OD2' ' A' ' 59' ' ' ASP . 6.0 mt -92.27 171.9 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.842 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 34' ' ' LYS . 12.9 t -79.79 -23.52 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.386 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.25 -28.94 26.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.298 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' A' ' 64' ' ' VAL . 2.7 m-20 -59.42 -36.3 75.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.6 mt -72.45 101.07 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.3 -9.86 24.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.365 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.62 -59.72 1.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.12 -9.17 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.998 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 59' ' ' ASP . 45.4 t -114.98 128.41 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 120.785 0.326 . . . . 0.0 111.344 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.35 -35.76 78.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.651 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.23 151.41 18.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 34.9 Cg_endo -73.21 -31.99 8.85 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.078 1.852 . . . . 0.0 111.595 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.8 t80 -71.41 -59.55 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.85 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -53.58 -34.27 57.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.794 0.33 . . . . 0.0 111.256 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.96 98.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.851 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.65 -39.66 76.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.216 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 68' ' ' TYR . 99.1 t -62.91 -27.33 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.838 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -36.65 57.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mt -75.87 -37.77 58.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.895 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.7 mt -54.73 115.27 8.4 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -91.46 122.15 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.732 2.288 . . . . 0.0 111.588 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.02 -26.18 65.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.74 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -97.92 14.21 28.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.564 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.07 136.47 15.83 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.668 0.271 . . . . 0.0 111.409 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 6.6 m -92.41 149.0 21.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.846 0.355 . . . . 0.0 110.413 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -159.17 173.84 15.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.349 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD2' HD12 ' A' ' 124' ' ' ILE . 66.3 m-85 -115.59 160.81 19.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.724 0.297 . . . . 0.0 110.349 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.974 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.72 133.61 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 0.0 112.216 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.54 116.44 31.98 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 16.7 t80 -130.98 151.44 51.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 0.0 111.171 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 t70 -104.0 114.68 29.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.659 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -89.28 114.97 26.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.023 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.8 m -100.81 113.53 26.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.923 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.858 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.84 165.01 26.96 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.127 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 3.3 pm0 -131.02 123.61 29.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.944 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -92.34 177.43 6.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.44 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -75.54 -2.84 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.89 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -108.79 -49.44 3.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.812 0.339 . . . . 0.0 110.982 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -161.74 143.8 11.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.178 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mttp -79.07 133.17 36.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.14 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.14 167.14 23.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.166 0.508 . . . . 0.0 112.031 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.831 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.8 mp0 -133.03 152.9 51.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.656 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.3 175.58 13.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.839 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -126.37 144.9 50.66 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.353 0.597 . . . . 0.0 111.069 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.803 HG21 HD21 ' A' ' 153' ' ' LEU . 36.2 t -129.27 148.03 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.706 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.597 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.7 t80 -96.52 109.85 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.672 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.15 142.32 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.243 0.544 . . . . 0.0 111.992 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 5.5 t80 -119.07 106.41 12.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.447 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.732 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.4 t-105 -88.63 109.19 19.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.822 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.0 86.33 20.81 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.47 159.44 46.38 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.133 1.889 . . . . 0.0 112.974 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -8.84 58.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.316 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -13.61 37.23 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.733 0.302 . . . . 0.0 111.31 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -75.58 135.4 71.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 31.4 Cg_exo -58.99 148.03 87.12 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.056 1.838 . . . . 0.0 112.018 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.38 -29.92 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -67.03 -23.3 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 t -85.96 -36.95 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.25 0.548 . . . . 0.0 109.613 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.5 mttt -75.22 -30.13 60.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.573 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -41.53 31.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -60.01 -48.77 86.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.443 0.639 . . . . 0.0 110.208 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 20.5 m-85 -70.67 -37.05 73.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.524 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -53.43 -33.53 54.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.133 0.492 . . . . 0.0 110.219 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.7 m -77.44 -27.12 52.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.732 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.468 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -91.15 -15.81 28.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.755 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -48.31 -40.7 26.01 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -42.57 47.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.923 0.392 . . . . 0.0 110.501 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.28 -44.6 95.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -68.42 -30.37 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.104 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -30.84 28.25 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -42.02 96.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.774 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -71.12 -11.68 61.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.951 178.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.663 ' O ' HG22 ' A' ' 131' ' ' ILE . 13.9 m-85 -95.8 42.99 1.08 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.04 0.448 . . . . 0.0 110.825 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.2 m -60.27 110.66 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.459 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.45 23.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.632 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.89 110.44 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 116.968 0.384 . . . . 0.0 110.167 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.7 -3.06 58.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.659 ' HB3' HG13 ' A' ' 100' ' ' VAL . 48.0 m-70 -127.74 151.93 48.38 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-O 121.229 0.538 . . . . 0.0 111.681 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -150.36 122.36 8.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.623 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.812 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -115.69 123.42 48.28 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 102.44 11.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.554 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.933 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.93 120.65 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 m-80 -82.95 -46.2 13.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -126.46 177.52 17.19 Favored Glycine 0 CA--C 1.502 -0.772 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.278 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.732 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -67.03 -26.84 66.97 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.248 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.801 ' CB ' HG12 ' A' ' 137' ' ' VAL . 45.6 m-20 -84.96 -19.42 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.305 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.933 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.21 -19.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -55.61 -30.4 60.83 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.061 -0.4 . . . . 0.0 110.997 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 1.0 OUTLIER -66.46 105.53 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.371 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -51.08 -27.57 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.622 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -75.72 -38.07 58.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 142' ' ' ASP . 66.5 m -55.73 -28.17 54.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.812 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.5 tp -87.61 -55.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.17 -23.12 15.82 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.321 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -86.26 -43.78 12.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.861 0.363 . . . . 0.0 111.687 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -54.05 -33.29 57.02 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.803 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -86.46 -48.89 8.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.03 0.443 . . . . 0.0 111.547 -179.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.06 -44.49 0.67 Allowed Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.987 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.75 -123.17 7.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.429 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -87.85 1.3 54.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -93.63 -15.11 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 89' ' ' TYR . 89.4 t -81.04 112.63 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.287 0.565 . . . . 0.0 111.181 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.37 -24.73 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.463 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.59 149.48 18.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.941 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.9 OUTLIER -135.88 137.15 41.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.228 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.11 26.98 15.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.307 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.74 0.21 86.15 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.534 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.2 142.28 34.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.974 0.387 . . . . 0.0 110.503 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.19 143.61 14.23 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.421 2.081 . . . . 0.0 112.801 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.926 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.76 0.314 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.95 169.92 17.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 t -174.84 74.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.16 162.99 38.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.387 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 116' ' ' ILE . 27.8 t -114.06 158.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -128.7 171.12 12.5 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.102 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG23 HG21 ' A' ' 11' ' ' VAL . 6.8 p -103.7 118.44 50.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.349 0.595 . . . . 0.0 110.622 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -61.44 144.72 53.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.811 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.678 ' HA ' HD13 ' A' ' 12' ' ' ILE . 58.5 m-20 -47.6 -26.55 1.51 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.893 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -58.25 -35.54 71.9 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.332 0.587 . . . . 0.0 110.617 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.817 HG21 HG23 ' A' ' 7' ' ' VAL . 61.5 t -65.33 -25.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.006 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -75.87 -52.43 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -30.68 61.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.116 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.3 t -77.25 -37.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 12.4 t80 -69.29 -47.63 64.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.001 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 20' ' ' VAL . 64.3 m-20 -66.23 -30.38 70.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.248 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -75.82 -46.56 29.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.803 ' SD ' HD23 ' A' ' 84' ' ' LEU . 89.1 mtp -74.57 -19.6 60.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.4 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -20.29 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.622 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 20' ' ' VAL . 33.6 t -118.38 12.89 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.956 0.407 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -60.34 112.28 1.88 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 146.51 43.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.62 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 29' ' ' ILE . 94.8 p -97.93 116.27 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.111 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 m -116.07 -63.92 1.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.6 p -132.1 135.52 26.66 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.319 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.17 -29.52 0.35 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.205 2.603 . . . . 0.0 113.642 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.343 . . . . 0.0 111.207 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -77.32 -37.04 53.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.88 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.5 mp -59.32 -24.03 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.382 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -66.57 -26.87 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.359 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -93.47 -10.02 36.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.639 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.13 111.92 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.785 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -71.11 110.06 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 110.632 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' A' ' 57' ' ' VAL . 14.5 tttt -99.12 -29.87 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.225 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.872 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -146.07 143.21 29.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.927 0.394 . . . . 0.0 110.098 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.847 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -160.53 138.65 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.376 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.938 HD23 ' HB2' ' A' ' 83' ' ' ALA . 4.8 mt -104.17 141.18 36.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.632 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 49' ' ' VAL . 60.1 m-85 -108.41 143.07 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.065 0.46 . . . . 0.0 111.101 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.9 m -138.5 173.84 11.17 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.984 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 116' ' ' ILE . 4.6 mt -80.86 135.73 35.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.814 0.34 . . . . 0.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.71 171.44 2.07 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.638 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -54.92 -20.45 8.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.827 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.29 -15.71 45.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.612 0.244 . . . . 0.0 111.314 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 12.6 ttpt 54.97 32.97 19.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.07 0.462 . . . . 0.0 111.45 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -120.11 -14.99 8.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' O ' HD23 ' A' ' 40' ' ' LEU . 1.7 pt20 -142.87 175.11 10.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.809 0.338 . . . . 0.0 111.545 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.751 HG21 HD12 ' A' ' 124' ' ' ILE . 26.7 mm -101.6 118.48 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.232 0.539 . . . . 0.0 111.486 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 tt -132.52 153.43 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.962 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG21 HG21 ' A' ' 14' ' ' VAL . 93.6 t -75.88 146.28 9.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.198 0.523 . . . . 0.0 111.51 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -108.71 115.85 30.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.867 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.01 -29.54 21.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.929 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.73 -7.95 53.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.906 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HB3' HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -134.53 79.23 1.79 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.098 0.475 . . . . 0.0 111.685 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.673 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.72 151.34 37.03 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.651 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.872 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 mt -136.15 114.63 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.315 0.578 . . . . 0.0 110.589 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.27 168.56 10.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 34' ' ' LYS . 19.2 t -75.06 -27.06 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.89 -29.88 24.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.39 -32.31 71.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.778 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 67' ' ' PRO . 4.8 mt -75.06 101.9 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.527 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.07 -22.1 12.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.78 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -61.1 1.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.646 0.736 . . . . 0.0 109.333 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -13.66 9.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.101 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 42.0 t -114.05 129.75 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.426 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -39.58 90.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.72 153.29 25.87 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.567 ' HG3' HD13 ' A' ' 60' ' ' ILE . 3.3 Cg_exo -71.69 -30.8 14.11 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.207 1.938 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.5 t80 -72.9 -59.51 2.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.206 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -53.54 -34.16 57.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.608 0.242 . . . . 0.0 111.343 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -64.73 -43.18 94.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -68.96 -38.25 79.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.374 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 68' ' ' TYR . 88.8 t -61.91 -30.47 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.39 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 53' ' ' LYS . 10.3 mt -75.04 -36.63 61.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.946 0.403 . . . . 0.0 112.053 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.3 mt -55.04 114.58 7.3 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -90.94 121.69 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.539 2.16 . . . . 0.0 111.424 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.22 -24.83 64.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -98.65 14.34 28.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.63 139.81 19.35 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.846 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.0 m -98.48 135.07 40.56 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -147.47 176.06 10.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.041 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 66.5 m-85 -114.26 160.46 19.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.832 0.348 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.52 132.54 12.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.841 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -109.01 129.87 55.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.649 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.1 t80 -142.93 152.38 41.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.329 0.585 . . . . 0.0 110.969 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 t70 -102.93 113.89 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.795 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -86.35 112.15 21.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.891 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.832 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.2 m -98.1 112.76 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.816 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.63 165.15 26.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.133 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.2 pm0 -128.99 123.95 33.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.875 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.594 HG21 ' HE3' ' A' ' 96' ' ' LYS . 21.8 p -92.84 177.64 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -73.98 -4.68 36.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.072 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -107.92 -49.83 3.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -161.98 151.32 15.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.245 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -79.1 133.59 36.76 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.921 179.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' HG21 ' A' ' 91' ' ' THR . 0.1 OUTLIER -142.52 163.51 32.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.138 0.494 . . . . 0.0 111.806 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.832 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.2 mp0 -133.01 151.51 52.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.529 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.86 175.39 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.671 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -128.25 144.82 51.16 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 111.039 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 HD21 ' A' ' 153' ' ' LEU . 39.0 t -130.15 148.52 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -96.5 108.75 21.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.74 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.16 141.88 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.367 0.603 . . . . 0.0 111.93 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -117.94 106.24 12.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.47 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.724 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.8 t-105 -89.05 110.16 20.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.746 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.07 86.22 20.83 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 161.17 46.17 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.259 1.972 . . . . 0.0 112.935 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.58 -8.48 59.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.278 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.11 -13.85 37.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.76 0.314 . . . . 0.0 111.509 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.71 150.8 86.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.204 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.34 148.33 26.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.288 1.992 . . . . 0.0 112.245 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -53.82 -31.29 48.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.018 0.437 . . . . 0.0 111.326 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.3 -21.8 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.115 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.11 -38.43 17.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.236 0.541 . . . . 0.0 109.557 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.3 mttt -73.08 -30.76 63.91 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.393 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -41.64 28.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.422 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.725 HG23 HD11 ' A' ' 40' ' ' LEU . 5.7 tt -59.08 -49.64 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.327 0.584 . . . . 0.0 110.649 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 28.9 m-85 -70.96 -35.87 72.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.015 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.49 -46.71 48.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.837 0.351 . . . . 0.0 111.232 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 -30.93 70.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.584 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 47' ' ' ILE . 5.1 p -77.62 -28.22 51.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.211 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -42.65 -44.75 4.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.965 -178.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -41.64 66.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.908 0.385 . . . . 0.0 110.532 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.69 76.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.162 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.751 HD12 HG21 ' A' ' 47' ' ' ILE . 7.1 tt -62.88 -32.24 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.235 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -81.71 -31.73 31.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.266 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.61 -43.05 89.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.983 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.723 ' HG3' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -73.53 -9.36 58.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.908 178.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.6 m-30 -96.12 41.89 1.1 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.459 . . . . 0.0 110.721 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.8 m -58.52 115.32 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.153 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.56 -11.02 25.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.5 tp -69.7 105.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.008 0.433 . . . . 0.0 109.96 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -89.4 2.3 54.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.34 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.724 ' CB ' HG22 ' A' ' 100' ' ' VAL . 76.5 m-70 -128.03 153.68 46.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.268 0.556 . . . . 0.0 111.637 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -151.75 123.18 7.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.488 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.831 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.24 122.98 46.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -105.08 102.52 12.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.737 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.92 121.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.413 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -83.57 -46.53 12.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.651 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.85 179.38 16.17 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.254 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.724 HD23 ' CH2' ' A' ' 104' ' ' TRP . 7.2 mt -69.6 -27.01 64.73 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.275 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.08 -17.29 63.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.724 0.297 . . . . 0.0 111.23 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' A' ' 137' ' ' VAL . 1.1 m-20 -83.85 -19.79 34.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.27 -17.64 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -54.44 -33.07 58.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.668 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -66.17 104.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.86 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -51.26 -36.31 41.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.8 p -66.77 -35.61 80.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 75.2 m -57.0 -28.41 62.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.831 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 14.1 tp -87.34 -55.28 3.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.275 0.56 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.91 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.95 -21.73 24.96 Favored Glycine 0 CA--C 1.519 0.289 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.036 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.48 -40.46 16.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 111.416 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -60.71 -33.43 72.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.683 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.799 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -83.14 -48.9 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 111.313 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.33 -44.76 0.65 Allowed Glycine 0 C--N 1.324 -0.127 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.709 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.64 -122.58 7.64 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.67 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -86.47 1.43 51.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.79 -15.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 166' ' ' LEU . 66.1 t -82.5 112.55 20.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.334 0.588 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.7 t -76.16 -23.54 15.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.664 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.45 150.19 8.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.91 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -133.58 127.46 33.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.868 179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.27 26.61 16.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.71 -1.42 78.52 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.438 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -110.01 126.3 29.3 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 117.066 0.433 . . . . 0.0 110.814 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.97 137.6 80.77 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.129 1.886 . . . . 0.0 112.585 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.177 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.771 0.319 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.2 142.39 47.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.121 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.9 t -78.47 -66.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.829 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.53 -179.16 53.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 116' ' ' ILE . 14.6 t -104.08 152.2 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.921 0.391 . . . . 0.0 110.603 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.8 171.16 9.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.773 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.86 HG23 HG21 ' A' ' 11' ' ' VAL . 5.9 p -103.2 119.8 52.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.361 0.6 . . . . 0.0 110.474 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -63.44 144.91 56.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.694 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.9 t0 -47.37 -26.64 1.35 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -57.61 -36.36 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.328 0.585 . . . . 0.0 110.46 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.86 HG21 HG23 ' A' ' 7' ' ' VAL . 46.3 t -63.9 -27.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.716 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -78.36 -49.97 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -55.24 -30.12 59.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.38 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.098 HG11 HG21 ' A' ' 36' ' ' VAL . 40.4 t -80.58 -33.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.256 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 10.0 t80 -72.53 -44.55 62.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.1 m-20 -67.52 -30.88 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.045 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -78.93 -47.24 16.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.631 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.758 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.0 mtp -71.28 -18.99 62.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.608 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.514 ' NZ ' HD11 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -90.85 -16.69 27.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.088 179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 20' ' ' VAL . 31.8 t -118.02 12.91 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.56 111.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.965 0.412 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.84 152.48 39.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.88 116.25 32.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -113.38 -65.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.5 p -131.49 137.42 30.43 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.6 -28.84 0.69 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.063 2.509 . . . . 0.0 113.53 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -33.93 62.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -78.91 -36.21 42.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.951 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.64 -25.88 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.562 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -67.09 -24.92 66.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.41 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -94.17 -11.74 29.78 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.387 178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -63.58 119.7 10.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.64 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HE3' HG13 ' A' ' 14' ' ' VAL . 2.7 ttpt -72.86 114.95 11.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 57' ' ' VAL . 18.2 tttt -96.97 -36.33 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.049 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 36' ' ' VAL . . . -159.47 159.23 33.29 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.028 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.098 HG21 HG11 ' A' ' 14' ' ' VAL . 5.1 m -162.35 152.96 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.876 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.075 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -114.07 134.3 54.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.731 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.717 ' CD1' HG22 ' A' ' 49' ' ' VAL . 42.2 m-85 -101.71 143.37 31.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.206 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.3 m -137.02 173.24 11.91 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.251 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.593 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -81.65 136.12 35.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.801 0.334 . . . . 0.0 110.788 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.15 171.46 2.3 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.678 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -55.07 -19.85 8.27 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.022 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.34 -15.57 40.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.614 0.245 . . . . 0.0 111.399 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 10.6 ttmt 55.62 32.86 20.06 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.993 0.425 . . . . 0.0 111.373 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -119.62 -13.62 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.782 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' THR . 7.6 pt20 -142.69 174.26 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.837 0.351 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.831 HG21 HD12 ' A' ' 124' ' ' ILE . 21.2 mm -102.77 112.28 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.11 0.481 . . . . 0.0 111.343 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.2 tt -124.63 154.43 32.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.668 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG22 ' CD1' ' A' ' 38' ' ' PHE . 47.8 t -78.19 144.61 11.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.628 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -108.36 113.24 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -26.9 13.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.02 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.65 -17.55 60.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.831 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.904 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -124.8 80.59 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.351 0.596 . . . . 0.0 111.526 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.1 153.36 40.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.042 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 16.6 mt -133.23 109.66 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.385 0.612 . . . . 0.0 111.346 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -93.73 173.02 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.486 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 34' ' ' LYS . 6.7 t -81.28 -20.84 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.138 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.17 -34.97 10.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.337 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -57.28 -36.15 70.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 111.008 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.579 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.6 mt -74.08 101.89 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.04 0.447 . . . . 0.0 110.66 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.03 -18.67 16.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.005 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.24 -60.55 1.6 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.578 0.704 . . . . 0.0 109.264 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -11.77 9.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.118 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.38 129.24 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.497 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.55 -38.18 88.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.95 153.08 21.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.147 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HG3' HG21 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -72.51 -32.19 10.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.236 1.957 . . . . 0.0 111.158 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.0 t80 -70.35 -57.3 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.8 m -55.7 -33.74 64.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.048 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.54 99.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.615 0.722 . . . . 0.0 109.405 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.82 -41.14 71.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.459 178.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CE1' ' A' ' 68' ' ' TYR . 74.4 t -61.37 -28.06 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.417 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -81.71 -30.75 32.41 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.322 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.904 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.5 mt -78.4 -34.69 47.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.761 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 20.1 mt -58.94 117.44 21.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -89.58 121.8 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.504 2.136 . . . . 0.0 111.809 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 8.8 mt -67.78 -23.93 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.122 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.33 13.03 36.34 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.506 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.32 139.72 19.54 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.7 m -92.09 150.67 20.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.351 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -160.59 176.78 11.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 75.7 m-85 -121.62 157.22 31.29 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.075 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -155.22 138.25 15.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 111.683 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.758 HD23 ' SD ' ' A' ' 18' ' ' MET . 2.1 tp -108.98 131.28 55.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.5 151.74 47.64 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.369 0.604 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 25.2 t70 -105.34 116.25 31.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.235 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB3' HD12 ' A' ' 153' ' ' LEU . . . -88.56 108.56 19.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.601 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.857 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -98.46 110.53 23.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.514 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.805 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.96 164.94 26.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 111.282 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 2.0 pt-20 -131.81 124.28 29.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 p -90.42 173.38 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.884 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -70.38 -8.52 51.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.869 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.55 -42.22 4.37 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.96 0.409 . . . . 0.0 111.001 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -160.9 163.38 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -100.34 134.03 43.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.127 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -137.74 159.83 40.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.857 ' HG2' HG23 ' A' ' 88' ' ' THR . 1.6 mp0 -133.21 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.582 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -157.21 175.46 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.514 HD11 ' NZ ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -129.97 145.34 51.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.322 0.582 . . . . 0.0 111.274 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.848 HG21 HD21 ' A' ' 153' ' ' LEU . 45.5 t -127.42 148.99 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.314 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.401 ' HA ' HD12 ' A' ' 84' ' ' LEU . 12.4 t80 -97.59 110.08 22.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.31 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.8 mt -99.63 149.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.5 0.667 . . . . 0.0 112.516 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.502 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 4.6 t80 -122.58 105.47 10.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.295 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.674 ' HH2' HD22 ' A' ' 140' ' ' LEU . 61.5 t-105 -89.18 108.8 19.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.569 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.18 86.37 25.43 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 52.0 Cg_endo -69.72 160.75 48.55 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.16 1.906 . . . . 0.0 112.757 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.83 -8.75 59.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.305 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.93 31.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 111.576 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -72.06 148.92 91.98 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.161 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.73 146.33 33.69 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.272 1.981 . . . . 0.0 112.073 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.12 -30.56 37.34 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -67.81 -24.19 65.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.94 -38.02 19.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 1.7 mttt -73.73 -29.78 62.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -40.89 28.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.593 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.09 -50.83 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.194 0.521 . . . . 0.0 110.51 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 29.8 m-85 -68.28 -37.66 80.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.401 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -57.11 -30.93 64.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.377 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 m -76.77 -30.52 56.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.887 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.549 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.81 -14.48 29.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.369 179.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 1.3 tmtt? -48.2 -34.55 10.27 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -42.03 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.917 0.389 . . . . 0.0 110.273 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.404 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -61.98 -45.15 94.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.075 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 47' ' ' ILE . 5.8 tt -67.65 -31.45 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.729 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 27.9 tttt -80.18 -32.69 38.68 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 0.0 110.097 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.9 -43.3 86.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.68 ' HG3' HD11 ' A' ' 12' ' ' ILE . 4.0 mmpm? -72.53 -10.31 59.64 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.924 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 m-85 -96.26 39.98 1.14 Allowed 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.96 0.41 . . . . 0.0 110.637 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -58.34 114.56 2.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.177 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.45 -11.49 21.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.054 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.4 tp -69.66 105.62 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -89.41 0.4 56.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.696 ' CB ' HG22 ' A' ' 100' ' ' VAL . 57.1 m-70 -128.03 151.04 49.65 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.196 0.522 . . . . 0.0 111.559 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.41 124.19 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.789 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -117.11 124.44 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.86 102.79 12.21 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.8 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.925 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -125.29 124.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.309 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.94 -45.62 9.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.733 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.39 163.59 14.79 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.176 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.778 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -59.32 -26.48 65.05 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.23 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.94 -19.25 61.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.724 0.297 . . . . 0.0 111.197 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.755 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.0 m-20 -78.72 -17.78 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.669 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.925 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -126.06 -16.87 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -54.86 -29.3 55.04 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 121.963 -0.461 . . . . 0.0 110.99 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 3.4 t0 -65.81 106.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.717 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -25.6 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.666 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 t -79.99 -33.77 39.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.288 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.504 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 26.1 m -57.13 -31.71 65.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.701 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.789 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.6 tp -87.85 -54.21 4.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.222 0.534 . . . . 0.0 111.189 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.85 -21.67 30.98 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.981 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 25.5 mt-10 -86.05 -45.73 11.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 111.745 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 0.3 OUTLIER -55.86 -33.06 64.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.848 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.75 -48.71 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.091 0.472 . . . . 0.0 111.438 -179.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.88 -44.71 0.67 Allowed Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.794 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 103.16 -132.93 11.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -85.12 1.38 48.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.19 -14.8 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 89' ' ' TYR . 87.0 t -80.95 112.74 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.084 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.31 -25.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.606 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.27 150.64 14.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.304 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.805 HD12 ' HB3' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -133.45 131.48 39.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.098 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.41 27.19 16.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.27 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.68 -2.85 84.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 140.21 25.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.983 0.392 . . . . 0.0 110.338 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.74 141.29 35.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.435 2.09 . . . . 0.0 112.601 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.681 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.842 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.828 0.347 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.51 158.14 30.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -178.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.16 -166.41 34.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.558 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.4 t -107.34 151.64 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.653 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.28 171.4 9.91 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.779 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.08 121.04 52.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.379 0.609 . . . . 0.0 110.525 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.57 144.38 54.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.649 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' A' ' 12' ' ' ILE . 3.8 p30 -49.68 -25.66 3.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.832 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.3 tt0 -59.08 -35.76 73.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.399 0.618 . . . . 0.0 110.519 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 7' ' ' VAL . 65.4 t -64.61 -26.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.953 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.732 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -76.51 -52.19 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -55.75 -28.66 57.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.002 HG11 HG21 ' A' ' 36' ' ' VAL . 28.8 t -80.09 -34.84 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.039 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 21.9 t80 -71.07 -47.26 59.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.811 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 20' ' ' VAL . 69.8 m-20 -65.95 -31.44 72.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.155 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.31 -45.89 24.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.678 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.823 ' SD ' HD23 ' A' ' 84' ' ' LEU . 75.0 mtp -72.68 -19.97 61.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.635 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.761 ' HE3' HD21 ' A' ' 99' ' ' LEU . 1.7 mmpt? -91.17 -17.96 25.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.866 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.0 t -118.81 12.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.639 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 111.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.05 0.452 . . . . 0.0 110.936 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -121.89 140.77 52.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.478 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.631 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -91.97 116.28 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -119.75 -62.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -131.93 138.04 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.685 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.12 -29.16 0.5 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.136 2.557 . . . . 0.0 113.491 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 -35.11 67.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.706 0.288 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 -36.12 45.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -61.34 -26.13 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.223 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -65.75 -26.92 67.95 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.356 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -93.31 -11.19 33.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.502 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -62.6 111.89 2.26 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.605 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -72.71 103.57 3.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.389 . . . . 0.0 110.671 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HB2' HG22 ' A' ' 57' ' ' VAL . 1.4 tppp? -88.23 -29.54 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.769 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.78 143.96 23.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.06 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.002 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.61 139.58 5.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.1 mt -109.97 135.5 50.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.154 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.663 ' CD1' HG22 ' A' ' 49' ' ' VAL . 54.2 m-85 -102.04 144.31 30.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.428 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 t -138.07 172.94 12.18 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.07 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.9 mt -81.13 135.29 35.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.829 0.347 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -63.07 171.22 2.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.25 -20.73 7.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.958 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -84.13 -15.68 46.36 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.181 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 7.4 ttmm 54.98 32.48 18.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.09 0.471 . . . . 0.0 111.243 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.2 ttpt -121.92 -12.14 8.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.85 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.474 ' O ' HD23 ' A' ' 40' ' ' LEU . 7.1 pm0 -142.59 174.73 10.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.86 0.362 . . . . 0.0 111.438 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 124' ' ' ILE . 20.0 mm -102.99 111.99 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.89 155.55 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.604 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 14' ' ' VAL . 60.1 t -75.74 145.49 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.544 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . 17.4 mm-40 -104.76 111.2 23.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -52.56 -28.19 19.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.121 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.03 -19.4 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.938 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.1 mptt -119.63 77.1 1.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.367 0.603 . . . . 0.0 111.671 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.733 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.4 152.71 39.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.824 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 18.0 mt -134.45 108.11 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.343 0.592 . . . . 0.0 110.913 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.546 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.2 mt -91.18 169.43 10.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.947 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 34' ' ' LYS . 15.7 t -77.38 -24.8 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.258 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.59 -30.34 21.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.241 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.546 ' OD2' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -60.17 -36.52 77.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.602 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 3.7 mt -72.84 100.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.98 -11.25 20.51 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.268 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -59.75 1.69 Allowed 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 -10.12 8.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.139 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.61 139.77 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.373 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.36 -36.03 39.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.034 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.12 149.55 16.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.224 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' O ' HD13 ' A' ' 55' ' ' ILE . 42.5 Cg_endo -75.84 -34.16 3.34 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.177 1.918 . . . . 0.0 111.493 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.7 t80 -72.2 -55.84 6.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.0 m -56.69 -35.32 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.93 99.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.493 0.663 . . . . 0.0 109.49 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.927 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.78 -39.21 70.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.372 178.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 68' ' ' TYR . 75.1 t -61.32 -30.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.03 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -79.25 -31.38 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 111.011 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.7 mt -76.35 -35.1 58.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.927 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 16.9 mt -55.85 115.14 8.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -90.26 121.95 0.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.347 2.032 . . . . 0.0 111.275 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.38 -25.43 64.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.66 14.54 29.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.33 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.66 137.65 17.23 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.813 0.339 . . . . 0.0 111.578 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.407 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.9 m -94.46 149.43 21.25 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.314 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -159.26 176.27 12.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 72.1 m-85 -116.2 160.05 20.95 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.444 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.3 130.21 10.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.823 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.5 tp -108.95 129.95 55.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.661 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.8 t80 -138.33 152.21 48.26 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.98 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.9 t70 -104.68 113.39 26.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.366 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -85.63 108.71 18.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.88 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.873 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -99.9 111.25 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.342 178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.904 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.35 164.85 25.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.161 0.505 . . . . 0.0 111.403 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 16.5 pt-20 -137.04 123.89 21.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.562 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 158' ' ' VAL . 43.8 p -94.13 177.41 5.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.612 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -3.82 34.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.825 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -113.66 -41.76 3.55 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 0.0 111.207 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -160.27 163.46 33.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.368 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -95.52 132.12 40.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.836 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.17 145.17 51.85 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.873 ' HG2' HG23 ' A' ' 88' ' ' THR . 2.3 mp0 -133.25 143.58 49.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.484 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.2 175.98 13.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.761 HD21 ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -126.53 145.28 50.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.221 0.534 . . . . 0.0 110.995 179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.836 HG21 HD21 ' A' ' 153' ' ' LEU . 38.4 t -130.78 148.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.374 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -96.61 111.55 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.733 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.6 mt -100.42 141.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 111.746 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.0 t80 -119.16 106.43 12.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.746 ' CH2' HD23 ' A' ' 140' ' ' LEU . 60.2 t-105 -88.73 109.48 20.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.811 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.21 20.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.33 160.03 48.01 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 112.533 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -9.72 59.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.368 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -12.67 48.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.739 0.304 . . . . 0.0 110.856 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.82 147.79 74.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.37 151.08 33.18 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.227 1.951 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mt -55.69 -30.39 61.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.354 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -66.31 -24.79 66.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.6 t -85.92 -36.4 19.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.268 0.556 . . . . 0.0 109.736 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.3 mttt -74.83 -28.56 60.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.561 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -40.44 20.98 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.326 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.664 ' CG2' HD11 ' A' ' 40' ' ' LEU . 5.8 tt -58.05 -49.6 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.36 0.6 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.1 m-85 -69.89 -36.71 75.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.438 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -56.65 -30.81 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.451 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 m -74.96 -32.19 61.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.766 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.56 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.38 -13.44 30.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.319 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.69 -40.15 5.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -42.47 38.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.73 -44.08 97.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.212 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -68.89 -30.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.918 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -82.22 -31.68 30.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.933 0.396 . . . . 0.0 110.101 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -60.61 -42.17 96.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -70.77 -14.96 62.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.662 178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 131' ' ' ILE . 17.0 m-30 -94.81 44.02 1.1 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.083 0.468 . . . . 0.0 110.687 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.3 m -61.02 113.62 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.121 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.32 -10.55 22.15 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.307 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -70.13 104.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 110.187 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -91.95 8.39 37.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.329 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.723 ' CB ' HG22 ' A' ' 100' ' ' VAL . 84.8 m-70 -133.35 154.49 50.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.076 0.465 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.04 122.99 7.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.004 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.729 ' HB3' HG23 ' A' ' 102' ' ' ILE . 5.8 t90 -113.98 122.48 47.08 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.82 102.54 11.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.784 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.957 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.91 119.66 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.702 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -80.88 -48.96 11.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.542 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.29 -178.79 15.5 Favored Glycine 0 CA--C 1.505 -0.536 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.312 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.746 HD23 ' CH2' ' A' ' 104' ' ' TRP . 5.8 mt -70.74 -25.62 63.0 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.334 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -17.28 62.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.695 0.283 . . . . 0.0 111.19 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.802 ' CB ' HG12 ' A' ' 137' ' ' VAL . 3.3 m-20 -85.12 -18.24 34.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.094 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.957 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.43 -17.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.82 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 111.018 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 0.8 OUTLIER -69.02 104.76 2.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.248 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -51.52 -30.1 19.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 t -73.77 -33.53 64.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.135 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 42.0 m -57.63 -29.06 64.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.662 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 7.2 tp -87.81 -57.34 2.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.263 0.554 . . . . 0.0 111.419 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -54.56 -19.51 13.67 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.843 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 30.3 tt0 -85.75 -33.54 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.274 0.537 . . . . 0.0 111.836 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -59.29 -39.39 82.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.836 HD21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.03 -48.58 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.096 0.474 . . . . 0.0 111.89 -178.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.63 -44.59 0.7 Allowed Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.201 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 151' ' ' GLU . . . 104.91 -129.84 9.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.619 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -86.78 1.15 53.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.35 -14.76 8.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 91' ' ' THR . 91.8 t -82.14 117.19 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.249 0.547 . . . . 0.0 111.124 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -77.82 -26.79 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.753 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.63 152.46 21.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.525 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.904 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.8 tp -133.26 124.69 27.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.234 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.517 ' OE1' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 54.33 37.82 28.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.027 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.12 86.31 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.876 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -111.8 134.92 21.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.22 139.28 63.48 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.156 1.904 . . . . 0.0 112.31 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.818 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.89 135.91 40.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m 60.0 169.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.24 160.37 9.88 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.499 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' OG ' ' A' ' 120' ' ' SER . 11.6 t -111.61 152.32 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.902 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -124.15 171.22 9.98 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.679 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.754 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -102.92 117.9 49.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.348 0.594 . . . . 0.0 110.539 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -61.19 144.75 53.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.836 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 12' ' ' ILE . 1.4 m-20 -48.54 -26.4 2.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.656 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.87 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.5 tt0 -57.68 -34.39 69.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 110.519 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 7' ' ' VAL . 87.7 t -66.47 -25.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.836 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -76.55 -52.2 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.979 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -54.27 -31.41 53.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.185 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 49' ' ' VAL . 26.4 t -76.03 -37.27 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.126 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -69.6 -46.89 65.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.898 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 20' ' ' VAL . 4.8 m-20 -66.62 -31.94 72.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -74.98 -46.74 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.031 0.443 . . . . 0.0 110.337 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.3 mtp -71.97 -19.39 61.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.334 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -20.66 21.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.371 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.2 t -119.03 14.36 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -59.9 112.71 1.96 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 111.163 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -121.22 147.62 45.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 80.4 p -102.16 116.87 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.19 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.0 t -115.72 -64.17 1.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -131.68 140.33 37.99 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.677 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.57 -28.75 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.104 2.536 . . . . 0.0 113.414 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.0 111.28 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.44 -37.2 44.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.696 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -60.41 -26.76 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.842 0.353 . . . . 0.0 110.127 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 19.0 ttpt -64.92 -26.11 68.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.891 0.377 . . . . 0.0 110.458 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -94.46 -10.55 32.0 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -63.22 135.54 57.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.702 0.287 . . . . 0.0 110.531 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -93.89 108.69 20.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -96.43 -30.99 13.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.871 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.89 146.05 26.05 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.963 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.947 HG21 HG11 ' A' ' 14' ' ' VAL . 2.9 m -157.6 138.24 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 11.4 mt -101.06 146.41 27.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.379 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -113.05 144.73 42.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.777 -178.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.07 172.94 12.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.231 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.57 136.68 35.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.827 0.346 . . . . 0.0 110.69 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.92 171.42 2.18 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.646 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.56 -20.4 7.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.987 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.63 -15.68 44.61 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.629 0.252 . . . . 0.0 111.297 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 3.9 tttp 55.07 32.4 18.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.997 0.427 . . . . 0.0 111.376 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -121.14 -12.5 8.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.886 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.469 ' O ' HD23 ' A' ' 40' ' ' LEU . 8.6 pt20 -142.88 174.78 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.887 0.375 . . . . 0.0 111.355 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.75 122.65 54.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.6 tt -136.62 150.47 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.785 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 14' ' ' VAL . 91.2 t -75.32 143.97 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.069 0.462 . . . . 0.0 111.341 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.58 110.82 23.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -29.37 34.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.742 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.24 61.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.922 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.8 mptt -125.39 76.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.161 0.505 . . . . 0.0 111.431 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.711 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.39 160.38 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.443 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.871 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 19.2 mt -134.91 107.73 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' OD1' ' A' ' 59' ' ' ASP . 8.1 mt -90.94 171.33 9.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.626 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.65 -24.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.969 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -83.65 -36.23 14.48 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.471 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD1' HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -57.31 -37.36 72.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.606 HD13 ' HG3' ' A' ' 67' ' ' PRO . 6.1 mt -73.28 101.74 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.681 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.17 -20.11 14.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.013 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.04 -61.13 1.59 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.575 0.702 . . . . 0.0 109.256 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -12.04 9.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.114 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 70' ' ' ALA . 43.4 t -114.37 133.61 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.57 -36.39 68.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.04 153.96 23.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.0 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.623 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 Cg_exo -71.73 -31.58 12.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.112 1.875 . . . . 0.0 111.531 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 13.6 t80 -71.54 -59.25 2.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.264 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -54.19 -34.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.369 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . . . -63.96 -42.18 97.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.583 0.706 . . . . 0.0 109.426 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.935 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.88 -39.42 72.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.441 178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' TYR . 78.6 t -61.06 -30.46 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.622 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -33.69 59.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.614 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' HG3' ' A' ' 53' ' ' LYS . 20.0 mt -79.63 -33.04 41.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.126 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.935 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 14.7 mt -55.27 114.32 6.99 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -88.39 121.64 1.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.158 1.905 . . . . 0.0 111.182 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 9.1 mt -70.54 -23.96 62.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -102.15 14.19 32.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.24 138.29 18.21 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.781 0.324 . . . . 0.0 111.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.3 m -91.19 153.0 20.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.351 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -162.63 175.93 10.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 87.0 m-85 -118.36 161.55 19.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.16 130.18 11.07 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.114 0.483 . . . . 0.0 111.693 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.33 116.06 31.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 17.0 t80 -132.28 152.1 51.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.429 0.633 . . . . 0.0 111.43 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 23.7 t70 -102.96 114.54 28.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.229 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.51 108.62 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.861 HG23 ' HG2' ' A' ' 97' ' ' GLU . 1.9 m -96.09 112.89 24.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.758 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.836 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -136.28 165.06 26.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 15.5 pt-20 -132.92 123.88 26.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.084 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.7 p -92.11 177.48 6.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -74.68 -4.06 35.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.78 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.1 -49.36 3.21 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -161.63 148.07 14.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.316 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 2.1 mtmm -77.97 134.56 37.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 160.71 39.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.66 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.861 ' HG2' HG23 ' A' ' 88' ' ' THR . 9.6 mp0 -133.29 150.42 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.758 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -153.59 175.61 13.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.538 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -128.45 144.83 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.417 0.627 . . . . 0.0 111.277 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.776 HG21 HD21 ' A' ' 153' ' ' LEU . 40.9 t -131.28 148.26 32.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.913 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.619 ' HA ' HD22 ' A' ' 84' ' ' LEU . 11.2 t80 -96.76 108.68 21.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.59 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -98.13 141.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.31 0.576 . . . . 0.0 112.04 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.498 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 7.0 t80 -117.19 106.04 12.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.299 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.759 ' CZ3' HD13 ' A' ' 75' ' ' LEU . 62.3 t-105 -89.06 110.15 20.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.73 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.63 86.51 22.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 50.2 Cg_endo -68.93 160.73 48.62 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.24 1.96 . . . . 0.0 112.474 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.68 -9.44 59.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.281 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.28 -13.68 32.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.395 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -73.54 135.96 78.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.282 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 32.4 Cg_exo -59.71 149.37 83.32 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.186 1.924 . . . . 0.0 112.182 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.27 -32.25 64.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -67.19 -22.58 65.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.113 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.0 t -84.85 -37.82 20.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -31.37 61.87 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -41.76 40.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.407 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.719 HG23 HD11 ' A' ' 40' ' ' LEU . 4.7 tt -57.62 -49.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.287 0.565 . . . . 0.0 110.679 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 29.3 m-85 -69.44 -37.77 77.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.9 64.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.948 0.404 . . . . 0.0 110.389 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 m -73.77 -32.11 63.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.514 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -94.0 -13.33 27.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.409 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -46.17 -39.25 9.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.93 -41.59 42.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 110.476 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.42 -46.48 89.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.221 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.636 HD12 HG21 ' A' ' 47' ' ' ILE . 4.4 tt -65.19 -32.95 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.892 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -32.88 39.54 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.017 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.17 -42.65 91.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.894 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 12' ' ' ILE . 28.8 mmtt -74.25 -8.63 56.88 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.001 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.1 m-85 -96.11 40.77 1.12 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.8 m -56.52 115.05 2.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.46 -10.56 26.17 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.096 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.713 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.7 tp -69.66 104.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.008 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -89.41 2.68 54.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.295 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.704 ' CB ' HG22 ' A' ' 100' ' ' VAL . 51.5 m-70 -130.56 152.29 50.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.288 0.566 . . . . 0.0 111.736 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -150.6 120.3 7.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.527 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.811 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -112.04 122.68 48.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -103.82 102.67 12.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.711 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.951 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.82 122.88 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.584 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -86.49 -45.47 11.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.11 -178.22 15.22 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.53 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' CH2' ' A' ' 104' ' ' TRP . 4.2 mt -70.99 -28.07 64.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.408 ' HA ' ' CD ' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -69.45 -16.54 63.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.609 0.243 . . . . 0.0 111.415 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.9 m-20 -85.98 -20.36 29.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.141 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.951 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.54 -18.53 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 141' ' ' ASP . 19.0 pttp -55.44 -31.29 61.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 110.77 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -65.8 104.45 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.998 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 -30.05 37.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.689 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -73.88 -33.59 64.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.8 m -58.21 -28.98 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.811 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 16.3 tp -87.65 -55.7 3.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.164 0.507 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.911 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -56.03 -20.47 27.4 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.367 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -85.67 -41.25 15.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.535 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -60.4 -31.98 70.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.799 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.87 -48.63 9.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.105 0.478 . . . . 0.0 111.193 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.24 -44.85 0.65 Allowed Glycine 0 C--N 1.322 -0.2 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.726 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.22 -124.22 8.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.732 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.84 1.04 53.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.48 -15.15 8.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.959 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 89' ' ' TYR . 92.4 t -84.45 113.75 23.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 111.314 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.71 -24.33 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.622 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 150.69 11.26 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.345 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.911 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.8 OUTLIER -133.44 127.44 33.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.997 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 57.61 29.06 16.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.976 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.72 -1.71 83.87 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.277 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -106.21 125.38 33.14 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.971 0.386 . . . . 0.0 110.638 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.99 136.8 71.88 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.116 1.877 . . . . 0.0 112.594 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.566 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.206 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' HD21 ' A' ' 166' ' ' LEU . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 166' ' ' LEU . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.11 148.15 79.3 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.77 -31.74 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -152.31 119.18 5.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.04 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 166' ' ' LEU . 5.3 m -72.07 -32.31 66.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.96 -29.94 65.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.627 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.789 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.771 0.32 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.46 155.27 36.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t 59.39 79.21 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.64 166.41 34.24 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 116' ' ' ILE . 13.6 t -109.88 152.27 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -120.5 171.42 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.535 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG23 HG21 ' A' ' 11' ' ' VAL . 10.0 p -107.25 115.24 48.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.342 0.591 . . . . 0.0 110.8 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -57.83 144.53 38.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 12' ' ' ILE . 2.9 m-20 -48.78 -25.44 1.84 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.049 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.892 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -56.59 -41.09 76.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG21 HG23 ' A' ' 7' ' ' VAL . 55.4 t -59.51 -28.28 39.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.675 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.2 mp -79.7 -49.7 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -55.34 -29.39 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.23 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.066 HG11 HG21 ' A' ' 36' ' ' VAL . 38.9 t -80.19 -35.44 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.258 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CZ ' ' HD2' ' A' ' 19' ' ' LYS . 19.8 t80 -71.61 -44.78 63.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 20' ' ' VAL . 23.2 m-20 -67.15 -31.7 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.151 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.42 -46.29 23.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.521 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.468 ' SD ' HG12 ' A' ' 14' ' ' VAL . 68.0 mtp -71.83 -19.86 61.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.537 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 15' ' ' PHE . 0.6 OUTLIER -90.11 -17.58 27.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.881 178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 20' ' ' VAL . 27.1 t -118.58 13.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 111.91 1.72 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -121.91 127.69 50.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.756 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.536 ' HA ' HD11 ' A' ' 29' ' ' ILE . 75.8 p -82.63 116.33 21.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.752 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 m -115.9 -63.74 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -131.59 138.79 33.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.576 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.71 -29.11 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.248 2.632 . . . . 0.0 113.5 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -73.91 -34.46 64.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -78.25 -37.68 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.736 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -58.28 -23.16 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.358 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' HA3' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -65.27 -28.67 69.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -94.02 -9.05 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.643 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.72 112.12 3.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.763 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -74.08 104.11 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.067 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 57' ' ' VAL . 10.9 ttmm -90.63 -28.27 18.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -150.86 141.69 22.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.066 HG21 HG11 ' A' ' 14' ' ' VAL . 2.8 m -153.54 139.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.011 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.6 mt -110.32 135.48 50.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.805 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' HG22 ' A' ' 49' ' ' VAL . 39.1 m-85 -101.63 146.17 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.652 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -138.51 172.46 12.85 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.0 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 116' ' ' ILE . 2.6 mt -81.56 136.78 35.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.926 0.393 . . . . 0.0 110.561 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -63.24 171.25 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.867 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -53.99 -20.61 6.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.11 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.29 -15.32 43.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.303 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 2.2 ttmm 55.09 32.0 17.4 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.04 0.448 . . . . 0.0 111.21 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.7 ttpt -121.4 -9.98 8.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.709 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' THR . 13.5 pt20 -142.91 174.53 10.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 124' ' ' ILE . 21.3 mm -103.89 113.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.283 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 tt -127.06 159.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.138 0.494 . . . . 0.0 111.536 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 10' ' ' GLU . 62.1 t -75.74 146.22 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.556 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 53' ' ' LYS . 59.0 mm-40 -112.66 111.77 22.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.335 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -54.25 -22.69 12.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.367 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -81.51 -17.13 49.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -126.51 75.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.088 0.47 . . . . 0.0 112.124 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.88 155.96 42.72 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.161 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 14.2 mt -135.13 110.94 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.37 0.605 . . . . 0.0 111.096 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mt -92.31 168.89 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -73.24 -28.96 26.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.724 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' HA3' ' CG ' ' A' ' 30' ' ' LYS . . . -79.57 -34.22 32.37 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.53 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.55 -40.19 74.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.9 mt -71.63 100.0 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.588 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.16 -8.72 20.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.406 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.64 -59.81 1.78 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -9.57 8.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.994 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -114.92 127.16 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 120.847 0.356 . . . . 0.0 111.412 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -72.14 -31.69 66.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.757 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.15 145.4 13.35 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 35.5 Cg_endo -71.73 -31.57 12.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.023 1.815 . . . . 0.0 111.95 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CE1' HG21 ' A' ' 72' ' ' VAL . 3.3 t80 -72.05 -58.65 3.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -54.55 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.192 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.15 98.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.493 0.663 . . . . 0.0 109.234 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.878 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.92 -39.58 76.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.516 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG21 ' CE1' ' A' ' 68' ' ' TYR . 70.6 t -62.21 -28.68 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.63 -31.58 36.5 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.314 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 71' ' ' PHE . 3.2 mt -75.45 -36.91 60.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 111.437 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.4 mt -54.94 115.24 8.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -91.78 122.34 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.667 2.245 . . . . 0.0 111.465 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.76 -25.93 64.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.99 14.14 30.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.573 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.66 135.34 15.34 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 14.9 m -89.07 155.61 19.35 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -162.49 170.75 18.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.314 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 76.4 m-85 -117.04 160.65 20.64 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.011 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.68 134.56 14.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.5 115.99 31.13 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 27.1 t80 -127.69 151.59 48.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.452 0.644 . . . . 0.0 111.189 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.6 t70 -105.55 112.51 25.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.318 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.8 108.22 17.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -96.64 110.82 23.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.883 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.32 164.22 28.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.095 0.474 . . . . 0.0 111.093 -179.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 4.3 pt-20 -138.19 123.54 19.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 158' ' ' VAL . 69.4 p -92.04 177.27 6.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -3.44 32.76 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.934 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.48 -46.08 3.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.788 0.328 . . . . 0.0 111.115 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -160.98 149.06 15.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.987 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 12.8 mtmt -85.29 137.3 33.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.159 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -143.37 157.42 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.191 0.52 . . . . 0.0 111.94 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.827 ' HG2' HG23 ' A' ' 88' ' ' THR . 16.4 mp0 -133.22 147.91 52.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.552 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.47 175.71 13.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.768 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -125.63 144.74 50.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.28 0.562 . . . . 0.0 111.023 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.841 HG21 HD21 ' A' ' 153' ' ' LEU . 39.6 t -126.97 147.82 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.681 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.562 ' HA ' HD22 ' A' ' 84' ' ' LEU . 8.1 t80 -96.73 109.71 22.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.741 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -99.82 142.23 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.258 0.551 . . . . 0.0 111.888 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 4.1 t80 -119.49 106.55 12.34 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.517 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.728 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.5 t-105 -88.67 109.59 20.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.633 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.96 86.36 21.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.02 157.5 46.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.046 1.831 . . . . 0.0 112.724 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.93 -8.67 57.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.55 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.45 -13.76 36.89 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.481 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.43 148.69 90.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.151 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.57 143.33 37.96 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.162 1.908 . . . . 0.0 111.741 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -52.13 -30.49 26.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.859 0.362 . . . . 0.0 111.272 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -69.8 -23.15 63.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.6 t -84.49 -38.17 20.44 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -31.05 62.24 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.637 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -39.52 43.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 40' ' ' LEU . 3.2 tt -60.76 -50.72 79.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.545 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 26.1 m-85 -65.77 -37.54 86.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.303 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.53 -31.48 69.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.062 0.458 . . . . 0.0 110.242 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.2 m -73.41 -33.26 64.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.88 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.524 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -91.49 -13.79 31.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -44.51 -39.34 4.78 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -42.31 56.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.839 0.352 . . . . 0.0 110.363 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.76 -51.21 70.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.224 0.535 . . . . 0.0 109.951 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -60.86 -31.25 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.153 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 12.8 ttpt -82.84 -31.6 27.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.058 0.456 . . . . 0.0 110.211 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -43.95 81.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.036 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmpt? -71.97 -10.97 60.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.917 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 131' ' ' ILE . 20.4 m-30 -93.99 44.22 1.12 Allowed 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.044 0.45 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 m -62.05 112.29 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.03 -8.7 23.21 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.611 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.4 tp -69.98 106.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.059 0.457 . . . . 0.0 110.391 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -89.6 -1.89 58.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.169 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.709 ' CB ' HG22 ' A' ' 100' ' ' VAL . 95.4 m-70 -125.47 153.71 43.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.204 0.526 . . . . 0.0 111.613 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.07 123.63 7.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.765 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -116.6 123.02 46.32 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.78 102.34 11.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.612 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -121.82 118.99 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.559 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 6.0 m-80 -81.4 -46.31 14.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.756 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -125.51 179.65 16.11 Favored Glycine 0 CA--C 1.502 -0.763 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.954 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.728 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.2 mt -65.21 -45.01 86.44 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -54.21 -21.67 9.54 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.77 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.8 m-20 -77.55 -21.45 52.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.314 . . . . 0.0 111.198 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.52 -12.22 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.01 -178.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -54.44 -31.84 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.04 0.448 . . . . 0.0 110.604 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -70.72 104.81 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.572 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -28.53 23.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.8 t -73.42 -32.69 64.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 21.6 m -58.1 -29.8 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.889 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 25.7 tp -87.77 -56.23 3.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 111.202 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.849 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.96 -18.75 34.64 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.278 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.57 -42.01 14.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.002 0.401 . . . . 0.0 111.542 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -58.22 -35.31 71.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.864 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -82.34 -48.86 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.1 0.476 . . . . 0.0 111.339 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.43 -44.93 0.63 Allowed Glycine 0 C--N 1.323 -0.188 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.075 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.72 -127.6 9.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.541 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -86.9 1.23 53.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.61 -14.81 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' HG22 ' A' ' 91' ' ' THR . 79.1 t -82.83 124.02 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.173 0.511 . . . . 0.0 111.246 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -83.37 -26.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.399 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.99 150.22 13.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.454 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.883 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.4 tp -130.73 119.32 22.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.267 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.77 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER 48.3 39.47 12.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.014 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.4 -2.62 83.31 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.508 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.3 115.5 56.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.988 0.394 . . . . 0.0 110.412 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.49 141.9 24.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.187 1.925 . . . . 0.0 112.614 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.755 0.312 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.79 150.26 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.061 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 p -79.08 -68.44 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.15 32.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.3 t -101.87 152.32 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -123.03 171.11 9.51 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.665 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.879 HG23 HG21 ' A' ' 11' ' ' VAL . 6.0 p -103.01 120.45 52.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 110.456 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.32 144.65 57.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.652 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.621 ' HA ' HD13 ' A' ' 12' ' ' ILE . 11.9 p-10 -47.79 -25.83 1.4 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.027 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 14' ' ' VAL . 6.9 tp10 -58.38 -37.11 74.59 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.301 0.572 . . . . 0.0 110.385 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.879 HG21 HG23 ' A' ' 7' ' ' VAL . 47.0 t -61.84 -27.67 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.701 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.3 mp -77.71 -50.03 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -55.21 -29.77 58.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.427 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.019 HG11 HG21 ' A' ' 36' ' ' VAL . 23.3 t -80.06 -35.77 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.503 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 7.2 t80 -72.24 -43.64 64.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 74.3 m-20 -68.02 -30.74 70.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.033 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.39 -46.85 16.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.718 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.807 ' SD ' HD23 ' A' ' 84' ' ' LEU . 78.9 mtp -70.48 -20.63 62.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HD3' HD11 ' A' ' 99' ' ' LEU . 14.4 mmmt -91.45 -18.35 24.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.681 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 20' ' ' VAL . 25.6 t -119.11 12.47 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.785 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.22 112.5 1.94 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.976 0.417 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -119.88 150.85 39.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.615 ' HA ' HD11 ' A' ' 29' ' ' ILE . 25.9 p -97.86 116.33 29.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.195 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -109.32 -67.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.686 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -131.34 141.84 43.26 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.741 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.38 -28.82 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.09 2.527 . . . . 0.0 113.306 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.34 -32.88 61.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.63 -34.36 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.1 mp -60.93 -23.75 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.366 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 19.6 ttpt -68.62 -27.95 66.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.386 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.62 -11.5 36.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.336 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -61.5 111.7 1.91 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.548 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.04 107.2 5.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.0 111.012 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HB2' HG22 ' A' ' 57' ' ' VAL . 27.2 tttt -94.58 -28.71 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.0 144.95 28.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG11 ' A' ' 14' ' ' VAL . 3.2 m -156.38 142.52 10.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.381 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mt -111.03 136.3 50.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.745 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.679 ' CD2' HG22 ' A' ' 49' ' ' VAL . 48.5 m-85 -101.71 145.34 29.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.19 0.519 . . . . 0.0 111.565 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -138.93 171.16 14.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.641 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.685 HD11 ' CG2' ' A' ' 116' ' ' ILE . 3.6 mt -80.9 137.32 36.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.806 0.336 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.32 171.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -54.73 -20.03 7.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.032 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.28 -15.55 40.34 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.605 0.241 . . . . 0.0 111.436 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 40' ' ' LEU . 11.8 ttmt 56.14 32.86 20.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.137 0.494 . . . . 0.0 111.384 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 5' ' ' VAL . 40.8 ttpt -119.26 -14.3 9.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.768 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.475 ' O ' HD23 ' A' ' 40' ' ' LEU . 5.0 pm0 -142.8 174.64 10.47 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.858 0.361 . . . . 0.0 111.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 124' ' ' ILE . 22.5 mm -101.95 118.43 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.46 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.5 tt -131.27 154.3 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.946 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 14' ' ' VAL . 52.4 t -75.49 146.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.128 0.489 . . . . 0.0 111.872 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -109.15 110.71 22.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -29.5 59.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.843 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -72.75 -19.36 61.39 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -125.8 76.32 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.288 0.566 . . . . 0.0 111.577 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.676 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.57 160.66 41.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.27 179.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.922 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 9.7 mt -133.26 118.11 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 111.21 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mt -97.91 170.18 9.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.654 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 34' ' ' LYS . 14.9 t -79.18 -24.5 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.404 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -87.22 -28.94 23.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.267 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.47 -34.94 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.603 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 4.8 mt -74.37 102.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.622 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -21.93 13.32 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.828 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -61.13 1.7 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.59 0.71 . . . . 0.0 109.351 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -11.91 8.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.205 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.47 126.23 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.404 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -69.25 -31.65 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.17 147.74 15.07 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.193 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 37.8 Cg_endo -73.48 -30.53 9.91 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.183 1.922 . . . . 0.0 111.643 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.769 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.1 t80 -72.16 -53.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.185 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.9 m -59.03 -34.6 72.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.947 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.33 99.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.57 0.7 . . . . 0.0 109.522 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.88 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.9 -41.09 71.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.294 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG21 ' CE1' ' A' ' 68' ' ' TYR . 66.8 t -62.89 -25.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.691 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -35.89 47.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.852 HD22 ' HG3' ' A' ' 53' ' ' LYS . 17.2 mt -77.55 -34.86 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.101 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.88 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.2 mt -55.5 111.4 3.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 79' ' ' ASP . 61.2 Cg_endo -91.01 122.18 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.741 2.294 . . . . 0.0 111.51 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mt -66.81 -26.05 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.023 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.06 14.06 30.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.691 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -152.68 134.63 14.79 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.388 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -88.18 157.42 18.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 110.566 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -164.44 167.46 19.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 71.5 m-85 -114.02 159.4 20.01 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -154.45 130.6 10.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.034 0.445 . . . . 0.0 112.127 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.807 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.4 tp -109.06 129.65 55.47 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.3 t80 -140.89 152.01 44.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.991 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 28.9 t70 -100.97 113.05 25.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.574 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.94 108.65 17.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.828 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.87 112.4 24.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.526 178.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.843 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.2 p90 -132.8 164.35 27.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.123 0.487 . . . . 0.0 111.338 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 0.8 OUTLIER -137.38 124.07 21.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.807 179.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 158' ' ' VAL . 66.0 p -93.68 177.44 6.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.532 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -3.36 32.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -113.52 -42.23 3.5 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 111.209 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m -160.37 163.47 33.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -94.83 132.96 39.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.961 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.73 145.19 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 112.14 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' HG2' HG23 ' A' ' 88' ' ' THR . 19.1 mp0 -133.11 142.18 48.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.266 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.2 176.42 12.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -124.69 144.84 50.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 0.0 111.02 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.854 HG21 HD21 ' A' ' 153' ' ' LEU . 43.2 t -128.06 149.28 32.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.071 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -96.91 111.12 23.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.65 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.785 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -101.91 142.89 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.67 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 3.8 t80 -121.32 106.59 11.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.047 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.689 ' CH2' HD23 ' A' ' 140' ' ' LEU . 57.5 t-105 -88.97 109.58 20.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.598 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.08 86.29 20.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.88 159.08 45.67 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.154 1.903 . . . . 0.0 112.677 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.42 -10.51 59.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.41 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.47 -12.72 48.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.87 135.79 67.24 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.239 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 148.12 79.59 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.1 1.866 . . . . 0.0 112.168 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -31.74 64.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -69.9 -19.99 63.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.279 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.9 t -85.95 -37.17 19.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.167 0.508 . . . . 0.0 109.771 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -33.26 58.81 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.253 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 51.7 mmm -73.61 -41.89 62.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.321 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.685 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.3 tt -58.92 -48.96 84.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.433 0.635 . . . . 0.0 110.513 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 20.0 m-85 -68.84 -38.17 79.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.331 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.91 -31.35 64.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.009 0.433 . . . . 0.0 110.269 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.4 m -74.6 -31.67 62.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.88 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.532 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.84 -13.58 28.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 124' ' ' ILE . 0.5 OUTLIER -46.48 -40.45 12.44 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.95 -42.45 48.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.943 0.402 . . . . 0.0 110.565 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.44 -46.04 91.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.308 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 47' ' ' ILE . 6.7 tt -66.94 -31.25 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.004 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.8 -32.37 35.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.003 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -57.69 -43.56 85.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.846 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.693 ' HG3' HD11 ' A' ' 12' ' ' ILE . 1.2 mmpp? -71.62 -11.24 60.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.806 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.727 ' O ' HG22 ' A' ' 131' ' ' ILE . 16.4 m-85 -96.39 39.31 1.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.076 0.465 . . . . 0.0 110.422 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.7 m -57.83 115.71 3.01 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.485 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.66 -10.14 27.97 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.245 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 128' ' ' PHE . 6.0 tp -69.79 105.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.001 0.429 . . . . 0.0 110.101 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -89.07 -0.87 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.229 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.737 ' CB ' HG22 ' A' ' 100' ' ' VAL . 83.1 m-70 -123.89 151.26 43.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.153 0.501 . . . . 0.0 111.307 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -152.3 119.18 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -111.53 123.67 50.69 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 102.72 11.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.94 120.48 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.81 -45.63 12.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.62 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -120.53 179.95 16.36 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.003 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.2 mt -73.46 -25.91 60.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.601 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.0 p30 -72.65 -18.2 61.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.839 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.2 m-20 -79.54 -18.15 52.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 110.6 178.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -125.62 -16.62 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.324 -177.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -53.14 -30.38 36.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 110.815 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.15 105.9 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -31.62 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.449 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 166' ' ' LEU . 5.3 m -72.08 -32.31 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.433 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 22.3 m -57.95 -29.94 65.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 22.8 tp -87.45 -56.52 3.32 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.199 0.523 . . . . 0.0 110.464 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.36 -20.43 22.42 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.277 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 1.1 tt0 -85.2 -45.76 11.71 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.938 0.369 . . . . 0.0 111.146 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 135' ' ' TRP . 12.8 mmmt -53.24 -28.34 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.854 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -90.25 -49.0 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 111.266 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.85 -45.15 0.6 Allowed Glycine 0 C--N 1.324 -0.135 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 151' ' ' GLU . . . 99.27 -131.02 10.41 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.004 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.2 0.63 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.62 -15.26 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HA ' HG22 ' A' ' 91' ' ' THR . 76.4 t -84.97 121.5 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.264 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.09 -24.37 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.739 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.42 148.71 13.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.765 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 89' ' ' TYR . 3.4 tp -128.9 122.24 29.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.123 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.789 ' OE2' HD23 ' A' ' 161' ' ' LEU . 0.2 OUTLIER 49.61 38.67 15.49 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.767 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.78 86.64 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.351 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.47 113.21 65.99 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.959 0.38 . . . . 0.0 110.489 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.68 136.67 71.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.977 1.785 . . . . 0.0 112.478 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.813 0.339 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.49 168.07 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.012 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.76 169.81 9.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.93 -165.79 30.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.41 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 116' ' ' ILE . 12.8 t -106.31 151.81 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.956 0.408 . . . . 0.0 110.787 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.33 171.49 8.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.551 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG23 HG21 ' A' ' 11' ' ' VAL . 3.0 p -101.01 120.38 50.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.315 0.579 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' ILE . 51.1 t30 -63.1 144.32 57.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.508 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 12' ' ' ILE . 47.0 m-20 -49.07 -25.25 1.96 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.337 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -58.93 -39.12 80.62 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.266 0.555 . . . . 0.0 110.479 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.616 HG21 HG23 ' A' ' 7' ' ' VAL . 59.7 t -61.29 -26.78 40.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.014 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD11 ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -77.42 -50.47 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.658 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -55.64 -31.59 62.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.047 HG11 HG21 ' A' ' 36' ' ' VAL . 41.2 t -79.11 -33.28 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.171 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.5 -46.22 55.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.2 m-20 -67.14 -30.98 71.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.978 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -76.81 -47.42 21.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.457 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.802 ' SD ' HD23 ' A' ' 84' ' ' LEU . 83.2 mtp -71.52 -20.37 62.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.307 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -90.41 -19.74 23.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 20' ' ' VAL . 28.4 t -119.19 14.8 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.631 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.87 112.29 1.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.014 0.435 . . . . 0.0 111.039 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -121.36 136.63 54.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.591 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 5.2 p -88.27 116.41 26.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.074 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -109.42 -66.97 1.01 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.801 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.2 p -131.33 139.07 34.26 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.523 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.65 -28.87 0.72 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.047 2.498 . . . . 0.0 113.429 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -33.45 61.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.441 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.07 -35.83 36.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.2 mp -57.85 -23.73 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.473 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 32.3 mtpt -65.06 -29.27 70.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.892 0.377 . . . . 0.0 110.59 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -93.08 -9.7 38.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.618 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -65.58 111.94 3.38 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.74 0.305 . . . . 0.0 110.77 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -71.24 112.87 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' HG22 ' A' ' 57' ' ' VAL . 4.6 ttpp -100.99 -28.86 12.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -148.83 144.62 27.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -158.15 140.24 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.02 HD23 ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -108.28 135.02 50.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.982 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.755 ' CE1' HG22 ' A' ' 49' ' ' VAL . 46.9 m-85 -103.47 144.63 31.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.291 0.567 . . . . 0.0 111.823 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.4 p -138.2 173.64 11.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.086 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 116' ' ' ILE . 3.3 mt -81.04 135.75 35.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -63.42 171.28 2.57 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -54.14 -20.98 7.58 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.914 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.17 -15.69 46.19 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.196 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG2' HD11 ' A' ' 116' ' ' ILE . 6.3 tttp 54.16 32.87 16.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.025 0.44 . . . . 0.0 111.418 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.2 tttt -119.79 -14.88 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 pt20 -142.53 174.32 10.74 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HD12 ' A' ' 124' ' ' ILE . 19.2 mm -101.97 114.71 42.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.921 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 tt -119.69 163.92 16.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG22 ' CE1' ' A' ' 38' ' ' PHE . 92.6 t -75.18 146.53 9.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.991 -179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB3' ' CD ' ' A' ' 53' ' ' LYS . 15.8 mt-10 -87.76 106.01 17.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.108 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -33.82 73.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.641 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.36 -9.19 51.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.901 ' HG3' HD22 ' A' ' 74' ' ' LEU . 5.6 mptt -127.67 81.64 2.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.5 0.667 . . . . 0.0 111.734 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.43 161.13 41.06 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.515 179.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 13.2 mt -135.3 113.58 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.268 0.556 . . . . 0.0 111.178 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mt -95.15 171.48 8.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.861 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -78.54 -23.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.165 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -83.68 -34.15 19.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.615 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -35.39 69.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.5 mt -75.35 102.98 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.472 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.34 -21.82 12.66 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.869 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -61.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.604 0.716 . . . . 0.0 109.267 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.38 -13.0 8.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.101 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.44 131.22 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -83.41 -27.97 29.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.96 131.38 7.44 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 23.9 Cg_endo -66.62 -31.13 41.44 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.099 1.866 . . . . 0.0 111.549 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' CE1' ' CG2' ' A' ' 72' ' ' VAL . 10.9 t80 -68.84 -57.34 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.367 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.1 m -54.81 -32.48 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.59 -42.27 95.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.516 0.674 . . . . 0.0 109.243 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.82 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.88 -40.95 75.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.224 178.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 140' ' ' LEU . 84.1 t -63.1 -26.61 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.976 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -33.4 46.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 111.053 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.901 HD22 ' HG3' ' A' ' 53' ' ' LYS . 15.8 mt -81.02 -35.94 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.163 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 18.1 mt -55.54 115.83 10.35 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -90.59 122.26 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.6 2.2 . . . . 0.0 111.969 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.45 -24.74 64.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.981 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.02 14.32 29.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.67 137.51 17.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.628 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.408 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 8.0 m -95.39 147.91 23.02 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.671 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -160.51 173.37 15.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.19 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.3 m-85 -114.64 160.2 19.6 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.79 0.328 . . . . 0.0 110.252 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.02 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -153.37 132.87 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.02 0.438 . . . . 0.0 111.886 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.802 HD23 ' SD ' ' A' ' 18' ' ' MET . 1.6 tp -109.09 130.41 55.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 14.9 t80 -143.12 152.28 41.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.308 0.575 . . . . 0.0 111.013 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 11.6 t70 -101.98 113.1 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.843 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -87.2 115.23 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.985 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.836 HG23 ' CG ' ' A' ' 97' ' ' GLU . 3.2 m -99.87 114.34 27.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.757 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -136.57 164.85 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 9.8 pt-20 -128.35 123.79 34.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.009 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 157' ' ' VAL . 17.4 p -89.96 175.11 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.758 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 159' ' ' VAL . 29.3 pttt -71.4 -7.04 44.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.152 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.93 -44.56 3.97 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.03 0.443 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 m -160.84 163.38 32.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 4.2 pttt -100.96 132.19 46.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.27 172.67 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.102 0.477 . . . . 0.0 111.779 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.836 ' CG ' HG23 ' A' ' 88' ' ' THR . 1.3 mp0 -133.58 154.64 50.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.84 175.5 13.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -128.14 145.05 51.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 111.071 179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 153' ' ' LEU . 39.9 t -130.28 149.27 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.235 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.76 108.72 21.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.446 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.747 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.4 mt -100.24 141.93 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 0.0 111.602 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 2.9 t80 -119.66 106.24 11.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.574 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.704 ' HH2' HD22 ' A' ' 140' ' ' LEU . 54.3 t-105 -88.86 109.92 20.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.644 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.22 86.38 20.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.51 159.73 48.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.043 1.829 . . . . 0.0 112.728 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.93 -8.47 58.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.394 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.64 -13.88 38.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.641 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.34 150.9 87.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.267 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.3 146.66 36.08 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.3 2.0 . . . . 0.0 112.148 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -32.06 51.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.272 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -66.22 -23.59 66.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.048 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.21 -35.79 19.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.52 . . . . 0.0 109.677 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 2.0 mttt -76.13 -29.64 57.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -40.59 24.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.251 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 40' ' ' LEU . 5.2 tt -58.44 -48.84 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.331 0.586 . . . . 0.0 110.68 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 25.2 m-85 -71.4 -36.97 71.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.537 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -55.28 -31.95 62.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.54 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.35 -31.14 57.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.863 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.544 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -90.39 -15.24 31.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.488 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -44.59 -40.63 5.92 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.88 -43.26 36.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.84 0.352 . . . . 0.0 110.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.77 -42.25 97.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.289 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.822 HD12 HG21 ' A' ' 47' ' ' ILE . 6.6 tt -70.33 -30.68 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.129 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -82.74 -30.74 28.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.863 0.364 . . . . 0.0 110.303 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -61.17 -40.8 95.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.707 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -72.35 -10.94 60.43 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.845 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 131' ' ' ILE . 14.4 m-85 -97.3 39.48 1.19 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.091 0.472 . . . . 0.0 110.385 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -55.89 115.8 2.6 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.542 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.32 27.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.31 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 128' ' ' PHE . 7.8 tp -69.99 106.02 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.11 0.481 . . . . 0.0 110.152 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -89.32 1.0 56.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.692 ' CB ' HG22 ' A' ' 100' ' ' VAL . 70.6 m-70 -126.8 153.47 45.57 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.229 0.538 . . . . 0.0 111.569 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.2 120.39 6.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.761 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.87 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.5 t90 -114.35 123.51 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 102.33 11.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.525 178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -122.25 116.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.525 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 17.3 m-80 -80.59 -47.48 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.632 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -121.4 165.37 14.4 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.724 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' CD1' HD12 ' A' ' 75' ' ' LEU . 2.0 mm? -57.18 -40.31 77.1 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 117.207 0.504 . . . . 0.0 110.042 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.439 ' HA ' ' HG3' ' A' ' 144' ' ' LYS . 6.8 p-10 -56.14 -22.71 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.599 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.795 ' CB ' HG12 ' A' ' 137' ' ' VAL . 2.3 m-20 -77.64 -16.92 58.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.073 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.935 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -127.07 -15.31 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -53.52 -32.13 49.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.859 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.34 104.82 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.355 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -29.98 27.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' HD21 ' A' ' 166' ' ' LEU . 1.2 m -70.76 -34.9 72.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.661 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 m -57.22 -28.53 62.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.657 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.87 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 24.9 tp -87.44 -54.77 4.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.218 0.532 . . . . 0.0 110.779 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.948 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -53.97 -22.19 19.28 Favored Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.252 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -85.57 -40.03 16.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.809 0.338 . . . . 0.0 111.429 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -61.89 -31.35 71.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.739 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -84.6 -48.8 9.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.139 0.495 . . . . 0.0 111.175 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.431 ' HA3' HG23 ' A' ' 158' ' ' VAL . . . -115.28 -44.43 0.67 Allowed Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.587 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 -117.91 5.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.624 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -88.02 1.56 53.9 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 91' ' ' THR . 27.1 m -96.95 -15.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 166' ' ' LEU . 61.0 t -82.45 112.65 20.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.22 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 92' ' ' LYS . 24.1 t -78.58 -21.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.641 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.09 148.41 7.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.222 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.948 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.6 OUTLIER -133.12 128.94 37.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.745 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.44 25.95 15.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.59 79.33 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.513 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -111.65 134.53 21.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.106 0.453 . . . . 0.0 110.765 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 138.57 60.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.213 1.942 . . . . 0.0 112.717 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.248 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpp . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.45 142.2 41.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.09 175.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.54 178.11 25.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.878 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 116' ' ' ILE . 43.8 t -99.56 159.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.475 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -125.57 171.32 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.09 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.888 HG23 HG21 ' A' ' 11' ' ' VAL . 4.6 p -104.54 120.27 54.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.256 0.551 . . . . 0.0 110.377 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -66.1 145.12 56.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.321 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 8.0 p-10 -45.53 -26.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.34 -40.81 78.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.32 0.581 . . . . 0.0 110.737 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.888 HG21 HG23 ' A' ' 7' ' ' VAL . 47.7 t -59.16 -27.27 35.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.999 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -79.96 -49.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.59 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.093 HG11 HG21 ' A' ' 36' ' ' VAL . 21.5 t -79.62 -35.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.3 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.86 -46.36 62.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 20' ' ' VAL . 93.1 m-20 -67.28 -29.99 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.26 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.8 -46.13 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.576 ' SD ' HG12 ' A' ' 14' ' ' VAL . 78.6 mtp -74.44 -17.42 60.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.774 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.02 -20.38 21.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 110.588 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 20' ' ' VAL . 21.5 t -118.69 15.73 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.65 111.99 1.64 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.266 0.555 . . . . 0.0 111.155 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -122.09 112.34 18.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.675 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.591 ' HA ' HD11 ' A' ' 29' ' ' ILE . 77.0 p -67.14 116.28 7.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 t -115.78 -63.55 1.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -131.66 136.94 29.28 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.676 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.8 -29.17 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.16 2.574 . . . . 0.0 113.634 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -72.72 -34.88 67.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.762 0.315 . . . . 0.0 111.231 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.11 -37.57 45.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.73 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.4 mp -59.28 -24.33 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.513 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -66.21 -27.53 68.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.0 110.389 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -93.26 -10.39 35.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.496 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -64.5 111.53 2.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.579 0.228 . . . . 0.0 110.627 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 103.73 4.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.002 0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' HG22 ' A' ' 57' ' ' VAL . 13.0 ttmm -88.8 -24.6 22.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.899 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -151.15 141.31 22.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.093 HG21 HG11 ' A' ' 14' ' ' VAL . 3.0 m -154.99 140.32 10.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.999 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 83' ' ' ALA . 2.6 mt -110.39 134.75 52.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.022 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.69 ' CD1' HG22 ' A' ' 49' ' ' VAL . 38.9 m-85 -101.78 143.97 31.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.372 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -139.26 172.73 12.4 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.7 HD11 HG23 ' A' ' 116' ' ' ILE . 4.0 mt -81.1 135.11 35.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.746 0.308 . . . . 0.0 110.519 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 48' ' ' ILE . 1.7 m -62.74 171.25 2.16 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.708 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -54.82 -20.16 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.024 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.44 -15.68 42.16 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.601 0.238 . . . . 0.0 111.399 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HD3' HD11 ' A' ' 116' ' ' ILE . 9.1 tttt 55.36 33.58 21.12 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.107 0.479 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -118.51 -16.95 9.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.721 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.585 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.5 pt20 -142.74 175.53 9.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.689 HD11 ' OG ' ' A' ' 120' ' ' SER . 23.6 mm -101.63 111.85 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.742 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 41' ' ' SER . 14.5 tt -121.92 157.17 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.033 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 10' ' ' GLU . 63.2 t -75.84 146.24 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.874 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.15 110.1 21.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.116 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.95 -31.2 49.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.161 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.88 54.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.932 ' HG3' HD22 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -120.75 76.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 112.019 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.668 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.89 154.01 40.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.871 178.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 11.5 mt -133.06 115.84 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.312 0.577 . . . . 0.0 111.046 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -96.41 168.34 10.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.22 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 32' ' ' ARG . 2.6 t -75.64 -26.4 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.291 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -86.93 -29.61 22.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.254 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.86 -36.9 84.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.67 0.271 . . . . 0.0 110.74 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 67' ' ' PRO . 3.5 mt -72.62 99.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.557 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.18 -5.0 21.94 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.21 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.3 -59.2 1.93 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 -11.05 9.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.022 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.54 141.56 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.293 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -77.12 -37.15 54.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.788 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.15 154.35 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 55' ' ' ILE . 6.4 Cg_endo -77.41 -33.19 2.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.092 1.862 . . . . 0.0 111.271 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.665 ' CE1' HG21 ' A' ' 72' ' ' VAL . 2.3 t80 -72.56 -51.33 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 91.5 m -60.09 -34.99 74.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.25 99.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.521 0.677 . . . . 0.0 109.504 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.903 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -71.59 -40.23 70.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.5 178.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.665 HG21 ' CE1' ' A' ' 68' ' ' TYR . 53.6 t -62.19 -26.96 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.166 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -82.64 -31.07 28.97 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.273 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.932 HD22 ' HG3' ' A' ' 53' ' ' LYS . 19.3 mt -77.8 -34.5 52.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 111.769 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.5 mt -55.36 116.29 11.34 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.56 122.16 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.575 2.183 . . . . 0.0 111.495 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -68.96 -25.8 64.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.851 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -99.18 14.39 29.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.84 137.5 16.92 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.73 0.3 . . . . 0.0 111.468 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 5.8 m -93.59 150.13 20.67 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.309 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -160.19 172.06 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.21 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 64.2 m-85 -114.29 160.34 19.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.439 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.967 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.52 135.67 15.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.187 0.518 . . . . 0.0 112.104 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -108.36 116.42 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 35.9 t80 -128.2 151.62 49.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.403 0.62 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 7.0 t70 -107.14 114.07 27.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.579 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -84.81 108.62 17.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.676 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.783 HG23 ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -97.25 110.41 22.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.375 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.792 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -135.04 164.95 26.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 1.2 pm0 -129.9 124.34 32.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -94.33 177.76 5.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -4.22 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.12 -47.05 3.24 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.827 0.346 . . . . 0.0 111.315 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -161.34 156.95 24.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -79.19 132.98 36.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 149.35 52.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.153 0.501 . . . . 0.0 112.092 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.783 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.5 mp0 -133.13 145.04 50.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -157.12 175.73 13.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -127.97 145.19 51.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.348 0.594 . . . . 0.0 111.158 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 153' ' ' LEU . 44.3 t -129.99 148.82 33.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.64 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 t80 -96.3 108.96 21.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.681 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.708 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.93 141.76 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 6.9 t80 -118.35 106.3 12.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.434 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.717 ' CH2' HD23 ' A' ' 140' ' ' LEU . 59.6 t-105 -88.55 109.83 20.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.621 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -137.16 86.42 20.17 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.69 160.27 44.15 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.267 1.978 . . . . 0.0 112.616 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -10.69 59.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.325 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.57 -12.73 47.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 110.96 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . . . -77.68 134.72 64.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.203 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 109' ' ' ALA . 35.5 Cg_exo -60.89 148.67 91.72 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.074 1.849 . . . . 0.0 112.195 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.431 HD13 ' HD3' ' A' ' 114' ' ' LYS . 4.5 mm? -56.23 -29.61 61.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.157 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -68.77 -21.87 64.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 t -86.22 -38.14 17.92 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD3' HD13 ' A' ' 111' ' ' LEU . 1.7 mttt -73.16 -31.17 64.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.577 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.95 -41.84 28.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HD11 ' A' ' 40' ' ' LEU . 2.7 tt -58.68 -48.68 85.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.261 0.553 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' CE1' ' HG ' ' A' ' 40' ' ' LEU . 23.4 m-85 -70.14 -37.63 75.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.758 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 114' ' ' LYS . . . -49.14 -43.86 42.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 111.154 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.7 m -68.89 -33.18 73.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 47' ' ' ILE . 6.5 p -74.89 -28.59 60.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 124' ' ' ILE . 17.0 ttpt -42.93 -42.9 3.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.937 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.6 -43.44 59.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.723 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -60.49 -45.71 92.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.191 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.64 HD12 HG21 ' A' ' 47' ' ' ILE . 5.4 tt -67.58 -31.11 51.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.958 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -80.31 -32.97 37.92 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -58.55 -42.38 87.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.725 ' HG3' HD11 ' A' ' 12' ' ' ILE . 11.6 mmtm -74.98 -7.49 53.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.972 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 131' ' ' ILE . 10.1 m-85 -96.52 41.09 1.11 Allowed 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.003 0.43 . . . . 0.0 110.955 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.7 m -58.11 110.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.287 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.67 -8.21 22.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.598 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.8 tp -70.25 105.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.144 0.472 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -89.68 0.03 57.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.306 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.769 ' CB ' HG22 ' A' ' 100' ' ' VAL . 59.5 m-70 -128.15 153.29 47.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.248 0.546 . . . . 0.0 111.531 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -152.06 121.98 7.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.64 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.796 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.6 t90 -113.97 122.34 46.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.57 102.67 12.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.684 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.937 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -123.62 120.51 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.519 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -84.1 -45.78 12.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -123.2 -178.85 15.6 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.991 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.717 HD23 ' CH2' ' A' ' 104' ' ' TRP . 8.6 mt -72.88 -25.21 61.0 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.756 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 144' ' ' LYS . 4.6 p30 -72.42 -18.53 61.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.214 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.852 ' HB2' HG12 ' A' ' 137' ' ' VAL . 25.0 m-20 -81.17 -18.1 47.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.662 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.937 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.8 -17.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -177.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -56.08 -28.06 56.13 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.137 -0.352 . . . . 0.0 110.826 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.24 104.83 2.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.455 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -30.55 41.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.439 ' HA ' HD21 ' A' ' 166' ' ' LEU . 70.7 m -72.68 -34.92 67.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.074 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.435 HG22 ' CZ2' ' A' ' 135' ' ' TRP . 20.2 m -56.28 -29.93 61.8 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.774 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.796 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 21.3 tp -87.54 -55.04 3.96 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.132 0.491 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.75 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -55.23 -21.18 24.8 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.286 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.48 -44.61 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -56.82 -29.53 62.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.974 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -87.92 -48.94 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.304 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.35 -44.84 0.64 Allowed Glycine 0 C--N 1.322 -0.203 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.614 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.76 -127.4 9.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.854 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.81 1.08 44.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.7 m -93.28 -15.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 89' ' ' TYR . 67.6 t -83.22 113.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.286 0.565 . . . . 0.0 111.273 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.78 -23.66 16.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.561 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.85 151.45 10.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.491 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 89' ' ' TYR . 1.3 tp -133.39 128.58 35.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.846 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.49 25.41 12.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.35 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.28 -0.62 68.81 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.443 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.18 129.55 23.91 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.964 0.382 . . . . 0.0 110.634 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.44 137.35 64.4 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.128 1.885 . . . . 0.0 112.622 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 147' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.21 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.77 129.07 40.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.31 -62.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.82 142.37 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.56 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.493 HG12 ' OG ' ' A' ' 120' ' ' SER . 12.6 t -120.0 153.19 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.025 0.441 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -121.34 171.38 8.79 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.738 HG23 HG21 ' A' ' 11' ' ' VAL . 7.5 p -104.79 117.56 50.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 48' ' ' ILE . 57.3 t30 -59.54 144.32 47.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.663 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.638 ' HA ' HD13 ' A' ' 12' ' ' ILE . 14.5 m-20 -48.84 -26.06 2.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.828 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -58.44 -36.25 73.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.437 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.738 HG21 HG23 ' A' ' 7' ' ' VAL . 98.2 t -63.86 -26.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.8 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.674 HD11 ' HG3' ' A' ' 127' ' ' LYS . 1.4 mp -77.59 -50.46 20.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -31.47 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.215 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.896 HG11 HG21 ' A' ' 36' ' ' VAL . 25.0 t -77.42 -37.18 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 127' ' ' LYS . 11.4 t80 -69.8 -45.98 66.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.009 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 m-20 -67.21 -30.53 70.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.096 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.67 -46.53 25.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.095 0.474 . . . . 0.0 110.588 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 81.6 mtp -73.18 -20.83 60.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.409 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HE2' HD11 ' A' ' 99' ' ' LEU . 12.4 tppt? -91.67 -17.85 24.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 20' ' ' VAL . 32.7 t -119.57 15.47 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -59.69 110.99 1.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.989 0.423 . . . . 0.0 110.943 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -122.69 108.71 13.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.654 ' HA ' HD11 ' A' ' 29' ' ' ILE . 91.7 p -62.9 115.94 4.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 t -111.31 -65.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.935 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.8 p -131.24 137.21 30.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -41.69 -28.95 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.156 2.571 . . . . 0.0 113.427 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -73.23 -33.69 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.658 0.266 . . . . 0.0 111.48 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.6 -33.08 31.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.348 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 23' ' ' SER . 1.3 mp -61.49 -26.66 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.692 0.282 . . . . 0.0 110.417 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 33.2 mtpt -64.7 -28.12 69.38 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -92.63 -11.54 33.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.532 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 136.72 58.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.726 0.298 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -92.67 103.59 15.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.0 110.803 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.636 ' HB2' HG22 ' A' ' 57' ' ' VAL . 7.3 tttm -89.23 -28.12 20.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . . . -152.97 144.73 23.56 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.896 HG21 HG11 ' A' ' 14' ' ' VAL . 2.7 m -156.54 137.99 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.018 0.437 . . . . 0.0 111.528 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 83' ' ' ALA . 9.3 mt -101.35 145.37 28.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.387 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -111.85 146.06 38.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.121 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.46 173.5 11.96 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.197 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.784 HD11 HG23 ' A' ' 116' ' ' ILE . 3.7 mt -81.71 137.78 35.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.777 0.322 . . . . 0.0 110.63 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -62.91 171.48 2.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.744 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.39 -19.7 9.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.078 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.22 -15.47 38.12 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.639 0.257 . . . . 0.0 111.424 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' HD11 ' A' ' 116' ' ' ILE . 3.7 ttpt 56.33 31.98 19.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.115 0.483 . . . . 0.0 111.458 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' VAL . 3.8 ttpt -117.99 -14.33 10.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -142.86 175.23 9.98 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.91 0.386 . . . . 0.0 111.567 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG21 HD12 ' A' ' 124' ' ' ILE . 25.6 mm -101.36 123.5 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.177 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.469 HD12 ' ND2' ' A' ' 8' ' ' ASN . 11.7 tt -139.03 152.29 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.833 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 14' ' ' VAL . 86.5 t -75.58 145.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.243 0.544 . . . . 0.0 111.398 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -106.47 111.63 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.346 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.95 -26.44 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.145 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.651 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -73.05 -19.08 61.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -128.34 77.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.07 0.462 . . . . 0.0 111.719 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HB3' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -146.45 160.42 42.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.599 179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 35' ' ' ALA . 12.8 mt -135.45 113.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.249 0.547 . . . . 0.0 111.087 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD12 ' OD2' ' A' ' 59' ' ' ASP . 7.1 mt -93.0 170.81 9.37 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.614 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 34' ' ' LYS . 13.4 t -77.89 -24.42 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.078 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . -82.34 -36.04 18.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.518 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -56.2 -37.98 70.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.003 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 67' ' ' PRO . 5.4 mt -72.59 100.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.673 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.81 -11.55 20.76 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.268 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.38 -59.46 1.73 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.65 -7.86 7.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.166 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 59' ' ' ASP . 41.2 t -114.89 124.77 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 120.888 0.375 . . . . 0.0 111.578 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.4 -33.76 74.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.12 144.75 12.96 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.482 ' O ' HD13 ' A' ' 55' ' ' ILE . 31.0 Cg_endo -69.83 -31.57 19.98 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.112 1.875 . . . . 0.0 111.75 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 72' ' ' VAL . 10.4 t80 -71.63 -59.41 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.344 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.3 m -53.55 -33.18 53.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.304 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.17 92.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.883 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -69.18 -38.4 78.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.416 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 68' ' ' TYR . 90.6 t -61.23 -32.96 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.43 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HG3' ' HG ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -77.11 -31.24 55.67 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.57 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 71' ' ' PHE . 4.7 mt -76.74 -36.41 57.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 111.603 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.883 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 17.3 mt -54.87 119.54 22.65 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -91.51 122.35 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.728 2.285 . . . . 0.0 111.638 178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 106' ' ' PRO . 11.9 mt -70.0 -24.11 63.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.74 14.18 32.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.42 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.41 138.2 17.96 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.405 ' O ' ' CE2' ' A' ' 117' ' ' TYR . 4.7 m -93.5 150.44 20.44 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.937 0.398 . . . . 0.0 110.55 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -159.68 176.09 12.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.103 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 103' ' ' PHE . 65.9 m-85 -116.25 162.06 18.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 37' ' ' LEU . . . -152.57 130.0 11.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.117 0.484 . . . . 0.0 111.882 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 101' ' ' PHE . 0.2 OUTLIER -107.63 116.31 31.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 35' ' ' ALA . 18.2 t80 -132.41 151.99 51.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.332 0.587 . . . . 0.0 111.117 -178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 31.9 t70 -101.68 115.02 29.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.344 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 153' ' ' LEU . . . -88.03 109.71 20.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.134 -178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.889 HG23 ' HG2' ' A' ' 97' ' ' GLU . 2.7 m -99.59 113.63 26.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.844 ' HB3' HD12 ' A' ' 161' ' ' LEU . 1.3 p90 -135.87 164.81 27.09 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.051 0.453 . . . . 0.0 111.227 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 7.4 pt-20 -131.42 124.37 30.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -92.95 177.55 6.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.608 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -73.24 -4.82 35.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.151 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.95 -45.33 3.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.897 0.38 . . . . 0.0 111.133 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.9 m -160.61 163.49 32.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 ptpp? -93.22 131.37 38.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.881 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 153.68 50.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 0.0 112.264 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.889 ' HG2' HG23 ' A' ' 88' ' ' THR . 3.0 mp0 -133.2 146.38 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.633 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.78 176.0 13.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD11 ' HE2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -123.62 144.58 49.52 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.622 . . . . 0.0 110.833 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 153' ' ' LEU . 38.9 t -128.72 147.53 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.647 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.671 ' HA ' HD22 ' A' ' 84' ' ' LEU . 17.5 t80 -96.62 108.54 21.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.633 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 135' ' ' TRP . 1.5 mt -97.71 141.34 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.351 0.596 . . . . 0.0 111.836 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 105' ' ' ALA . 7.9 t80 -117.31 106.38 13.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.555 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.737 ' CH2' HD23 ' A' ' 140' ' ' LEU . 61.8 t-105 -88.73 109.14 19.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.585 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 103' ' ' PHE . . . -136.84 86.34 21.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 109' ' ' ALA . 55.4 Cg_endo -70.11 160.63 48.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.204 1.936 . . . . 0.0 112.744 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.94 -9.68 59.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.309 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.5 -13.68 34.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.687 0.279 . . . . 0.0 111.451 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . . . -75.4 136.36 71.85 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.83 152.38 74.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.09 1.86 . . . . 0.0 112.084 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 112' ' ' LYS . 3.2 pp -57.54 -36.51 71.69 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.574 ' N ' HD12 ' A' ' 111' ' ' LEU . 51.9 tptt -63.28 -17.86 62.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.096 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.4 t -87.26 -39.09 15.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 109.73 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' CD ' ' HA ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -76.32 -30.82 57.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.571 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -39.82 55.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 40' ' ' LEU . 2.9 tt -59.5 -47.43 90.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.356 0.598 . . . . 0.0 110.559 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 80' ' ' CYS . 29.2 m-85 -72.21 -37.52 69.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.568 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.64 61.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.024 0.44 . . . . 0.0 110.521 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.9 m -75.31 -31.43 60.65 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.883 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -92.96 -13.97 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.355 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 124' ' ' ILE . 2.4 tttp -45.57 -42.71 11.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.93 -43.86 56.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 0.0 110.674 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.12 90.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.389 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.825 HD12 HG21 ' A' ' 47' ' ' ILE . 7.0 tt -66.45 -31.1 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.061 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -33.06 33.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.075 0.464 . . . . 0.0 110.022 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -42.19 89.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.674 ' HG3' HD11 ' A' ' 12' ' ' ILE . 37.9 mmtt -74.45 -7.9 54.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.076 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.648 ' O ' HG22 ' A' ' 131' ' ' ILE . 9.4 m-85 -96.67 41.14 1.11 Allowed 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.005 0.431 . . . . 0.0 110.351 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 m -55.43 111.27 0.84 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.828 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 114.34 -9.76 22.31 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.448 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 128' ' ' PHE . 8.5 tp -70.01 104.37 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.097 0.475 . . . . 0.0 110.029 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -91.07 5.04 50.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.42 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.682 ' HB3' HG13 ' A' ' 100' ' ' VAL . 88.4 m-70 -131.61 152.97 50.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.3 0.571 . . . . 0.0 111.487 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.82 121.33 7.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.687 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.815 ' CZ3' HD13 ' A' ' 149' ' ' LEU . 5.7 t90 -112.95 121.5 44.85 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 102.49 12.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.717 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -124.43 120.62 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.463 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.99 -46.09 12.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.689 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' CH2' ' A' ' 104' ' ' TRP . . . -124.81 179.29 16.21 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.373 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.737 HD23 ' CH2' ' A' ' 104' ' ' TRP . 6.3 mt -69.21 -27.14 65.22 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -70.12 -17.34 63.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.606 0.241 . . . . 0.0 111.229 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.81 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -85.16 -18.8 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.167 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -124.85 -18.07 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -56.6 -31.44 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB3' ' OG1' ' A' ' 148' ' ' THR . 5.7 t0 -66.72 104.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.284 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -52.29 -28.46 19.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.631 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.414 ' HA ' HD21 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -74.6 -35.86 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 145' ' ' ASP . 45.5 m -57.58 -27.4 62.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.827 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.815 HD13 ' CZ3' ' A' ' 135' ' ' TRP . 15.8 tp -87.28 -55.37 3.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.199 0.524 . . . . 0.0 110.51 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.954 ' HA2' HD13 ' A' ' 161' ' ' LEU . . . -57.24 -20.08 34.62 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.122 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -85.7 -44.32 12.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.614 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -58.22 -28.97 65.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.144 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -89.22 -48.09 7.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.075 0.464 . . . . 0.0 111.222 -179.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.93 -44.56 0.68 Allowed Glycine 0 C--N 1.322 -0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.49 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.65 -124.73 8.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.771 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -84.62 1.29 46.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.26 -15.28 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.45 112.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.333 0.587 . . . . 0.0 111.22 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.6 t -77.84 -21.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.789 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.91 150.56 9.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.234 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.954 HD13 ' HA2' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -136.03 131.96 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.92 26.9 12.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.73 -1.76 83.9 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.136 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -106.83 127.28 28.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.885 0.342 . . . . 0.0 110.682 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.35 137.53 78.94 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.148 1.899 . . . . 0.0 112.641 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 150' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.152 179.762 . . . . . . . . 2 2 . 1 stop_ save_